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Abstract 
Coleophomones, metabolites reported first in a Japanese patent in 1998 and then by 
Merck in 2000 from a Coleophoma fungus, have antifungal and antibacterial 
properties and inhibit bacterial cell-wall transglycosylase and human heart chymase. 
Their unique molecular architecture contains a cyclic tricarbonyl moiety embedded in 
an ll-membered macrocycle. In our synthetic strategy the reactive ~,~-tricarbonyl 
structure is masked as an isoxazole to allow elaboration elsewhere in the molecule. 
We have investigated two isoxazole based approaches to these targets: 1) via an 
isoxazole ring with ketone or ester substituents; and 2) via a reduced benzisoxazole. 
The formation of isoxazole building blocks for the two approaches was by nitrile 
oxide l,3-dipolar cycloaddition. Several substituted phenylisoxazole diesters were 
made from approach 1 successfully, however, the attempt for 6-membered ring 
closure failed. For approach 2, a number of benzisoxazoles with different substituted 
phenyl groups were made in moderate to good yield. The side chain additions towards 
these building blocks have also been elaborated, and the formation of II-membered 
macrocycles have been attempted by ring closing metathesis (RCM) with Grubbs II 
catalyst. 
Precursors for total synthesis of coleophomone A, B, C and D have been made. 
Irradiation reactions have been used to prepare oxime precursors for coleophomone D 
and use of co-solvent (HMAP and DMPU) was applied in the synthesis to alkylate the 
benzisoxazole ring. 
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Introduction 
1.0 Introduction 
The aim of the work described in this thesis is to approach the synthesis of the 
coleophomones and analogues by an isoxazole route. 
The coleophomones have antifungal and antibiotic activity, as they inhibit both the 
bacterial cell wall transglycosylase and human heart chymase. Coleophomones and 
analogues are molecules having a unique cyclic tricarbonyl structure embedded in an 
Il-membered macrocyc1e. 
Coleophomones A and B exist in equilibrium via an aldol interconversion, B and C 
are geometric isomers. Coleophomone D belongs to the same family but without the 
II-membered macrocycle. 
We have proposed two routes to these heterocyclic tricarbonyl natural products using 
isoxazoles. Route 1 is through an isoxazole ring with ketone or ester substituents, and 
route 2 is through a reduced benzisoxazole, but before outlining these proposals, we 
should present some more background on the natural products. 
1.1 What are Coleophomones? 
Coleophomones were first reported in a Japanese patent in 1998 on behalf of the 
Shionogi Pharmaceutical Co .. ! The three coleophomones A (1), B (2) and C (3) 
identified at this stage were isolated from a fungal broth of Stachybotrys 
cylindrospora. The fourth member of the family, coleophomone D (4) was disclosed 
one year later in another patent by the same company.2 It was isolated from 
Stachybotrys parvispora Hughes fungal broth. In 2000, a Merck research group 
published a paper describing coleophomone A and B that they isolated from an 
1 
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acetone extraction of a liquid fennentation of Coleophoma sp. (MF6338),3 which is a 
fungus isolated from an unidentified plant litter collected in the Sierra ViIIuercas 
(Spain). 
--
-
Coleophomone 1(1) Coleophomone ~2) 
""'~ 
/, 
Coleophomone q4) 
Coleophomones were proven to inhibit human heart chymase and transglycosylase in 
the fonnation of bacterial cell walls. Human heart chymase is responsible for 
converting angiotensin I to angiotensin II.4 Angiotensin IT has been suggested to have 
various important local effects on the heart tissue, which include myocyte hypertrophy 
and interstitial fibrosis that lead to pathological structural remodeIing and thereby 
predispose to ventricular dysfunction and symptomatic heart failure. 5 
Transglycosylase catalyses the polymerization of disaccharide-pentapeptide units 
I 
from lipid IT to fonn uncrosslinked peptidoglycan.6 Peptidoglycan, also called murein, 
is the primarly substance for fonnation of the bacterial cell wall, which is essential to 
the survival of many bacteria. Coleophomones A and B show weak antibacterial 
2 
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activity against aerobic bacteria. With these properties, coleophomones can be 
envisaged as antifungal and antibacterial substances, or for use to treat diseases such 
as hypertension and congestive heart failure. 
1.2 Structure offhe Coleophomones 
Coleophomones are structurally novel compounds containing a unique molecular 
architecture with a cyclic tricarbonyl moiety. They comprise a compact carbon 
framework and multiple inter-connected rings. Coleophomones A, B and C have an 
ll-membered macrocycle, a bridging carbocycle complete with a quaternary centre, a 
fused aromatic ring and an ethereal oxygen (Figure I). 
Figure I 
Coleophomones A and B exist in equilibrium and have a molecular formula C2SH260S; 
they are isomeric to each other and can be interconverted by an aldol reaction.7 
Coleophomones B and C are stereoisomers, with an E- and Z-macrocycle respectively. 
Coleophomone D does not display the ll-membered macrocycle. It exists as a 
complex mixture of isomers (Scheme 1).2 Retro-aldol ring-opening, bond rotations 
and tautomerisation of the enolised 1,3-dicarbonyl system, and aldol closure gives rise 
to this mixture of coleophomones D1-D4. 
3 
Coleophomone D1 
Aldol H 
o H~O 
Coleophomone ~ 
Aldol 
. 
-
# 
Rotation 
Tautomerization 
-::?' 
. 
-Aldol 
Scheme 1 
1.3 Outline of the Retrosynthesis 
Introduction 
Coleophomone D4 
1l Aldol 
Coleophomone Cl.J 
The aim of this project is to attempt a synthesis of the coleophomone natural products 
and analogues through an isoxazole building block. We planned to synthesise the 
building block from two approaches (Scheme 2). The first approach (Approach 1) 
involves the di-alkylation of methyl 
5-methoxycarbonylmethyl-3-arylisoxazole-4-carboxylate (5) followed by ring closure 
of a six-membered ring to achieve the building block, while the second approach 
(Approach 2) involves forming a ring-closed structure, 
6-methyl-3-aryl-4,5,6, 7 -tetrahydrobenz[ d]isoxazol-4-one (6) before alkylation. 
In this project, a key principle of our strategy is to mask the highly polar, potentially 
reactive ~,W -tricarbonyl moiety as an isoxazole until it is necessary to reveal it. This 
should allow elaboration reactions to be completed on the· non-polar core of the 
4 
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structure. 
o 
, ,C Coleophomone A B 
Wittig 
or 
RCM 
0 0 
Coleophomone D 
A 
o 
OR 
~ N 
N-O ~,1 R' N-O R' Approach 2 (11) A ~~~-. 0 A ,1 ""R" ' ,1 o OR A \1 0Me ,1 \ o n (12) 0 R' " R" 
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Scheme 2 
5 
Introduction 
The building block isoxazoles for the first and second approaches were to be prepared 
by cycloaddition of a nitrile oxide, prepared from an aromatic aldehyde oxime (7), 
with an enamine (8) derived from an acetonedicarboxylate (9) (Approach I) or a 
cyclohexane"I,3-dione (10) (Approach 2), respectively (Scheme 2). The aromatic 
aldehyde oxime (7) could have different substituent groups on the aromatic ring, 
depending on which coleophomones we are targetting. 
Approach 1 proposes cycloaddition of a nitrile oxide, prepared from an aldehyde 
oxime (7) chlorinated by N-chlorosuccinimide, with an enamine (8) derived from 
acetonedicarboxylate (9) and pyrrolidine. Alkylations will be carried out at the CS 
substituent of the isoxazole cycloaddition product (11) to give the two carbon chains 
needed in the natural product. After alkylation and manipulation, the esters should be 
closed by an aldol closure to form a 6-membered ring, thereby completing the 
isoxazole building block (12). From the building block, we propose to furnish the 
ll-membered macrocycle by joining the carbon chain from the cyclohexanone ring 
with the carbon chain on the aromatic ring, by Wittig reaction or ring closing 
metathesis; the latter is illustrated. Finally, the isoxazole N-D bond will be cleaved 
and the product hydrolysed to reform the highly reactive enolised dicarbonyl function. 
In a similar fashion, isoxazole ring formation in Approach 2 is through cycloaddition 
of a nitrile oxide with S-methylcyclohexane-I,3-dione (10) to yield the isoxazole (6) 
with an already-closed 6-membered ring. Carbon chains will be added to the CS 
carbon, followed by double bond generation at the (l,~ position. Alternatively, we can 
undertake these transformations in the reverse order by forming the double bond first 
to yield an aromatised structure (11), and then perform the alkylations. These should 
yield the same building block (12). The ll-membered macrocycle will be closed by 
6 
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Wittig reaction or ring closing metathesis as mentioned above, and isoxazole 
cleavage-hydrolysis will afford the potentially reactive tricarbonyl group. Note that 
either CS or C7 alkylated benzisoxazoles (12) are useful, as these positions become 
equivalent after N -0 cleavage-hydrolysis. 
Synthesis of coleophomone D does not require ring closure of an ll-membered 
macrocycle. The synthesis steps are the same as for coleophomones A, B and C, with 
the ring closing step omitted. We will try to compare the efficiency, yield and cost 
between Approaches I and 2, in order to figure out the best synthetic route towards 
these valuable natural products and its analogues. 
2.0 Use of Isoxazole as a Masked Dicarbonyl 
Isoxazole is often used as a masking ring for the polar di- or tricarbonyl moiety during 
a synthesis, due to its strong and broad tolerance to many reactions. 
In our project, isoxazole will be used to mask the polar tricarbonyl structure of the 
coleophomones. The use of isoxazole as a building block allows elaborations around 
the non-polar core of the molecule, with the highly reactive tricarbonyl moiety 
masked as a five-membered isoxazole ring (Figure 2). 
Tricarbonyl 
masked up by 
isoxazole 
.. .. 
Figure 2 
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The reactive groups of the structure are covered up until required. The masking 
principle can be used because the N-O bond can be easily cleaved to regenerate the 
functional groups. The use of isoxazoles in this way is well precedented. 
2.1 Isoxazole 
Isoxazole was first proposed by Claisen8 in 1888 and the name monoazole was 
suggested. It was later named isoxazole by Hantsch.9 There were two isoxazole 
compounds isolated as early as 1852,10 although the structures were not arranged 
until 1946.11•12 Many isoxazole derivatives have been shown to possess a range of 
pharmacological activities,13.14.15.16 which are of considerable interest to medicinal 
chemists. 
The isoxazole ring is numbered as below (Figure 3). The three ring positions available 
for substitution were indicated as a (alpha), ~ (beta) and"( (gamma). 
Method of Preparation 
N-O 
alpha V gamma 
beta 
Figure 3 
Isoxazole ring synthesis can be classified according to their ring closure pattern into 
the following five main types (Figure 4): two (3+2), one (3+1+1) and two (4+1) 
processes.17 
8 
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C-C C .C C C C-C C-C \ / \ I I I \C N, C N, C N, C N, C N 
0 0 0 0 0 
(3+2) (3+2) (3+1+1) (4+1) (4+1) 
Figure 4 
The (3+2) methods can be further divided into two types, the [CCC + NO] and [CNO 
+ CC] processes. These two processes involve oximation of 1,3-dicarbonyl 
compounds and cycloaddition of nitrile oxides to unsaturated compounds. An 
example of the frequently used [CCC + NO] process is condensation between 
hydroxylamine and a three carbon atom component, such as a 1,3-diketone or 
a,p-unsaturated ketone (Scheme 3).18 The method relevant to this thesis is the (3+2) 
[CNO + CC] process. 
Scheme 3 
[CNO + CC] Processes 
The most common method for constructing an isoxazole ring by a [CNO + CC] 
process is a 1,3-dipolar cycloaddition involving a 1,3-dipole and dipolarophile, such 
as a nitrile oxide with an alkene or an alkyne. 
While a nitrile oxide is used as the 1,3-dipole in the ring formation, the dipolarophile 
can be any kind of alkene or alkyne. As the nitrile oxide is highly reactive, it is 
9 
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usually generated in situ in the present of excess dipolarophile to allow immediate 
cycloaddition. The 1,3-dipolar cyc1oaddition process to fonn an isoxazole is 
~egioselective and stereoselective and is controlled by the energy difference between 
the HOMO and LUMO of dipole and dipolarophile. This will be discussed in a later 
section, where we will also look at different methods of generating nitrile oxides. 
Nitrile oxides can react with an alkene to give an isoxazoline by method a),19 and 
then to yield the isoxazole ring by further elimination or dehydrogenation. On the 
other hand, the isoxazole ring can be formed directly by reacting a nitrile oxide with 
an alkyne (Scheme 4). 
a) Reaction with alkene 
+ 
nitrile oxide Ph-C=N-O 
+ 
H2C=a-CI 
b) Reaction with alkyne 
. + 
-
Ar-C=N-O 
nitrile oxide 
[ 
N-O 1 Ph~CI -HCI -
Isoxazoline 
+ HC=C-R 
-
Scheme 4 
N-O 
Ph~ 
However, it has been shown that alkynes are much less reactive dipolarophiles2o than 
alkenes, therefore, isoxazole ring formation is preferable by reacting with an alkene 
rather than an alkyne. For example, styrene is ten times more reactive than 
phenylacetylene and methyl acrylate is six times more reactive than 
methylpropiolate?1 In the case of conjugated enynes, competition between the two 
10 
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dipolarophilic sites occurs and the products of double bond reaction always dominate 
over those from the triple bond. Furthermore, a mono-substituted bond is always more 
reactive than a disubstitufed unsaturated bond. The reaction between benzonitrile 
oxide (13) and vinylacetylene (14) is a very good example (Scheme 5),22.23 where the 
isoxazoline is the first formed product. 
(13) 
+ -
Ph-C=N-O 
+ 
H2C=g-C=CH 
(14) 
• 
N-O 
Ph~C=CH 
+ -
Ph-C=N-O 
\ • 
SchemeS 
2.2 Isoxazole Reactions 
N-O O-N 
//\/.\\ Ph~Ph 
The isoxazole ring shows some aromatic character with the oxygen atom acting as an 
electron-donating group and nitrogen atom as an electron-withdrawing group. C4 is 
the preferred position for electrophilic substitution and its reactivity is affected by the 
substitutents at C3 and CS. Electron-donating groups activate the electrophilic 
substitution, while electron-withdrawing groups deactivate it. The C3 proton is the 
most acidic proton in the ring. The N-O bond is the weakest bond among the five 
bonds and can be cleaved by some controlled reaction conditions (Figure 5). Many 
other chemical properties have been reported since the 1960s.24 
11 
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Only the C4 position of isoxazole can undergo electrophilic substitutions. It can be 
attacked by e1ectrophiles to perform several well-known substitutions, such as 
nitration, sulfonation, halogenation and chloroalkylation. 
4-Nitroisoxazole can be generated in low yield by heating isoxazole with nitric acid 
and sulfuric acid. Sulfonation of isoxazole occurs less readily than nitration, the 
4-sulfonated isoxazole being obtained only in a very low yield under drastic 
conditions with chlorosulfonic acid. 25 Nitration and snlfonation of 
3,5-dialkylisoxazoles works better than for non-substituted isoxazoles_ 26 • 27 
Halogenations and chloroalkylations always give C4 substitution (Scheme 6). 
12 
Nitration 
N-O 
V 
20 % oleum, reflu~ 
N-O y 
S03H 
Sulfonation 
Scheme 6 
Nucleophilic Reactions 
Chloroalkylatior y 
CH2CI Ac~O)3HCI' Znq 
.......... Br2, 100 -110°C 
" N-O Y 
Br 
Halogenation 
Introduction 
Nucleophilic substitutions usually occur at the C3 and CS positions. They may also 
take place at C4 with a strong nucleophile when C3 and CS leaving groups are not 
available. The 3-haIogen group can be displaced by methoxy group as a nucleophile,28 
and then hydrolysed under acidic conditions (Scheme 7). 29, 30 Nucleophilic 
substitution reactions can take place on side chains as well. 
H 
If:\ • If:\ • '/ ~ j :\ N-O MeOH N-O acid hydrolysis ~N 0 _......-, N-O X~R KOH MeO~R HO'o R O~R 
X= Halogen 
Scheme 7 
If the attacking nuc1eophile is a base, it will cause the isoxazole ring of C3 
unsubstituted isoxazoles to open (Scheme 8). 
13 
I" N-O 
:Base 9!... /J..-... 
'----- H '( -R' 
R 
Side Chain Reactions. 
• 
Scheme 8 
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Nonnally, no electrophilic reactions take place at the C3 and C5 carbons, but the side 
chains at C3 and C5 can be elaborated under basic conditions. Protons at C3 and C5 
substituents can be removed by strong base, such as LDA and BuLi. Quenching by an 
electrophile allows addition onto those side chains. C5 substituents are comparatively 
more reactive than those at the C3 position. 
Taking the reactivity of 3,5-dimethylisoxazole (15) as an example,31,32 3-methyl and 
5-methyl can be deprotonated26 to yield a carbanion and the results have shown that 
the 5-carbanion is more reactive than the 3-carbanion for electrophilic attacks (Figure 
6). 
~o . 280 times faster ~-q .ij - » -!} CH2 CH2 ~ 
C5 (15) C3 
Figure 6 
The C4 position sometimes competes with C3 and C5, depending on the pattern of the 
isoxazole substitutions (Scheme 9). Work conducted by Ross et al. 33 and Suschitzky 
et al. 34 shows some examples of these reactions. 
14 
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N-O 
R~ n-Buli, E, + R -_. I E R 8 1 n-Buli, Ez+ R=Me 
n-B~ N-O 
R~ C4 substitution occurs depending on other substituent groups 
E = electrophile El 
Scheme 9 
2.3 Isoxazole Ring Opening 
The isoxazole ring acts as a mask for highly reactive functional groups, allowing 
elaboration at the rest of the molecule in an organic synthesis. After reactions on the 
. non-polar core have been perfonned, the isoxazole can be cleaved to reveal the 
functional groups. The comparatively weak: N-D bond of the isoxazole can be cleaved 
and hydrolysed to reveal the 1,3-dicarbonyl functionality.3S 
The unmasking can be achieved by hydrogenolysis of the isoxazole to cleave the N-D 
bond. The enamino ketone or imine-enol yielded can be further converted into the 
dicarbonyl moiety by hydrolysis or diazotization (Figure 7).36 Hydrogenolysis has 
been carried out over different catalysts, such as Raney nickel, 37.38 palladium 
charcoal39 and platinum black etc.40 
... 
Hp 
-
Figure 7 
15 
Introduction 
Isoxazole ring opening by hydrogenation usually works very well, however, one of 
the disadvantages is the reduction of unsaturated bonds in the side chains. To avoid 
this drawback, other reduction reagents41 such as molybdenum hexacarbonyl,42,43,44 
samarium diiodide,45 TiCh and sodium in moist ether or ethanol46 can be a better 
choice. 
In the presence of moist Mo(CD)6, an isoxazole is transformed into a ~-enamino 
ketone followed by water hydrolysis to yield the 1,3-amino ketone. The nitrogen atom 
of the isoxazole coordinates with the Mo metal to form a complex. Although this 
complex is stable at room temperature, the N-D bond breaks down under reflux 
(Scheme 10). However, the full mechanism for this reaction is still not confirmed. 
Mo(CO)s 
t 
N-O N-O 
~ + MO(CO)6 ~ • - MO(CO)6 0 
MO(CO)6 ! II Heat 
~\ Mo(CO)s t 
NHO HP :N 0 ~ • 1-)) 0 
beta-en amino ketone 
Scheme 10 
Cleavage with Smh involves electron transfer; and a radical anion is formed as an 
16 
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intennediate (Scheme 11). An excess of reagent, about 2 equivalents, is needed for the 
ring opening using Smh 
. .. 
N-O Jlf NH2 0 +e HyH V • H 0 H • 
H H 
radical anion 
Scheme 11 
Other less common ring cleavage methods included deprotonation by base at C3 
position, which has been mentioned before and ozonolysis.47 Instead of breaking the 
N-O bond, ozonolysis open the isoxazole ring at the double bond between C4 and CS, 
so is not relevant to the unmasking strategies. 
3.0 l,3-Dipolar Cycloaddition 17,57,58,59 
Cycloaddition reactions are commonly used in organic synthesis to assemble four, 
five and six membered heterocycles. The three most important types are a) 
Diels-AIder reactions, b) [2+2] cycloadditions and c) 1,3-dipolar cycloadditions 
(Figure 8). 
17 
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a) 
B-;;A E B ..... A'E I 
11 • 11 1 Oiels-Alder c~ C ... O ..... F 
A=B A-B b) I I [2+2] cycloaddition • C-O C=O 
+ ~B, - B 
c) A C • A..... 'c 1 ,3-dipolar cycloaddition \ , 
O=E O-E 
Figure 8 
The 1,3-Dipolar cycloaddition is one of the most efficient methods of making 
five-membered rings. It is related to the Diels-Alder reaction, a [41t + 21t] process, 
with the 41t-electron component as a 1,3-dipole rather than a diene.48 To create a 
five-membered ring by cycloaddition, a three-atom, four-electron 'diene' is required, 
which is called a 1,3-dipole (a_b_c),49 and a multipl~ bonded two-atom section, the 
dipolarophile (d-e) (Figure 8). The 1,3-dipole and the dipolarophile can be two 
molecules reacting in an intermolecular fashion or two parts of the same molecule 
reacting in an intramolecular process. 1,3-Dipolar cyc1oaddition can account for the 
stereo- and regio- selectivity of the products formed. It goes via a 61t-electron 
aromatic transition to yield the five-membered heterocyc1e. 
18 
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• 
The isoxazoles in this project were made from nitrile oxide cycloaddition, which is a 
1,3-dipolar cyc1oaddition reaction, using a dipole derived from an aldehyde and an 
enamine as dipolarophile. 
3.1 The 1,3-DipoJe 
A 1,3-dipole is a three-atom fragment, (a-b-c) in which can be presented in two 
canonical forms, sextet and octet. The sextet has six electrons in the outer shell of 
atom a, while the octet has eight electrons. An atom with six electrons in the 
outermost shell would be unstable, therefore, the 1,3-dipole usually has more than one 
resonance form and the octet form is drawn as the the preferred form. 
There are two main types of 1,3-dipolar compounds. Type 1 has a 1,3-dipolar 
canonical form, which has a double bond between atom a and b on the sextet form 
and a triple bond on that atom in the octet resonance form, and a central sp-hybridised 
atom (Figure 9). This type of 1,3-dipole is linear and is also known as the 
propargyl-allenyl type. 
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sextet form 
+ 
Type 1 a=b-c • 
sp-hybridised 
Figure 9 
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octet form 
+ 
a b-c 
Type 2 has a dipolar canonical form, which has a single bond between atom a and b in 
the 1,3-dipolar sextet form and a double bond between these atoms for the octet form 
(Figure 10).50 Molecules of this 1,3-dipole type have a central Sp2 -hybridised atom. 
They are bent and are called the allyl anion type. 
Type 2 
sextet form 
-c 
1 
+a/~ • • 
sp2-hybridised 
Figure 10 
octet form 
-c 
+1 
r=~ a 
The possible elements for atom a, b and c are suggested in the following table (Table 
1). 
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Atom a Atomb Atomc 
Type 1 C,N N only C, N, 0, S 
Type 2 C,N,O N,O, S C,N,O 
Table 1 
Examples of some common 1,3-dipolar intennediates are shown in Figures 11 & 12 
below. 
Common Type 1 1,3-dipoles 
+ + 
R-N-N=N 
-
R-N-N=N Azides 
+ - + 
R2C-N=N -
R2C-N=N Diazo compounds 
+ + 
O-N=CR 
-
O-N CR Nitrile oxides 
+ - + 
R-N-N=CR 
-
R-N-N-CR Nitrile imines 
+ + 
R2C-N=CR - R2C-N=CR Nitrile ylides 
+ + 
S-N=CR • • S-N=CR Nitrile sulfides 
Figure 11 
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Common Type 2 1,3-dipoles 
-NR" - NR" 
1 1+ 
,N, + 
-
,N, Azomethine imines 
R CR' R 'CR' 
yR2 
-CR2 1+ 
N,+ 
-
N, Azomethine ylides 
R"/ CR' R"/ 'CR' 2 2 
0 -0 
1 1+ 
N,+ N, Nitrones 
R'/ CR - R'/ 'CR 2 2 
+ 
- 0 + - 0 Carbonyl ylides R' C" 'CR 
-
R'2C" ~CR2 2 2 
+ 
- s + - S Thiocarbonyl ylides R' C .... 'CR 
-
R' C .... ~CR 2 2 2 2 
+ 
- 0 + - 0 Ozone 0.... ....0 
-
0 .... ~O 
Figure 12 
The 1,3-dipoles used in our experiments contain C, N and 0 atoms. They are called 
nitrile oxides and belong to type 1 in the categories mentioned above. They have an 
electrophilic end and a nucleophilic end (Figure 13). 
Type 1 
Nucleophilic end 
.(J, 
+ 
R-C-N-O 
is 
Electrophilic end 
Nitrile oxide 
Figure 13 
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3.2 The DipoJarophile 
A dipolarophile is a two-atom 21t-electron unsaturated compound (d-e), which is not 
limited to an alkene or an a1kyne. Many other multiply bonded structures containing 
elements other than carbon can be dipolarophiles (Figure 14). 
R-C----X-R' 
sp or sp2-hybridised 
Figure 14 
Examples of some common dipolarophile units are shown in (Figure 15) below. 
Common dipolarophile functions 
C=C Alkene 
C==C Alkyne 
C=N Diazo 
C=N Nitrile 
C=O Carbonyl 
C=S Thione 
Figure 15 
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3.3 FMO Theory and Mechanism of l,3-Dipolar Cycloaddition 
A 1,3-dipolar cycloaddition involves the formation of two cs bonds from one It bond 
and one lone pair.51 During the cycloaddition the lone pair from atom c forms a cs 
bond with the dipolarophile, while the It bond of the dipolarophile forms a cs bond 
with the dipole atom a, moving the It bond between a and b towards the positively 
charged central atom b (Scheme 13). 
-c0 
I '" 
" +b ....... , 
t. III 11 ~ -----0 .. -
b-c 
'U~ /a R 
~ bonds formed 
Scheme 13 
The success of the reaction depends on the favourable interaction between a filled 
It-orbital of one reactant and an empty It·-orbital of the other. This interaction must be 
sterically feasible and the orbitals must be of the correct phase for interaction. 52 The 
smaller the energy gap, the stronger is the interaction and the higher the reactivity. 
The reactivity can be explained by the energy difference between the FMOs (Frontier 
Molecular Orbitals). The HOMO (Highest Occupied Molecular Orbital) and LUMO 
(Lowest Unoccupied Molecular Orbital) of the 1,3-dipole interacting with the LUMO 
and HOMO of the dipolarophile, respectively (Figure 16),48 are the key FMO 
interactions considered. 
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LUMO 
1,3-dipole 
dipolarophile 
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LUMO 
HOMO 
The electrons involved in the new Cl bond fonnation come from the HOMO because 
they are the least tightly held and thus most reactive. 53 
1,3-Dipolar cycloadditions can be classified into three types, depending on the 
relative disposition of the FMOs of the 1,3-dipole and dipolarophile (Figure 17). 
HOMO~controlled reactions (Type I), are those in which the interaction of the dipole 
HOMO with the dipolarophile LUMO is greatest. LUMO-controlled reactions (Type 
2), are those in which the interaction of the dipole LUMO with the dipolarophile 
HOMO is greatest. And HOMO-LUMO-controlled reactions (Type 3), have both the 
FM 0 interactions as significant. 
Electron-donating substituents in a dipole, which raise the dipole HOMO energy, or 
electron-withdrawing substituents in a dipolarophile that lower the dipolarophile 
LUMO energy, accelerate Type 1 reactions. In contrast, electron-withdrawing 
substituents in a dipole which lower the dipole LUMO energy, or electron-donating 
groups in a dipolarophile that raise the dipolarophile HOMO energy, accelerate Type 
2 reactions. Type 3 reactions will be accelerated by an increase of either FMO 
interaction. S4 
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Type 3 
Type 2 Type 1 
dipolarophile dipolarophile dipolarophile 
dipole dipole dipole 
~ X ! , . , . -- -- , ~~:~---~X------------ -------------t-*---
. '-H- *~ ~ 
.~ 8-£ 
HOMO dipole-
LUMO dipolarophile 
dominant 
No dominant 
interaction 
Figure 17 
LUMO dipole-
HOMO dipolarophile 
dominant 
1,3-Dipolar cycloaddition reactions involve a 41t-electron dipole and a 21t-electron 
dipolarophile through a 67t-electron transition state. However, it is as yet impossible 
to generate a direct mechanistic proof for this cycloaddition, therefore, this type of 
reaction has been considered as a ''no mechanism" reaction. 55 Several mechanisms 
have been suggested, and these include a concerted or stepwise process. 56 
The concerted mechanism was proposed by Huisgen,57,58 which involves a cyclic 
five-atom transition state. The 47t electrons of the 1,3-dipole interact with the 7t bond 
of the dipolarophile in the transition state. The mechanism is usually drawn as below, 
(Figure 18) for nitrones and nitrile oxides. 
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, ' \") : I , 
. , 
, , 
r=\ 
R R' 
• 
• 
Figure 18 
. N-O 
Jl J--R, 
Ph .... \" 
R 
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An alternative stepwise mechanism was suggested by Firestone,57.58 who proposed 
that the cycloaddition involves a biradical intennediate or a zwitterion (Figure 19). 
diradical 
+ 
[R)5] 
R-C-N-O N-O 
+ 
-
or 
- RN [RY5] 
zwitterion 
Figure 19 
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There are possible stereo- and regio-isomers fonned from 1,3-dipolar cycloaddition 
(Figure 20). Selectivity usually favours one of the isomers over the others. 
Stereoisomers 
R1>=<R3 
R2 R4 
• 
+ 
-;-Y" -X z 
Regioisomers 
• 
A=B 
+ 
+ 
Figure 20 
The stereochemistry of the products depends on the geometry of approach of the two 
components of the 1,3-dipolar cycloaddition, with endo and exo transition states being 
possible. The configuration of the dipolarophile is usually retained, which is strong 
evidence in favour of a concerted one-step mechanism. 
The stereochemical issue does not apply in the case of nitrile oxides reacting with 
enamines to fonn planar isoxazoles in our proposed synthesis. In this case, the focus 
is on the regiochemistry. Regioselectivity is a result of small energy differences 
between two regioisomeric transition states. 
Consider the addition of diazomethane (16) to methyl methacrylate (17) as an 
example. The interaction between HOMO of dipole and LUMO of dipolarophile is 
dominant in this cycloaddition. The coefficients at C3 and C4 are larger than the other 
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end of the fragment for both 1,3-dipole and dipolarophile, respectively. Therefore, the 
larger coefficients interact with each other to yield the isomer A as a major product 
(Scheme 14). 
(16) r~ + /.N - HOMO ~:) ~:)<Me NO:::- 'C3 
Me>=C4 ---
• N C02Me 
Me02C Me~ LUMO Me C02Me 
(17) Me02C A B 
Scheme 14 
In organic synthesis, 1,3-dipolar cycloadditions are used to generate heterocyclic 
structures as part of the target product or (as in our proposals) as a masking ring for 
sensitive functional groups. Another well-known 1,3-dipolar cyc1oaddition is 
ozonolysis, in which ozone is the 1,3-dipole reacting with a dipolarophile alkene to 
result in cleavage of the alkene. 
4.0 Nitrile Oxides 
Nitrile oxides have been known for a long time, and their applications are still under 
investigation. Nitrile oxides are generally not stable towards moisture and therefore 
are prepared in situ. The two 1t bonds formed between the C and N atoms of the nitrile 
oxides restrict their configuration to linear (Figure 21). 
Ph.O 
linear 
Figure 21 
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4.1 Formation 
There are four common methods to generate nitrile oxides: dehydrohalogenation of 
C-halogenated oximes, dehydration of nitroalkenes, thennolysis of furoxans and 
oxidation of a1doximes.59 
Dehydrohalo~enation of Hydroximoyl Chlorides 
In 1894, Wemer and Buss 60 introduced the dehydrohalogenation method. Ibis 
method involved two steps, starting from an aldoxime. Aldoxime (18) can be 
C-halogenated by different halogenating agents, such as N-chlorosuccinimide, 
N-bromosuccinimide, chlorine or t-butyl hypochlorite to give an a-haIonitroso 
compound (19) that tautomerises to a hydroximoyl chloride. Ibis compound can be 
isolated but it decomposes gradually in air. The halogenated oxime (19) obtained then 
undergoes dehydrohalogenation to yield nitrile oxide (20) in situ. A base like 
triethylamine or pyridine is usually added slowly as a dehydrohalogenating agent. An 
example is shown below (Scheme 15) 
-
..... OH ..... OH E~N + ..... 0 J NCS N N .. RACI .. )1 R H R 
(18) (19) (20) 
Scheme 15 
The two steps mentioned above can be combined into one-pot by skipping the 
isolation of halogenated oxime. 
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Dehydration of Nitroalkanes 
This is an effective one-step reaction for both aromatic and aIiphatic nitrile oxide 
formation. Hoshino and Mukaiyama 61 introduced phenyl isocyanate (21) and 
triethylamine as the dehydrating agent for nitroaIkane dehydration in 1960. The 
mechanism is as below (Scheme 16). 
O=C=NPh 
(21) 
• 
Scheme 16 
Di-tert-butyl dicarbonate (Boc20) can be used instead of phenyl isocyanate, which 
leads to respective N- or O-tert-butoxycarbonyl (Boc) protected products. The 
byproducts resulting from this reaction are readily separable from the nitrile oxide 
cycloadducts.62 
Thermolysis of Furoxans 
Nitrile oxides dimerise to yield furoxans (22) as a stable heterocyclic product.63 In 
reverse, nitrile oxides can be regenerated under thermal conditions (Scheme 17).64 
Preferably, the nitrile oxide is generated in the presence of dipolarophiles to avoid 
re-dimerisation. One of the drawbacks from this method is the rearrangement of 
nitrile oxide at high temperature to give isocyanate (23). 
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.1)+ R rN-O-R-N=C=O .... ....-- c 
heat heat 
(23) R 
(22) 
Scheme 17 
Oxidation of Aldoximes 
Oxidation of aldoximes to approach nitrile oxides is carried out using different 
oxidising agents in mild conditions. The commonly used reagents are manganese 
dioxide, 6S lead tetraacetate,17 chlorobenzotriazole 66 and diammonium 
hexanitratocerate. 
Summary of Nitrile Oxide Formation 
X=Halogen 
Dimerise 
/ 
+ R-C=N-O 
Nitrile oxide 
! 
• 
A-S 1,3-D~ 
cycloaddition ,N-O 
If ~k R~A" 
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4.2 Regioselectivity of Nitrile Oxides 
For an electron-rich and conjugated dipolarophile, the dipole LUMO is in control and 
leads to a CS substituent from a mono-substituted dipolarophile. For an 
electron-deficient dipolarophile, a HOMO-LUMO control is dominant, the 
regioselectivity is decreased and a mixture of C4 and CS substituted product is 
obtained from mono-substituted dipolarophiles (Figure 18).57 
electron-rich 
! 
N-O C5 ii '-~'R' Ph~ 
electron-cieficient 
! 
It) ,+ 
Ph .... \' C4 
R 
Figure 18 
Ph 
~ \C5 N-R' 
However, comparing the effect from number of substituents, the effect of 
electronegative substituents is much smaller. Research shown that mono-substituted 
aIkenes tend to give CS substituted isomers as the predominant regioselectivity. 1bis 
fact is backed up by the FMO calculations.67 
Cycloaddition of nitrile oxides to 1,2-disubstituted alkenes may give a mixture of two 
regioisomers. The dominant regioisomer depends on the substituents present, however, 
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the predictions from FMO calculations do not apply to every single case. Taking the 
acetal (24) and thioacetal (25) substituent as an example (1), the FMO calculation 
predicts isomer A (C4) as the major product. However, it failed to predict the major 
product for the thioacetal. The result is in reverse of the prediction, as isomer B (CS) 
is afforded as the major product (Scheme 19).68 One explanation for this result is 
steric interaction between the phenyl group and bulky sulfur groups, which increases 
the energy of transition state for isomer A, therefore yielding isomer B. 
Example 1 
+ -Ph-C=N-O 
. X\ +~X)-
A B 
(24)X=O 68:32 
(25)X=S 17: 83 
Scheme 19 
Another example (2) is with carbonyl substituents. FMO calculation predicts the 
fonnation of C4 amide isomer (A) as the major product for tertiary amides (27). A 
contrasting result is obtain, CS isomer (B) is generated as the major product (Scheme 
20). The calculation by density functional theory (OFT) suggests a repulsion force 
caused by the phenyl group of the nitrile oxide and an ethyl group from the amide 
sterically disfavours the C4 transition state.69 
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+ -Ph-C=N-O + ~-Ph~+ r~O 
A 
(26) Y = H 
(27)Y= E~N 
B 
Scheme 20 
81: 19 
12: 88 
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TI~O Y Ph o 
Other factors such as hydrogen bonding may also alter the regioselectivity of 
cycloaddition reactions. 
5.0 Previous Synthesis 
The unique structure of coleophomones has drawn the attention of several organic 
chemists, especially after the potential use as hypertension and congestive heart 
failure drugs was realised. There are papers published in the last few years about 
synthesis toward the target product. 
5.1 Nicolaou's Synthesis7o,71 
Nicolaou approached the synthesis of coleophomones A, B and C by a different 
approach to our proposal. They started with a commercially available phenol (28), 
which was transformed into acetonide/primary alcohol (29).72 The primary alcohol 
(29) was protected as its para-bromobenzoate ester, the protecting group chosen for 
easy crystallization due to the para-bromobenzoate group. The acetal group was 
removed by p-TsOH, followed by Mn02-mediated benzylic oxidation to generate the 
phenolic aldehyde (30). K2C03 was used to alkylate the phenolic aldehyde (30) with 
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3-bromo-2-methylpropene. The resulting aldehyde was then converted into its acyl 
cyanide congener (31) by Nagata's reagent followed by PCC oxidation to yield (31). 
Compound (31) was coupled with bisalkylated 1,3-cyclohexanedione (32), in the 
presence of triethylamine and 4-DMAP to yield the fully substituted precursor (33). 
4-DMAP has a crucial role as an additive in the acyl cyanide coupling reaction. 
Bisalkylated 1,3-cyclohexanedione (32) was made from a four-step protocol starting 
with 5-methyl-l,3-cyclohexanedione (34). Dione (34) was refluxed in methanol with 
catalytic amounts of concentrated H2S04,73 and then alkylated by prenyl bromide in 
the presence of LiHMDS. The second alkylation with prenyl bromide was achieved 
slowly using LDA as base (Scheme 21). 
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• 
(28) 
OXO 
C< a) Et,N, 4-0MAP I ~ p-BrBzCI. h b) p-TsOHH20 c) Mn02 (29) OH 
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..... H 
(30) 
p-BrBzO 
I ) If CO I b) EIzAICN 
+ a ''2 3' ~Br c) PCC 
p-BrBzO 
(33) 
• 
(32) 
Et,N, 4-0MAP 
p-BrBzO 
(31) 
o 0 c) LOA, HMPA, 
prenyl-Br ~a) MeOH, H,S~. • b) LiHMOS, o prenyl-Br MeD • d) 1M HCI 
(34) 
Scheme 21 
(32) 
The core structure of coleophomones was made up to this stage. To furnish the natural 
product, substituted precursor (33) was protected using diazomethane, to yield a 
mixture of three products (35), (36) and (37), Two of these protected precursors (35) 
and (36) were subjected to ring closing metathesis by Grubbs II catalyst to furnish the 
ll-membered macrocycle, The ring closed products E- (38) and Z- (39) were brought 
through a one-pot phenylselenide formation/oxidation/syn-elimination sequence to 
afford the a,p-unsaturation in (40) and (41). The para-bromobenzoate ester was 
removed by methanolic potassium carbonate solution to approach (42) and (43). 
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Alcohol (42) was oxidized using Mn02 to afford colephomone B, while (43) was 
oxidised using freshly prepared CoIlins reagent to yield coleophomone C (Scheme 
22). 
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p-BrBzO (35) 
p-BrBzO (38) 
I Grubbs' 11 cat, 
• DCM,40OC 
! .) UHMDS, PhSeCl; aq H20Z 
p-BrBzO (40) ~ b) K,CO" MaDH 
HO 
(42) ~ c) MnO~ Et,O, 360C 
coleophomone B 
p-BrBzO 
.) CH,N, 
I 
? p-BrBzO M. 
p-BrB..o 
(36) I Grubba' 11 ca~ 
• DCM,40OC 
! .) UHMDS, PhSeCI; aq H 20z 
p-BrBzO 
MaO 
(41) I t b) K,CO" MaOH 
HO 
(43) ~ d) CrO,.2py, DCM 
coleophomone C 
Scheme 22 
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p-BrBzO 
(37) 
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Nicolaou has also tried synthesising coleophomone A from coleophomone B 
according to the information in the report from Merck, which stated that 
"coleophomones A and B exist in equilibrium with each other under physiological 
conditions".3 
Starting from (33), the para-bromobenzoate group was removed by K2C03 and the 
alcohol oxidised using manganese dioxide to afford a mixture of two isomeric 
products (44) and (45) (1:1.6). Alcohol (45) was oxidised using cr03"2py (Collius 
reagent) to give (46), which was ready for ll-membered macrocycle formation. 
Various olefm metathesis conditions have been tried but the II-membered macrocycle 
ring closure was unsuccessful and therefore, the synthesis of coleophomone A was not 
completed (Scheme 23). 
40 
o 
p-BrBzO (33) 
i 
t 
• 
c) Crq,·2py, 
DCM 
Scheme 23 
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9 % (44) 
Nicolaou has also tried the total synthesis of coleophomone D. Starting from 
l,2-dimethylanisole (48), an aldehyde (49) was made by a radical tribromination, and 
elimination under acetolysis. This aldehyde (49) was then treated with Nagata's 
reagent to afford cyanohydrin (50) as a major product and its regioisomer (51). The 
mixture of (50) and (51) was oxidised by PCC to yield the acyl cyanide (52). 
Acylating agent (52) was put forward to couple with (53) in Et3N to afford the 
precursor (54), which was reacted with methanolic K2C03 to remove the acetate 
protecting group. The deprotected precursor (55) was then oxidised by Mn02 to give 
coleophomone D (Scheme 24). 
41 
4 prenyl-Br a) MeOH, t1S0 ! b) LiHMDS, 
MeO 
c) LDA, HMPA'l 
prenyl-Br V 0; 
MeO 51 % (50) 
d) LDA, HMPA, I e) LiOH, MeOH:H,O (2:1), 8IYC 
PhSeCI; 1-I.!°2 ~ V 
. O.JJ 
o 
O .... H .... O 
Coleophomone D 
83% 
j) Et,N, THF 
O .... H .... 
94 % (55) 
Scheme 24 
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(48) 
I f) NBS, cq, tungsten lamp 
~ g) CH"COONa, acetic acid 
te../"...OAC u. ... u (49) 
CHO 
1 h) E~ICN, toluene, IYC 
OH + 
CN 
Me 
OAc 
CN 
H 59 % (51) ! i) PCC, DC M, 4CYC 
o 
OAc (52) 
CN 51 % 
1 
O .... H .... O 
80 % (54) 
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The coupling reactant (53) was made from 1,3-cyclohexadione (34). It was treated 
with a catalytic amount of concentrated H2S04 and then alkylated by prenyl bromide 
in the presence of LiHMDS. The second alkylation was performed with LDA and 
HMPA to afford (57). With the key additive HMPA, (57) was again reacted with LDA 
and PhSeCI to afford the phenylselenyl intermediate, which was oxidised by H202, 
and hydrolysed in a special protocol using LiOH in methanol-water, to yield the 
desired coupling block (53). 
5.2 Suzuki's Synthesis74 
A fungal metabolite was reported by Shionogi researchers as a coleophomone-related 
fungal metabolite and its relatively stable derivative, ammonia adduct (58) was made. 
Suzuki was trying to synthesise this ammonia adduct (58) and the biosynthetically 
expected structure (59), using an isoxazole route. This allows direct access to the 
cyclic structure. 
OH 
o 
OH 
OMe 
.... 00 
.~\ 
Reported ammonia adduct (58) Biosynlheticallyexpected structure (59) 
Starting with aldehyde (60)75, it was converted into a dioxolane followed by treatment 
with t-BuLi and DMF to yield a protected aldehyde (61). Compound (61) was made 
into an oxime and then the nitrile oxide by hydroxylamine hydrochloride and NCS. 
The corresponding nitrile oxide (62) was condensed with 1,3-cyc1ohexadione (34) to 
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yield the fused isoxazole (63). The isoxazole (63) was aIkylated by prenyl bromide in 
the presence of LDA and HMPA. A second alkylation was carried under the same 
conditions resulting in a di-aIkylated precursor (65). A phenylselenyl group was added 
affording (66). The isoxazole ring was opened by MO(CO)6 at this stage by a selective 
reduction of ouly the N-O bond. Subsequent oxidative C-Se bond 
cleavage-elimination was achieved by H202 oxidation to give the unsaturated 
vinylogous amide (67). The targeted cyclic aminaI (59) was obtained upon removal of 
the acetal with aqueous HCl (Scheme 25). 
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r'-, . (l 
o. ,0 00::0 + 0 (£ c) NH,oItHCI, K,Co. 4-N~ '" H • '" I d) NCS, pyrtdine I,,:; 
,,:; OMe OMe 
(62) 
H 0 O a) l,3-propanediol, CSA '" . I b) t-BuLi, Et,O, ,,:; OMe then OMF 
(60) (61) + 
o;:\~1 
1 e) Et,N 
g) LOA, prenyl-Br, I 
THF:HMPA + 
(65) 
t) LOA, prenyl-Br, 
THF:HMPA 
-
-
h) LOA, PhSeBr, 
THF:HMPA 
(66) 
Scheme 25 
\ 
r 
i) Mo(C01 
-
I 
j) aq H,O, ~' 
k) aq HCI I (67) 
OH 
(59) 
The reported ammonia adduct (58) was also made by a similar method. It started with 
2-methoxybenza1dehyde (68), brominated 76 to serve as starting material for the 
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preparation of aldehyde (70). It was then converted into nitrile oxide, condensed with 
(34) and then alkylated and ring-opened as stated previously for the biosynthetically 
expected structure, to yield (58) (Scheme 26). This sets out a general approach 
towards coleophomone-related structures that was published as we began our 
programme, and acts as good precedent for our own studies. 
~ 
(68) 
f) LOA, prenyl-Br, 
THF:HMPA 
g) LOA, prenyl-Br, 
THF:HMPA. 
() 
H 0 
'"'''. "15-""" a) 1,3-propanediol, CSA J)50Me ___ •• H I~ b) t-BuLi, E~O,· ,& 
then OMF (70) 
(69) 
~ ~ OMe 
! 
(73) 
c) NH.OHHCI, ~C03 ! 
d) NCS, pyridine, 
OCM 
e) ElaN, Et0;iH' 0 <> +~() 
, 50
o
C 0 'N 
. + ~ ~OMe 
1,& 
(34) (71) 
h) LOA, PhSeBr, 
THF:HMPA 
i) Mo(CO~ 
j) aq H.02 
k) aq HCI 
Scheme 26 
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Result and Discussion 
6.0 Result and Discussion 
We are aiming to syntheses the coleophomones and analogues by an isoxazole route. 
The very reactive polar tricarbonyl system seen in the coleophomones is masked by 
the isoxazole ring in the synthesis process, allowing elaboration of the rest of the 
molecule to be achieved. 
At 
R=OMe approach 1 
r-O 1# R o R 
(5) 
N-O R' -~: 
o RO 
,OH 
) (7) 
o 
N 0 (8) ~OMe 
aAoMe 
t 
Jl)lJl (9) 
MeO OMe 
approach 2 
N-O R' _Ar~" -
o 
(12) 
isoxazole building block 
1 
N-O Ar~11 
HO 
+ O~(10) 
,OH 
) (7) 
To achieve our target isoxazole building block (12), we proposed two routes. 
Approach 1 is through cycloaddition of a nitrile oxide, prepared from an aldehyde 
oxime (7), with an enamine (8) derived from an acetonedicarboxylate (9) to generate a 
diester (5), and the 6-membered ring will be closed by aldol closure after alkylation 
and manipulation. Approach 2 is through cycloaddition of a nitrile oxide with 
5-methylcyclohexane-l,3-dione (10), followed by alkylation. The synthetic 
47 
Result and Discussion 
equivalence of (12) and its CS bis-alkyl regioisomer has been mentioned previously. 
6.1 Formation of the 1,3-Dipole 
The isoxazole ring was made by a 1,3-dipolar cycloaddition, using a 1,3-dipole and a 
dipolarophile. In our synthesis, the 1,3-dipole was formed from the chlorinated oxime 
(74), which was obtained from the corresponding oxime by chlorination using NCS. 
Dehydrohalogenation by Et3N gave the nitrile oxide (75) in situ. The chlorinated 
oxime has to be used immediately, since exposure to air would cause gradual 
decomposition; The 1,3-dipole attacked the double bond of the dipolarophile in a 
concerted step to form initially the isoxazoline ring (Scheme 27). We have built in a 
substituent (on the dipolarophile) that will then eliminate to give the isoxazole . 
.... OH 
11 (74) 
.v"'CI 
• 
-HX 
-
}-~ Ar/Y -R' 
R 
Scheme 27 
6.2 Phenyl Group as Isoxazole Substituent 
6.2.1 Approach 1 
To begin our synthesis, we have chosen the simplest non-substituted benzaldehyde 
oxime (76) as a ftrst example. The chlorinated benzaldehyde oxime (77) was used as a 
1,3-dipole and dimethyl-3-(1-pyrrolidino)pent-2-ene-l,S-dioate (8) as a 
dipolarophile.77 The benzaldehyde oxime was chlorinated by N-chlorosuccinimide 
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under reflux in chlorofonn.'8 and the reaction mixture was checked by TLC to ensure 
complete chlorination before pyrrolidine enamine (8) and triethylamine were added to 
the reaction mixture. A catalytic amount of amine base, triethylamine, was used to 
speed up and increase the yield of the reactions.79 This reaction had to be perfonned 
under an atmosphere of nitrogen as the nitrile oxide fonned in situ is highly reactive. 
Dimethyl 3-(I-pyrrolidino)pent-2-ene-I,5-dioate (8) was prepared from dimethyl 
1,3-acetonedicarboxylate (9) and pyrrolidine at reflux under a Dean-Stark trap 
(Scheme 28),80 and used without further purification. 
N .... OH (76)d 000 MeOJl...Jl...JloMe (9) 
! pyrrolidine. 
NCS. CHC!.! Dean-Stark reflux 
reflux 
.... OH ~. (77) d" + • OMe 
crude crude (8) 
Scheme 28 
Different ratios of enamine to oxime were tried to give the best yield of product, 
methyl 5Cmethoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5) (Table 2). The 
yield increased from 17 % to 44 % as the ratio of enamine to oxime was increased to 
8:1. However, the purification of the product by flash colunm chromatography 
became more difficult as the amount of enamine used was increased, therefore, the 6: 1 
ratio was chosen as optimum. Use of chlorinated oxime that had been partially 
purified by partition between DCM and water, instead of un-extracted crude material, 
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increased the yield of (5) to 55 %. 
Conditions Chlorinated Oxime Enamine % Yield 
Not 1 1 17 
extracted with 1 2 28 
DCM/fhO 1 4 36 
1 6 43 
1 8 44 
Extracted 1 6 55 
Table 2 
6.2.1.1 Attempts at 6-Membered Ring Closure 
To make the isoxazole building block through Approach 1, we needed to ring close 
between the two esters to form a 6-membered ring. The methyl 
5-methoxycarbonyImethyl-3-phenyIisoxazole-4-carboxylate (5) was reacted with 
methylmagnesium bromide in an attempt to convert one ester into a methyl ketone in 
order to yield a precursor for ring cIsoure. Looking at the structure, the ester A should 
be less reactive than the ester B due to the conjugation (Scheme 29). However, a 
mixture of products, included diketone and diol (which were seen from the IR spectra), 
was obtained and the spectra were difficult to assign. This may due to insufficient 
selectivity between these two esters. 
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ester B 
o 
0/ ---X----
/ 
o ester A MeMgBr ~ 
ring closure 
Scheme 29 
Methyllithium was also tried for the same purpose. The methyl 
5-methoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5) was converted into 
5-carboxymethyl-3-phenylisoxazole-4-carboxylic acid (78) by aqueous sodium 
hydroxide in a 81 % yield.81 The diacid was then reacted with methyllithium in an 
attempt to convert the carboxylic acid into a ketone (Scheme 30). However, again, a 
mixture of products was fonned due to difficulty in controlling the selectivity of the 
reaction.82 
o-n I "'" Q -Q Q o 
isoxazole building block 
NaOH. 
H:,O/MeOH 
• 
N-O 0 
~OH 
o OH 
---x---; MeLi 
I 
(78) 81% t 
~~.iJ. V J:,_.~~' 
o OH ~ 
. ring closure 
Scheme 30 
Due to this failure to modifY suitably the two ester tennini, we moved the focus to 
alkylation, with ring closure to be completed at a later stage. 
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6.2.1.2 Side Chain Elaboration 
Methyl iodide was initially used in a model reaction to methylate methyl 
5-methoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5). The diester was 
deprotonated by 2.0 equiv. of LDA in dry THF at -78°C, and then quenched by 
excess methyl iodide. However, this reaction failed, possibly because methyl iodide 
was highly volatile and lost from the reaction. I-Bromo-3-methyl-2-butene was 
chosen as the second alkylating reagent, because the carbon chain was same as the 
one needed for the target molecule. Methyl 
5-methoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5) was again 
deprotonated by 2.0 equiv. of LDA at -78°C and alkylated by 1.0 equiv. of 
I-bromo-3-methyl-2-butene to yield methyl 
5-(1-methoxycarbonyl-4-methylpent-3-enyl)-3-phenylisoxazole-4-carboxylate (79) at 
70 % (Scheme 31). 
After the success of mono-alkylation, a second alkylation was tried. Using the same' 
alkylation reagent (l-bromo-3-methyl-2-butene), the dialkylated product, methyl 
5-[I-methoxycarbonyl-4-methyl-l-(3-methylbut-2-enyl)pent-3-enyl]-3-phenylisoxazo 
le-4-carboxylate (80) was made successfully from the mono-alkylated product, after 
deprotonation by 1.5 equiv. ofn-BuLi at-78°C in dry THF. The best yield so far is 23 
%. We attempted to modify the yield of the second alkylation by using a palladium(O) 
complex, tetrakis(triphenylphospbine)palladium(O) (Figure 19), well known to assist 
such couplings,83 as a catalyst. 
Figure 19 
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Methyl 5-(I-methoxycarbonyl-4-methylpent-3-enyl)-3-phenylisoxazole-4-carboxylate 
(79) was deprotonated again by n-BuLi (1.5 equiv.) in dry TIIF, and 10 mol % of 
Pd(PPh3).i was added followed by the I-bromo-3-methylbut-2-ene. Di-alkylated 
product (80) was obtained in 25 %. This showed that the palladium complex did not 
have any marked effect on the yield of the di-alkylatedproduct (Scheme 31). 
Di-alkylated product could only be made by a two-step process: di-alkylation by a 
one-pot reaction was not successful using either LDA or n-BuLi as the base with 
excess alkylating agent. 
1.5 equiv. nBuLl, Pd (0) 
)=yer 
2.0 equiv. I 
LOA, _ 
h 
MeO 0 
70% (79) 
1.5 equiv. 
nBuLl 
)=yer 
"X" )=yer 
5.0 equiv.'" 
LOA, ", 
• 
COOMe 
5.0 equiv. LOA 
or 
2.5 equiv. nBuLi 
----- -X -------.-----... 
2.0 equiv.)=yer 
MeO 0 
Scheme 31 
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The second alkylation was not successful if LOA was used instead of n-BuLi, as the 
base. LOA was made from n-butyllithium and diisopropylamine, since n-BuLi is a 
stronger base than LOA. The pk:i value of n-BuLi is 45, while LOA is 35. Therefore, 
deprotonation by n-BuLi was more efficient. On the other hand, LDA is a much 
bulkier base comparing to n-BuLi, the hindered structure making it less nucleophilic. 
1.5 Equiv. of n-BuLi should be sufficient because it is highly reactive towards other 
functional groups, and the reaction could be adversely affected if too much was 
added. 
6.2.1.3 Use ofWeinreb Amide 
There are many reagents available for converting esters into ketones, such as Grignard 
reagents, and other organometallic agents. However, these reagents may convert the 
ester into alcohol instead of ketone if the conditions are not carefully controlled.84 
During the organometallic reaction, the ester is first converted to a ketone, and if it 
cannot be controlled at this stage, a second attack of the reagent will convert the 
ketone further into an alcohol (Scheme 32). An ester is less reactive than a ketone due 
to the electron density donated by the lone pair of electrons from the "ether" oxygen 
attached to the carbonyl carbon. 
First attack Second attack 
Q R'M GO RUM OH 
R'O/ 
.. 
R:JlR, 
.. 
k-R' ( R R" 
.c M = MgBror Li M-R" 
Scheme 32 
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In order to prevent the second nucleophilic attack, a Weinreb amide can be used. 
Weinreb amides are highly effective towards a wide range of nucleophiles, and work 
efficiently to generate ketone from carboxylic acid. Even in the presence of excess 
organometallic reagents, the stabilised tetrahedral intermediate prevents formation of 
alcohol from a second nucleophilic addition (Scheme 33). 
Nucleophilic addition to Weinreb amide 
o )l ..... OMe 
R 7 
Me 
Weinreb amide 
R'M 
• 
M=Li, MgX 
tetrahedral 
intermediate 
Scheme 33 
• 
At the intermediate stage, chelation of the metal ion between alkoxide and the oxygen 
atom of the N-methoxy group avoids further addition of nuc1eophiles. Only on an 
acidic work-up, is the tetrahedral intermediate released to give a ketone. Any excess 
of the organometallic reagents will be hydrolysed at the same time of the acidic 
work-up, therefore preventing second addition and alcohol formation.ss 
The use ofWeinreb amides has proved to be a very efficient reaction for generation of 
ketones instead of alcohols from carboxylic acid. Weinreb amides are usually formed 
from a carboxylic acid group, therefore, esters needed to be converted into carboxylic 
acid by hydrolysis before proceeding. 
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Weinreb Amide Formation 
After the success of our enolate alkylations, we then returned to the ring closure. To 
close the six-membered ring, the ester groups needed to be converted into ketones. 
Grignard reaction had been tried previously (see earlier), but a mixture ofketones and 
alcohols were obtained. 
(5) 
N,O-Oimelhylhydroxylamine 
! hydrocl1loride, DeM, reflux' 2.5 equlv. NaOH, AlMe, H20IMeOH 4% oY{l { Grignard reaQ?Jlon NI 
~I "" .&' N,OMe I "" .&' OH • I.&' f 'I ---!.~ I "" .&' R .&' 'N 0" hydrolysis.&' , HO 0 Weinreb amide fonnation tlr..e R-X :!t..., 0 
~~ ~% ~1) ~% 
1 addition only 
Scheme 34 
Use of Weinreb amides prevents the formation of alcohols, so was relevant to our 
studies. We attempted treatment of the diester, methyl 
5-methoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5) with 
N,O-dirnethylhydroxylamine hydrochloride and AIMe3 as a Lewis acid, at reflux in 
dry DCM to yield the Weinreb amide (81) in a single step, but the yield was 
comparatively low at just 4 %. It was suggested that Weinreb amides usually could 
not been formed directly from esters. Therefore, we had to first convert the two ester 
groups into carboxylic acids by sodium hydroxide in MeOHlH20 to afford, 
5-carboxymethyl-3-phenylisoxazole-4-carboxylic acid (78) in 81 % yield. It was then 
reacted with N,O-dimethylhydroxylamine hydrochloride, N-methylmorpholine and 
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EDCI to give the corresponding Weinreb amide, 
5-[(N-methoxy-N-methylcarbamoyl)methyl]-3-phenylisoxazole-4-carboxylic acid 
N-methoxy-N-methylarnide (81) in 48 % yield (Scheme 34). The EDCI acted as an 
activator for the carboxylic acid groups. 
Formation of ketones was tried again by reacting the Weinreb amide with a methyl 
Grignard reagent. 86 To the Weinreb amide (81), 1 equiv. of methylmagnesium 
bromide was added in dry THF at 0 °C to form a ketone. However, no ketone was 
found. The fractions collected from the column were starting material and some 
unidentified materials. 
Other methods to generate ketones have also been attemped. We planned to use an 
anhydride as a precursor for Grignard alkylation. We thought that carbonyl group A of 
the anhydride (82) should be more reactive than the carbonyl group B, because B was 
conjugated with the isoxazole ring. Therefore, if we reacted 
3-phenyl-7 H-pyrano[3,4-dJisoxazole-4,6-dione (82) with methyl Grignard reagent, 
the methyl group should attack the carbonyl group A, forming a methyl ketone, while 
. the other end would remain as a carboxylic acid after acidic work-up (Scheme 35). 
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(78) (82) 
o-nN1 0 Carbonyl A ..." ,& v-:.. -~ ... I t:£ ,& 000 {} 
Carbonyl B 
Grignard Reaction 
~ ~/M.-MgBr ..." 1,& ~ _ I ,& YJi;,;,~ o 0 '-!V 
(82) 
Scheme 35 
We attempted to prepare the anhydride 
3-phenyl-7H-pyrano[3,4-dJisoxazole-4,6-dione (82) from the dicarboxylic acid, 
5-carboxymethyl-3-phenylisoxazole-4-carboxylic acid (78) by three different 
conditions shown in the table below (Table 3). However, the expected anhydride 
structure (82) was not isolated from all the reaction conditions we tried. 
Entry Reagents Solvent Temperature Time Result 
I Acetic anhydride, pyridine DryDCM Reflux 4h Unidentified product 
2 TsOH Toluene Reflux 16h Unidentified product 
3 Acetic anhydride DryDCM Reflux 2h Unidentified product 
Table 3 
6.2.2 Approach 2 
In the second approach, the isoxazole building block 
6-methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) was also constructed 
by a 1,3-dipolar cycloaddition in 61 % yield, using phenylhydroximoyl chloride (83) 
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as a 1,3-dipole precursor and 5-methylcyclohexane-I,3-dione (10) as a dipolarophile 
in the presence of sodium isopropoxide (Scheme 36).87 The phenylhydroximoyl 
chloride (83) used for approach 2 was prepared from commericai benzaldehyde oxime 
(76) and N-chlorOsuccinimide at 50°C in chloroform. 88 The preparation of 
chlorinated oxime was similar to Approach I, and it was extracted by DCM and then 
used directly without purification. It was used immediately after it was made, or 
stored under nitrogen in a refrigerator for a short period of time. The hydroximoyl 
chloride (83) was dehydrohalogenated to give a nitrile oxide, which was ready to 
attack the enol form of dione (10) in a 1,3-dipolar cycloaddition manner (Scheme 36). 
/OH aY (761 
! NCS 
/OH 
100%crue;r.de ~ 
I '-'::: Cl 
.lj (83) 
+ 
.Jt. sodium isopropoxide AA . 
o (10) 
1.3-dipolar cycloaddition 
Scheme 36 
6.2.2.1 a,p.Unsaturation 
61% 
The 6-methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) was reacted with 
several reagents to try to generate a double bond at the a,p-position to the ketone 
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group, as that is the oxidation level required in the natural product (Scheme 37). The 
first attempt used bromination followed by elimination of the bromide as HBr. 
(6) 
N-O 
I beta 
-
if alpha (84) 
Scheme 37 
N-O 
I 
Bromine was added to ketone (6) at room temperature for bromination at the 
a-position, 89 starting material disappeared but a mixture of brominated products was 
obtained instead of one a-brominated product, possibly because bromine is volatile 
and difficult to measure accurately in the small scale we used. Deshielded CS and C7 
protons confirmed the formation of brominated products. Next, chlorotrimethylsilane 
was used with triethylamine to generate a silyl enol ether, in situ, followed by 
N-bromosuccinimide to brominate (6), but starting material was recovered. The hoped 
for reaction sequence is shown below (Scheme 38). 
Scheme 38 
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The alternative method of using LDA as a base to deprotonate the ketone and fonn the 
silyl enol ether before bromination was also tried (Scheme 39). However, starting 
material was recovered again. 
a) LOA 
_ .... _)(._ ....• 
b) Me3SiCI 
(6) H 
Scheme 39 
As the reactions above were perfonned in one step without isolation of any 
intennediate product, sHyl enol ether fonnation was doubted. 
t·Butyldiphenylchlorosilane was used instead of chlorotrimethylsilane,90 with LDA 
(1.2 equiv.) in THF at -78°C, to produce a silyl enol ether, which should be stable 
enough to be isolated to confinn the formation of the intennediate, silyl enol ether. 
Starting material was recovered, proving that the silyl enol ether was not fonned. 
Phenylselenium bromide is another common reagent used in sequences for the 
generation of a,~·unsaturation. 6-Methyl-3-phenyl-4,5,6,7-
tetrahydrobenz[d]isoxazol-4-one (6) was deprotonated by LDA in dry THF and then 
reacted with phenylselenium bromide.91 Without purification, the crude product was 
oxidised by sodium periodidate and sodium hydrogen carbonate.92 Starting material 
was recovered instead of the a,~-unsaturated product. The required mechanism is as 
below (Scheme 40). 
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Use of DDQ is also a very common method for generation a,~-unsaturation by 
dehydrogenation. 93 DDQ was added to 
6-methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) and the mixture was 
refluxed in l,4-dioxane over two days. Still none of the expected product was formed. 
The following is a summary of reactions tried for generation of the a,~-unsaturation 
generation (Table 4). 
• 
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Summary of reagents and conditions used for generating the a,p-unsaturation 
Base Reactant Solvent Conditions Result 
--
Br2 CHCh RT,3h Mixture ofC3, C5, C3/C5 
brominated products 
Et3N TMSCl,NBS DryTHF Reflux, 2 h S.M. 
LDA TMSCl,NBS DryTHF -78°C, 4 h; S.M. 
80°C, 1\1, h 
LDA TMSCl, Br2 DryTHF -78°C, 4 h S.M. 
LDA TBDPSCl DryTHF -78°C, 5 min S.M. 
LDA NBS DryTHF RT,I h Unknown 
LDA PhSeBr, DryTHF RT,>24h S.M. 
NaI04 Water RT, >24h 
LDA PhSeBr DryTHF RT,>24h S.M. 
---
DDQ 1,4-dioxane Reflux,50h S.M. 
---
i) Br3-, DCM RT,3h 
ii) DBU DCM O°C, 1 h Non-brominated 
---
i) Br3-, DCM RT,3h 
ii) DBU DMF 50°C, 1 h 41 % of (84) 
Table 4 
After many failed reactions, tests were carried out to investigate whether the proton at 
the alpha position is exchangeable or not. ~-Methanol (CD30D) was added to 
6-methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) after attempted 
deprotonation with LDA (THF, -78 °C). A reduction of IH NMR signal of the 
a-methylene group by proton exchange with ~-methanol would prove that the alpha 
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proton is exchangeable under these conditions. However, no reduction of the integral 
for this signal was observed and we concluded that the alpha proton cannot be 
exchanged under the conditions we had tried. 
After reviewing the data, we returned to bromination and found a paper, by Bode88 et 
al., which had shown that bromination by pyridinium hydrobromide perbromide is 
easier to carry out, because the perbromide is a more convenient reagent as it could be 
weighed out much more accurately and it reacts less vigorously. 
5-Bromo-6-methyl-3-phenyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-0ne (85) was 
generated in 66 % yield by pyridinium hydrobromide perbromide with glacial acetic 
acid in DCM (Scheme 41).94 Bromide (85) was then reacted with DBU9S in DMF at 
so °C to yield 6-methyl-3-phenylbenzo[dJisoxazol-4-01 (84), 41 %. Debrominated 
material (6) was recovered if the reaction was carried out in DCM at 0 °C. We 
presume these different results were due to the polarity of the solvent. The elimination 
product exists as its phenolic tautomer (84) rather than the cyclohexanedione form, 
due to aromatic stabilisation. The structure of the mono-bromo intermediate (85) was 
confirmed by an Xray crystal structure determination (Figure 20). 
(6) 
Pyridinium Br. 
acetic acid, 
DCM 
• 
(85) 
Scheme 41 
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Figure 20 [X-ray crystal structure of (85) Appendix I] 
The C-S and C-7 protons of 6-methyl-3-phenylbenzo[dJisoxazol-4-o1 (84) were 
difficult to assign in the NMR spectra as they are under a similar environment. In an 
attempt to assign the IH NMR spectrum, 6-methyl-3-phenylbenzo[dJisoxazol-4-o1 (84) 
was converted into 4-acetoxy-6-methyl-3-phenylbenzo[dJisoxazole (86) (Figure 21) 
by acetic anhydride. A nOe (nuclear Overhauser enhancement) spectrum was 
performed to investigate the proton-proton interaction. An interaction between the 
ester methyl and proton c (at CoS) but not proton a (at C-7) was expected, as the 
proton at position c was located closer to the ester methyl. However, both the protons 
a and c appeared to be interacting with the ester methyl. No conclusion was drawn 
and the two proton peaks remain unassigned. 
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(86) 
Figure 21 
Continuing with the approach 2, further bromination was carried out on the 
aromatised isoxazole building block, 6-methyl-3-phenylbenzo[dJisoxazol-4-o1 (84) 
with a view to provide a substrate for a coupling reaction. Bromine was added 
dropwise to 6-methyl-3-phenylbenzo[dJisoxazol-4-o1 (84), and either 
5-bromo-6-methyl-3-phenylbenzo[ dJisoxazol-4-o1 (87) or 
7-bromo-6-methyl-3-phenylbenzo[dJisoxazol-4-o1 (88) was isolated in 18 % yield 
(Scheme 42), as one of the unidentified a or c proton signals disappeared from the 
NMR spectrum. The unambiguous proof of formation of either product would be 
potentially useful for our synthesis . 
(84) 
AcOH 
18% 
• 
(87) 
Scheme 42 
OR 
(88) 
Since the identification of the position of brornination was uncertain, methylation was 
carried out on 6-methyl-3-phenylbenzo[dJisoxazol-4-o1 (84) to help' clarify the 
reactivity of the compound. Looking at the molecule, it was anticipated that soft 
methyl iodide and hard methyl trifluoromethanesulfonate should attack the soft and 
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hard nucleophilic positions of the molecule, respectively. Unfortunately, after LDA 
deprotonation and electrophile addition, no alkylation was observed and starting 
material was recovered in both reactions (Scheme 43). 
N-O 
LDA I Me 
----X----
Mel HO 
N-O 
LDA I 
(84) ----)(----
Hard 0 
11 
MeO-S-CF 11 3 
0 
Scheme 43 
Next, we tried to deprotonate 6-methyl-3-phenylbenzo[dJisoxazol-4-ol (84) with 3 
equiv. of LDA (THF, -78°C) and reacted with l-bromo-3-methyl-2-butene with the 
hope that either the CS or C7 position would be attacked. However, instead of 
C-alkylation, the hydroxyl group was attacked to form O-alkyl product 
6-methyl-4-(3-methyl-but-2-enyloxy)-3-phenyl-benzo[dJisoxazole (89) in 58 % yiel~. 
In similar fashion, reaction with dimethyl sulfate formed 
4-methoxy-6-methyl-3-phenyl-benzo[dJisoxazole (90) in 36 % yield (Scheme 44). 
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(89) 
58% 
(90) 
36% 
phenol, 
S-bromo-6-methyl-3-phenyl-benzo[dJisoxazol-4-ol (87) or the 7-bromo isomer (88) 
by LDA and then reacted with I-bromo-3-methyl-2-butene, an unexpected 
C-alkylation at either CS or C7 was observed. We could not give an explanation for 
this switch in reactivity, but this unexpected attack at the aromatic carbon was just 
what we wanted for our carbon chain to be added on for the target molecule (Scheme 
45). As the aromatic protons 0 have not been assigned from the spectra of 
6-methyl-3-phenylbenzo[ dJisoxazol-4-0l (84), we could not identify which carbon, CS 
or C7 was actually brominated and thus which had been alkylated in the reactions 
above, brit tentatively we assume the CS (ortho) position is more reactive and is 
brominated, and thus alkylation is at C7 to give (91). Either the CS alkylated or C7 
alkylated product could be useful for further reactions towards our final targets. 
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6.2.2.2 C-Alkylation ofCyclohexenone (6) . 
An alternative approach to introduce the alkyl groups into the 6-membered ring 
required in Approach 2, is to attempt alkylation before introducing unsaturation into 
the ring. We thus examined C-alkylation of ketone (6). Deprotonation using the 
hindered and non-nucleophilic base, lithium diisopropybunide (LDA) in dry THF is a 
very common and effective method for alkylation. LDA is made from n-butyllithium 
(n-BuLi) and diisopropylamine, with the lithium cation coordinated with the nitrogen 
of the diisopropylamide anion. The negatively charged nitrogen atom is responsible 
for deprotonation of an acidic carbon. The use of co-solvent, 
hexamethylphosphoramide (HMPA) (Figure 22) helps to coordinate the lithium cation 
extremely powerfully, reducing aggregation and separating it further from the 
diisopropylamide anion, allowing the latter to approach closer to the carbon to be 
deprotonated. The lithium cation is solvated leaving the anion unsolvated and very 
reactive (Scheme 46),96 therefore, increasing the efficiency of the LDAdeprotonation 
for bulky groups or around electron-rich functional groups. 
69 
Result and Discussion 
Hexamethyl phosphoramide (HMPA) N,N'-dimethylpropylene urea (DMPU) 
Figure 22 
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HMPA is a highly polar solvent with strong dipole moment. One of its major 
drawbacks is its toxicity, since it is a very carcinogenic chemical. Special handling 
and disposal precautions are necessary for this chemical, therefore a replacement has 
been introduced, N,N-dimethylpropylene urea (DMPU) (Figure 22). DMPU is far 
less toxic then HMPA, but with similar properties and the same effect as HMPA as a 
co-solvent. It has a dipole moment at 14.1 x 10-30 Cm.97 
In the earlier discussion of phenylselenation of (6), we have mentioned that the CS 
deprotonation of 6-methyl-3-phenyl-4,S,6,7-tetrahydrobenz[dJisoxazol-4-one (6) 
could not be verified under the conditions of LDA as the base in dry THF. at -78°C 
under atmosphere ofnitrogen.98 
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To promote this deprotonation and subsequent alkylation reaction, a method of using 
HMPA as a co-solvent was suggested.74 We applied this methodology to the 
deprotonation of 6-methyl-3-phenyl-4,S ,6,7 -tetrahydrobenz[ dJisoxazol-4-one (6), 
which had failed previously. LDA (2 equiv.) in THF:HMPA (6:1) at -78°C was used 
to deprotonate the CS position, which was then alkylated by 
I-bromo-3-methyl-2-butene (1 equiv.). A mixture of mono-alkylated product, 
6-methyl-S-(3-methylbut-2-enyl)-3-phenyl-4,S,6, 7 -tetrahydrobenz[ dJisoxazol-4-one 
(92) and di-alkylated product, 
, 6-methyl-S,S-bis-(3-methylbut-2-enyl)-3-phenyl-4,S,6,7-tetrahydrobenzo[dJisoxazol-4 
-one (93) was isolated at 21 % yield for each product as well as 21 % of unchanged 
starting material. 
The IH NMR signal of the CS . protons of 
6-methyl-3-phenyl-4,S,6,7-tetrahydrobenz[dJisoxazol-4-one (6) was deshielded more 
by the adjacent ketone when compared to the C7 protons. The CS protons were 
recorded at 2.64 ppm (J 10.0 & 17.4 Hz) and 3.13 ppm (J 4.8 & 17.4 Hz), while C7 
protons were recorded at 2.30 ppm (J 11.1 & 16.0 Hz) and 2.61 ppm (J 3.8 & 16.0 
Hz). After dialkylation, the signal of the CS protons were absent, leaving only the 
peaks at 2.45 ppm (J 11.1 & 16.0 Hz) and 2.73 ppm (J 3.8 & 16.0 Hz), which are 
signals representing the C7 protons. The NMR signals and J values indicated the 
alkylation was performed at CS to give (92) and (93). 
After this success in alkylation on CS, we tried to add a phenylse1enyl group at the C7 
position under similar conditions, in order to introduce the required unsaturation. 
Using the di-alkylated product (93), HMPA was used as co-solvent with THF at -78 
°C and LDA to deprotonate the C7 carbon, which then was attacked with 
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phenylselenium bromide. 50 % of the phenylselenyl product 
6-methyl-5,5-bis-(3-methyl-but -2-enyl)-3-phenyl-7 -phenylselanyl-4,5,6, 7 -tetrahydro-
benzo[dJisoxazol-4-one (94) was obtained. Purification of this product was very 
difficult, and impurity peaks were still found in the proton NMR spectrum after a 
second chromatographic separation. These peaks possibly derived from the co-solvent 
HMPA. After this, oxidative elimination of the phenylselenyl group was attempted 
using sodium periodate and sodium hydrogen carbonate to give a double bond before 
isoxazole ring opening, but starting material was recovered. However, the 
phenylselenyl group was eliminated successfully by reversing the order of the steps, 
and first, by ring opening the isoxazole with MO(CO)6 in moist acetonitrile99 and then 
oxidation with H202 to yield 
2-[ l-amino-l-phenyl-meth-(E)-ylidene ]-5-methyl-6,6-bis-(3-methyl-but-2-enyl)-cyclo 
-hex-4-ene-l,3-dione (95) in 30 % (Scheme 47). The yield obtained was always 
higher when these reactions were performed on a small scale than a large scale. 
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Looking back at the coleophomone target molecules, we observed that putting carbon 
chains on either CS or C7 positions of benzisoxazole (6) would give us the same 
product after elimination of the phenylselenyl group, as these positions become 
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equivalent by bond rotation after the isoxazole ring is opened and the enamine 
hydrolysed (Scheme 48).100 
! Ring opening - hydrolysis ! 
Bond rotation 
Scheme 48 
Therefore, as an alternative sequence we attemped to put a phenylselenyl group at the 
C5 position first. The use of HMPA as co-solvent for LDA deprotonation was applied 
to phenylselenyl group addition on the C5 carbon, to afford 
6-methyl-3-phenyl-5-phenylse1enyl-4,5,6,7 -tetrahydrobenzo[dJisoxazol-4-one (96) in 
25 % (Scheme 49), in contrast to earlier findings with LDAin THF alone (see above). 
C5 
LDA. THF. PhSeBr 
-------)E------~ 
LOA. THF:HMPA (6:1) 
PhSeBr 
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Next we attempted to further alkylate 
6-methyl-3-phenyl-5-phenylselenyl-4,5,6,7-tetrahydrobenzo[djisoxazol-4-one (96) at 
the C7 position using I-bromo-3-methylbut-2-ene and LDA in THF:HMPA (6:1). We 
anticipated that despite the increased acidity of (96) at C-5, deprotonation and 
alkylation at C-7 might be favoured on steric grounds. However, the formation of the 
desired mono-alkylated product, 6-methyl-7-(3-methyl-but-2-enyl)-
3-phenyl-5-phenylselenyl-4,5,6,7-tetrahydrobenzo[djisoxazol-4-one (97) and 
di-alkylated product, 6-methyl-7, 7 -bis-(3-methyl-but-2-enyl)-
3-phenyl-5-phenylselenyl-4,5,6,7-tetrahydrobenzo[djisoxazol-4-one (98), could not 
be confirmed because the NMR spectrum after colunm chromatography was not clear 
enough to be fully analysed. If the alkylated phenylselenyl product formation is 
confirmed, the phenylselenyl group would be removed by oxidative elimination to 
give a,~-unsaturation in a similar way to that described earlier (Scheme 50). 
LDA. THF:HMPA (6:1) 
--------*--------
se~ 
V 
)=vBr 
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Because of the toxicity issues with HMPA, the alternative additive DMPU was also 
tried for the CS alkylation of ketone (6). Reactions with DMPU replacing HMPA were 
carried using the same conditions, and the results are compiled in the following table 
(Table 5). Different ratios of LDA and alkylating reagent have also been tried, and the 
optimum condition for mono-alkylated product so far was using 2 equiv. of LDA and 
1 equiv. of alkylating reagent. Some of these results refer to the artha substituted 
phenyl group, which will be introduced in the following section. 
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Starting materal & Co-solvent LDA Alkylating reagent Yield (%) 
alkylating reagent (C5-Monoalkylated, 
C5-Dialkylated, 
SM) 
N-O HMPA 2.00 eq 1.00 eq 21,21,20 ~ I~ (92), (93), (6) .6 0 
~Br HMPA 2.50 eq 2.02eq 13,13,11 
(92), (93), (6) 
DMPU 1.50 eq 1.02 eq 6,17,10 
(92), (93), (6) 
N-O HMPA 1.20 eq 1.00 eq 25 (96) ~ I~ .6 0 
PhSeBr DMPU 1.50 eq 1.02 eq 20 (96) 
~ DMPU 2.50 eq 1.02 eq 23, 10,--(126), (127), (117) I~ . I ~ ~ 0 
~Br 
~ HMPA 1.20 eq 1.00 eq 11,7,42 (124), (125), (117) I~ I~ ~ 0 
~Br DMPU 1.20 eq 1.02 eq 20, --, 25 
(124), (125), (117) 
Table 5 
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6.2.3 Conclusion 
We have developed a good base of synthesis towards the isoxazole building blocks for 
both proposed approaches to the coleophomone system. For Approach 1, we have 
successfully elaborated by alkylation the side chains at C3. However, we failed to 
complete the ring closure of the 6-membered ring to afford a benzisoxazole, even with 
the use ofWeinreb amide to help forming ketones. 
For Approach 2, we have successfully prepared the benzisoxazole, and looked at the 
alkylation of the C5 and C7 positions using co-solvent, and generation of the required 
a,~-unsaturation by different methods, such as phenylselenyl oxidative elimination 
and bromination. These investigations provided with valuable information to apply to 
the isoxazole building blocks having substituted phenyl substituents, described in the 
next section, as well as towards the target natural products. 
6.3 o-Substituted Phenyl Group as Isoxazole Substituent 
6.3.1 Formation of Building Blocks 
After reactions using phenyl group as the aromatic isoxazole substituent, we decided 
to also investigate substituted aromatic groups, which should look more like our target 
molecule. We chose an ortho-substituted phenyl ring, 2-hydroxybenzaldehyde oxime 
(104) as the next trial aromatic substituent (Scheme 51). 
78 
Result and Discussion 
o-hydroxy 
~ 
> 
.... OH 
&H ~ 2-hydroxybenzaldehyde oxime =~> I (104) h-
Scheme 51 
The elaboration of ortho-substituted building block would be based on the same 
retrosynthetic analysis, namely the two approaches from the benzaldehyde oxime: 
forming an isoxazole with diesters for the first approach and generating the isoxazole 
with a pre-fonned six-membered ring for the second approach. 
Before chlorinating the commercial2-hydroxybenza1dehyde oxime (104), we decided 
to first mask the reactive alcohol function at the ortho position (Schem~ 52). We 
attempted to protect the o-hydroxy group by different groups, namely benzyl,101,102 
allyll03 and 1,4-dibromobut-2-ene. Our initial plan was that, after the isoxazole ring 
was fonned by the 1,3 dipolar cycloaddition, the benzyl or allyl group would be 
removed by strong acid or hydrogenation, allowing the recovered o-hydroxy group to 
be coupled with a carbon chain. 
2-Benzyloxybenza1dehyde oxime (105) was isolated in just 1 % yield on reacting 
benzyl bromide and potassium carbonate with 2-hydroxybenza1dehyde oxime (104) in 
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dry acetone at reflux. Allyl bromide was used with similar reaction conditions to yield 
allyl protected product, 2-allyloxybenzaldehyde oxime (106) injust 3 % yield. 
(104) 
OH WOH 
1% 
Benzyl bromide, ~C03' ~ 
dry acetone IV Allyl bromide, ~C03' o / Chlorination \ dry acetone 
lo N,OH ~O N,OH 
(105) (i (i (106) 
n 
3% 
Approach 1 
OR 
Approach 2 
(107) 
OR N-O 
I 
OMe 
o 
OMe 
OMe 
n Remove protecting group 
OH N-O 
I 
(108) 
Scheme 52 
1,4-Dibromobut-2-ene was also tried as a masking group using similar conditions to 
those employed with benzyl bromide and allyl bromide. However, a mixture of 
products was obtained from the reaction (Scheme 53), and the spectra were difficult to 
identify; we deduced that both single and double alkylation had occurred. We had 
planned that a remote bromide could act as alkylating agent for a benzisoxazole later 
in the synthesis. 
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The yields of the benzyl and allyl protected products, 2-benzyloxybenzaldehyde 
oxime (105), and 2-allyloxybenzaldehyde oxime (106), were not good enough for 
continuing with the sequence. The problem of low yield might have been caused by 
the reactive oxime hydroxyl group or nitrogen atom reacting instead of or as well as, 
the a-hydroxy group. We also found that the whole amount of crude material was not 
collected after column chromatography. We decided to start with the commercial 
salicyaldehyde instead of the oxime to solve these issues (Scheme 54). 
~ 
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Dry THF./ "" 
,/" 16 
.. 
I"" 
16 
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2-Hydroxybenzaldehyde (109) was deprotonated by potassium carbonate and then 
reacted with benzyl bromide or allyl bromide, in dry THF under reflux to generate the 
protected products, 2-benzyloxybenzaldehyde (110) and 2-allyloxybenzaldehyde (111) 
in 75 % and 93 % yield, respectively. Some other conditions have been tried (Table 6) 
but these give the best yield of protected aldehyde. 
Entry Protecting agent Solvent Conditions Yield 
1 Benzyl bromide Dry acetone K2C03, Kl, reflux 25% 
2 Benzyl bromide DryTHF K2C03, reflux 75% 
3 Allyl bromide Dry acetone K2C03, reflux Trace 
4 Allyl bromide DryTHF K2C03, reflux 93% 
Table 6 
After the protected o-hydroxy aldehydes were obtained, further reactions were 
performed to convert both protected aldehydes, 2-benzyloxybenzaldehyde (110) and 
2-allyloxybenzaldehyde (111) into their oximes using 2 equiv. of hydroxylamine 
hydrochloride and 4 equiv. of sodium acetate in water/ethanol. 
2-Benzyloxybenzaldehyde oxime (105) and 2-allyloxybenzaldehyde oxime (106) 
were collected as crude products under these conditions in> 100 % yield. 
To progress our two synthetic approaches now that we had obtained the crude oximes, 
we needed to make the corresponding isoxazole diester and isoxazole with a fused 
six-membered ring. The crude 2-benzyloxybenzaldehyde oxime (105) was treated 
with NCS in chloroform at reflux and then work up by extraction with DCM gave the 
chlorinated oxime, 2-benzyloxyphenylhydroximoyl chloride (112) in good yield. 
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Without purification, this reactive chlorinated oxime was used directly. For the first 
approach, we heated the pyrrolidine enamine of dimethyl 
3-( l-pyrrolidino )pent-2-ene-I,5-dioate (8) (in excess) with 
2-benzyloxyphenylhydroximoyl chloride (112) and triethylamine in chloroform at 
reflux to yield the isoxazole diester, methyl 
5-methoxycarbonylmethyl-3-(2-benzyloxyphenyl)isoxazole-4-carboxylate (il3) in 8 
% (based on oxime). For the second approach, the chlorinated oxime (112) was stirred 
with 5-methylcyclohexane-I,3-dione (10) in sodium isopropoxide, which was 
prepared by dissolving sodium metal in propan-2-01 carefully. 
3-(2-Benzyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazo1-4-one (114) was 
isolated in a 5 % yield (based on oxime) (Scheme 55). These low cycloaddition yields 
are based on crude oxime so are minimum yields. There may also be steric effects of 
the bulky benzyloxy group, hindering the approach of 1,3-dipole to dipolarophile. 
00 ~ 
~OM. 0 ...... 
~~~ 0 ...... ~ (113) 8% A . ,OH & • ~ ~ NCS, CHC\, reflux 
(105) (112) ~&h o "" A 100% o~ lA 0 
(114) 5% 
Scheme 55 
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For the crude 2-allyloxybenza1dehyde oxime (106), chlorination using exactly the 
same condition was used to form the chlorinated oxime, 
2-allyloxy-phenylhydroximoyl chloride (11S). This was reacted without purification 
with the same pyrrolidine enamine (8) and with 5-methylcyc1ohexane-l,3-dione (10) 
in attempts to form the isoxazole diester, 
methyl-3-(2-allyloxy-phenyl)-5-methoxycarbonylmethyl-isoxazole-4-carboxylate 
(116) and the isoxazole with a fused six-membered ring, 
3-(2-allyloxy-phenyl)-6-methyl-4,5,6, 7 -tetrahydrobenzo[ dJisoxazol-4-one (117) 
respectively (Scheme 56) . 
. lo WOH ~ ~I l..o N,OH &. "<:: . Cl (106) I "<:: ---... cY (115) Chlorination I & 
o Q 0 
(8) -O~O-
. 
, 
1 
• .
, 
, 
~ 
lo· ~-O 0 
~O/ V 0)..0/ 
(116) 
Scheme 56 
(117) 
However, neither of the expected products was isolated, instead, two unpredicted 
products were obtained from both of the above reactions. After analysis of the IH and 
I3C NMR spectra, we concluded the compounds were the intramolecular cyclisation 
product (118) and unsymmetrically dimerised product (119), i.e. the nitrile oxide 
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formed in the dehydrohalogenation step had reacted in either intramolecular or 
intermolecular mode with the allyl double bond before addition of the dipolarophile 
(Scheme 57).104 The formation of intramolecularly cyclised product (118) was proved 
by IH NMR spectroscopy. Peaks around 3.15 ppm, 3.78 ppm and 4.01 ppm 
corresponded to protons at a, b and c, respectively. The dimerised adduct (119) was 
suggested from its IH NMR spectrum, as a 2:1 ratio of aromatic peaks to allyl protons 
was observed. 
\.f' _N_C_S_ 
Q 
(106) 
Dimerisation 
Intramolecular cycloaddition 
l ... OH (Ye, l + ... 6 . &1 
(119) 
I"'" 
~ 
ifJc b-.ap 1 "'" N 
~ 
(118) 
Scheme 57 
As the tactic of protecting the o-hydroxy group by benzyl and allyl groups was not 
proving very effective, we changed our plan and decided to attempt the cycloaddition 
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directly with the unprotected 2-hydroxybenzaldehyde oxime (104) for both 
approaches. 
6.3.2 Approach 1 
2-Hydroxybenzaldehyde oxime (104) was heated at reflux with NCS and pyridine in 
chloroform and then worked-up by extraction with DCM, to afford 
2-hydroxyphenyJhydroximoyJ chloride (120) in 100 % crude, which was used without 
purification. The 2-hydroxyphenyJhydroximoyJ chloride (120) was then reacted with 
6 equiv. of the pyrrolidine enamine (8) with dropwise addition of triethylamine in 
chloroform to yield methyl 
5-methoxycarbonylmethyl-3-(2-hydroxy-phenyl)-isoxazole-4-carboxylate (107) as the 
product in 7 % (Scheme 58). We are unclear whether the unprotected alcohol function 
at ortho position was responsible for the low yield. Although the yield is not yet 
satisfactory, we wished to carry on further investigation with this cycloadduct. 
&r
OH 
~ -I b NCS, CHCI3, 
reflux 
(104) 
cY
0H ~,OH + 0 Q 0 
I ~ Cl It 1 11 --O~O--
b >100% 
(120) ! Et3N, CHCI3, reflux 
N-
I 
(107) 7 % (based on 
oxime) 
Scheme 58 
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Looking at our target molecule, we planned to put a carbon chain on the alcohol group 
in order to allow further reaction to fInish the Il-membered macrocycle by metathesis. 
Allyl bromide was chosen to allylate the hydroxy group, so methyl 
5-methoxycarbonylmethyl-3-(2-hydroxyphenyl)isoxazole-4-carboxylate (107) was 
deprotonated by potassium carbonate in dry THF and reacted with allyl bromide. 
Unfortunately, none of the expected product (116) was obtained, instead the oxygen 
from the deprotonated phenol attacked the ester at C4, forming a six-membered ring 
instead of reacting with the allyl bromide, and 27 % of the 
(4-oxo-4H-chromeno[4,3-c]isoxazol-3-yl)-acetic acid methyl ester (121) was 
observed (Scheme 59). A project student from our group discovered that this lactone 
formation also occurred slowly under room temperature after extended storage of 
crude isoxazole (107). 
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Although no expected product was obtained, 
(4-oxo-4H-cbromeno[4,3-c]isoxazol-3-yl)acetic acid methyl ester (121) would still be 
very useful for approaching our target molecule. We might alkylate the C3 methylene 
substituent of (121) and re-open the lactone ring by hydrolysis. However, we did not 
have time to explore this further. 
In addition, we have also tried ring closure from methyl 
S-methoxycarbonylmethyl-3-(2-hydroxyphenyl)isoxazole-4-carboxylate (107) to form 
the fused 6-membered ring. To form a possible precursor for ring closure, we tried 
converting diester (107) into the diacid, 
S-carboxymethyl-3-(2-hydroxyphenyl)isoxazole-4-carboxylic acid (122) by treatment 
with SM hydrochloric acid under reflux. Without purification, the pale yellow solid 
was treated with K2C03 and allyl bromide to allylate the hydroxyl group. We 
understood that there were several acidic protons, which could potentially be 
deprotonated to give different allylated products. However, none of the predicted 
products were obtained. Instead, surprisingly, 3-acetyl-4-amino-cbromen-2-one (123) 
was isolated in 51 % yield. The structure of (123) was determined by an X-ray crystal 
structure determination (Figure 23). We suggest that (107) could have undergone 
decarboxylation during the acidic hydrolysis, and that lactone closure might be caused 
by K2C03. The isoxazole ring opening, however, requires a reductive process that we 
cannot explain satisfyingly (Scheme 60). 
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6_3.3 Approach 2 
For the second approach, 2-hydroxybenzaldehyde oxime (104) was again heated 
under refluxed with NCS and pyridine in chlorofonn. After extraction, the crude 
product was stirred with 5-methylcyclohexane-l,3-dione (10) in sodium isopropoxide, 
in propan-2-01 to yield 3-(2-hydroxy-phenyl )-6-methyl-4,5,6, 7-
tetrahydrobenzo[dJisoxazol-4-one (108) in 52 % (based on oxime) (Scheme 61). 
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! sodium isopropoxide 
52 % (based 
on oxime) 
Using a similar strategy as in Approach I, we plarmed to put a carbon chain on the 
phenolic group followed by another on the C5 carbon to allow a coupling reaction or 
a ring closing metathesis to furnish the II-membered macrocycle (Scheme 62). 
Scheme 62 
3-(2-Hydroxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[djisoxazol-4-one (108) was 
deprotonated by potassium carbonate in dry THF and then reacted with allyl bromide 
to yield 3-(2-allyloxyphenyl)-6-methyl-4,5,6,7 -tetrahydrobenzo[ djisoxazol-4-one (117) 
in 43 %. Ketone (117) was further deprotonated by LDA in dry THF with HMPA as a 
co-solvent at -78 ·C. Allyl bromide was added at -78 ·C to give both mono-allylated 
and di -allylated products, 
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5-allyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (124) 
and 5 ,5-diallyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6, 7-
tetrahydrobenzo[ dJisoxazol-4-one (125) in 11 % and 7 %, respectively (Scheme 63). 
Reactions using DMPU instead of HMPA gave similar yields. The evidence of C-5 
alkylation was deduced from the IH NMR spectra. The CS protons next to a ketone in 
(117) were shifted more downfield: 2.70 ppm (J9.7 and 17.0 Hz) and 3.08 ppm (J 5.2 
and 17.0 Hz), compared to the C7 protons: 2.39 ppm (J 11.0 and 15.9 Hz) and 2.65 
ppm (J 3.6 and 15.9 Hz). Those CS signals disappeared after dialkylation, leaving 
only signals at 2.28 ppm (J 11.0 and 15.9 Hz) and 2.86 ppm (J 3.6 and 15.9 Hz), 
which represented the C7 protons. The J value patterns provided a very clear 
confirmation of protons that disappeared after alkylation, therefore the position of 
alkylation. 
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Besides allyl bromide, we also tried CS alkylation with l-bromo-3-methylbut-2-ene. 
3-(2-Allyloxyphenyl)-6·methyl-4,5 ,6, 7 -tetrahydrobenzo[ dJisoxazol-4-one (117) was 
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deprotonated by 2.S equiv. ofLDAin THF:DMPU (6:1) at -78 ·C, followed by adding 
I-bromo-3-methylbut-2-ene. Mono-alkylated product, 
3-(2-Allyloxyphenyl)-6-methyl-S-(3-methylbut-2-enyl)-4,S,6,7-tetrahydrobenzo[d]-
isoxazol-4-one (126) and di-alkylated product 
3-(2-aIIyloxyphenyl)-6-methyl-S,S-bis-(3-methylbut-2-enyl)-4,S,6,7-tetrahydrobenzo-
[dJisoxazol-4-one (127) were isolated in 23 % and 10 %, respectively (Scheme 64). 
Again, C-S alkylation was suggested by the disappearance of the more downfield 
signal representing CS protons (similar to the situations discussed above). We now 
had available four potential substrates, (124)-(127), for ring-closing metathesis. 
(117) 
43% 
LOA, 
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• 
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6.3.3.1 Ring-Closing Metathesis (RCM) 
Ring-closing metathesis has recently been used widely in many natural product 
syntheses. It is a very effective method to form different ring systems, especially 
medium and large rings in natural product synthesis. 10s Ring-closing metathesis 
offers rearrangement of carbon-carbon double bonds in the presence of metal carbene 
complexes. It is one variety of alkene (olefin) metathesis. 
Introduction 
There are three main types of alkene metathesis reactions: 1) ring-closing metathesis 
(RCM), 2) cross metathesis and 3) ring-opening metathesis polymerisation (ROMP) 
(Figure 3). Ring-closing metathesis is a reaction that closes rings from acyclic dienes 
promoted by the catalysts. Ring opening metathesis polymerisation is, as its name 
implies, a reaction where a cyclic olefin is ring opened by the catalyst and then 
polymerises .with another unit. Cross metathesis takes place intermolecularly between 
two olefins to yield a "dimerised" product (Figure 24). ROMP processes will not be 
further discussed here. 
Ring-closing metathesis has been demonstrated to work efficiently despite different 
conformations of the starting material. No matter whether the conformation of the 
starting material· is in the suitable arrangement or not, by modifying the reaction 
conditions, such as amount of catalyst added, time of addition, temperature and 
reacti~n time, macrocyclisation of the molecule can usually be achieved.106 This big 
advantage circumvented the usual considerations of ring closure for large ring 
systems (ring carbon ~ 9).107 
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Although there are a lot of metal carbene catalysts developed from transition metal 
salts and their complexes with organometallic compounds, the most commonly used 
are molybdenum and ruthenium complexes. They are also known as Schrock and 
Grubbs catalysts, respectively. The catalysts can be used with a solid support.I08 
Schrock catalyst is highly reactive towards a broad range of sterically or electronically 
varied substrates. However, it is highly sensitivity to air, moisture or even trace 
amounts of impurities present in solvent, which means reaction using Schrock catalyst 
has to be carried out in an inert atmosphere within adosed system. Its drawbacks also 
include moderate to poor functional group tolerance.109 
Grubbs catalysts are much more stable in air compared with the Schrock systems. 
They can be weighed out in open air without significantly reducing catalytic 
reactivity.llo They have a very good functional group tolerance towards many 
different functional groups, like most ethers, alcohols, secondary amides, carbamates 
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and sulfonamides. Compared to Grubbs I catalyst, the second generation, Grubbs II 
catalyst has a higher thermal stability and is less sensitive to double bond substitution 
in alkene substrates (Figure 25).107 
Cl PICy3 Ph ". / Ru~ 
cll 
PCy3 
Grubbs I catalyst 
. Mechanism 
Grubbs 11 catalyst Schrock catalyst 
Figure 25 
Ring-closing metathesis has an entirely different mechanism to other ring-closing 
reactions. It includes a new carbon-carbon bond formation through a four-membered 
metallacycle with the metal catalyst. 
The mechanism of the ring closing metathesis proceeds through a series of [2+2] 
cycloadditions. The following is an example of a ring-closing metathesis reaction 
catalyzed by Grubbs II catalyst (Scheme 65). 
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The first step of the reaction is a [2+2] cycloaddition of the carbene complex (128) to 
one of the alkenes, forming a four-membered ring (129) containing the metal. Then, 
the same type of reaction occurs in reverse, cleaving two bonds of the four-membered 
ring, and generating a new carbene complex (130) with styrene as a leaving group. An 
intramolecular [2+2] cycloaddition occurs between the new carbene complex and the 
second alkene, in order to close the five-membered ring. A second metallacyclobutane 
(131) is made in this stage, which decomposes in the same way as before to give a 
methylene carbene complex and the product (132) required. 1bis new carbene 
complex then attacks another molecule and repeats the cycle.1l1 The ring closing 
metathesis reaction cycle is reversible, so generation of a volatile leaving alkene will 
97 
Result and Discussion 
drive the reaction forwards. In the case above, ethene is generated in every cycle after 
the first cycle (when Ru=CH2 was generated and used as the catalyst). 
Attempted RCM to Form the ll-Membered Macrocycle 
To approach our target molecule, we need to furnish the ll-membered macrocycle 
and we decided to use Grubbs 11 catalyst to attempt the RCM reaction. Beginning 
with a simpler version, the mono-C-a1lylated product, 
5-a1lyl-3-(2-allyloxy-phenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one 
(124) was reacted with Grubbs 11 catalyst in dry DCM under reflux to attempt to form 
a closed ll-membered ring molecule. A low concentration (O.OIM) of 
5-allyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6, 7 -tetrahydrobenzo[ dJisoxazol-4-one (124) 
was used to avoid dimerisation instead of intramolecular ring closure. l12 The IH 
NMR spectrum shows some indications of the product we needed, however, the mass 
spectrum did not match (Scheme 66). 
Another ring-closing reaction was performed under the same condition and using 
Grubbs 11 catalyst with the di-allylated product 
5,5-diallyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one 
. (125). 5-Cyclopentene-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-
tetrahydrobenzo[ d]isoxazol-4-one (134) was isolated in 27 % yield. It proved that the 
Grubbs 11 catalyst we were using was active. Also it showed that the RCM between 
two adjacent allyl chains was much more efficient than two alkenyl chains that are far 
away from each other. 
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11-mem bered ring 
Grubbs 11 Cat 20 mol %, . 
dry DCM, reflux (133) 
-------*---------
l o l o 
Grubbs 11 cat 20 mol% 
,. 
Scheme 66 
The failure of RC M to close the ll-membered ring may be caused by the rigidity of 
the structure of 5-ally l-3-(2-allyloxyphenyl)-6-methyl-4,5,6, 7-
tetrahydrobenzo[ dJisoxazol-4-one (124), reducing the flexibility of the molecule, and 
not allowing the two chains to come close enough for the catalyst to co-ordinate in a 
4-membered ring. Molecular modeling by Spartan also showed a repulsive force by 
the carbonyl oxygen. The oxygen is stericaIly blocking the carbon chains (Figure 26). 
-
c 
Carbonyl oxygen blocking the two chains 
Figure 26 
99 
27% 
(134) 
Result and Discussion 
Since ring closure of the Il-membered ring in our isoxazole system was unsuccessful, 
we were prompted to further our investigation in this area We have tried ring closing 
a 12-membered ring, see if a larger ring size would allow a better conformation for 
the ring-closing metathesis to occur. In the same way as before, 
3-(2-hydroxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (108) was 
deprotonated by potassium carbonate in dry THF and then reacted with 
4-bromo-but-l-ene to yield 3-(2-but-3-enyloxyphenyl)-6-methyl-4,5,6,7-
tetrahydrobenzo[dJisoxazol-4-one (135), which has one more carbon atom than allyl 
derivative (117), in 4 %. It was further deprotonated by LDA in dry THF and DMPU 
as a co-solvent at -78 'C. Allyl bromide was added at -78°C to quench the reaction 
and give both mono-allylated and di-allylated product, 5-allyl-
3-(2-but-3-enyloxyphenyl)-6-methyl-4,5,6, 7 -tetrahydrobenzo[ dJisoxazol-4-one (136) 
and 5,5-diallyl-3-(2-but-3-enyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo-
[dJisoxazol-4-one (137), both in 21 % yield (Scheme 67). Mono-allylated product 
(136), was brought forward for RCM with Grubbs 11 catalyst in DCM at 40°C. 
However, none of the desired product (138) was obtained and starting material 
recovered. The result suggested a ring with one more carbon (12-membered ring) also 
cannot be closed. The reason is probably the same as the ll-membered case, namely 
the rigidity and size of ring. 
100 
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Thus, it seemed that the rigidity of the isoxazole ring disallowed the formation of 
ll-membered macrocyc1e. To overcome this problem, we decided to open the 
isoxazole ring. Isoxazole rings can be opened by a range of different reagents, Smh, 
Raney nickel and iron complex, Fe2(CO)g1l3 etc .. As a model reaction the isoxazole 
ring of 6-methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) was opened 
successfully by MO(CO)6 (in moist MeCN) and hydrogen to yield 
2-(amino-phenyl-methylene)-5-methylcyc1ohexane-l,3-dione (139) in 18 % for both 
conditions. Allyloxy substituted isoxazole, 
3-(2-allyloxyphenyl)-6-methyl-4,5,6, 7 -tetrahydrobenzo[ dJisoxazol-4-one (117) was 
opened by the MO(CO)6 protocol to yield 
2c[(2-allyloxyphenyl)aminomethylene]-5-methylcyclohexane-l,3-dione (140) in 47 %. 
Hydrogenation was not tried in this case because the double bond of the allyl group 
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would be reduced at the same time. However, we were not able to ring-open the 
mono-C-allylated product, 5-allyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-
tetrahydrobenzo[dJisoxazol-4-one (124) (Scheme 68). We have tried MO(CO)6, Raney 
nickel and Smh reactions but none of these were able to open the isoxazole ring, and 
starting material was recovered. We have no idea why the isoxazole ring-opening of 
this compound was not successful, although we doubted whether it was affected by 
other active co-ordinating groups present in the molecule, since compounds (6) and 
(117) reacted successfully. 
(6) 
l 
(117) 
(125) 
6.3.4 Conclusion 
a) Mo(CO)" 
or 
• 
b) ~ PdlC 10 % 
Mo(CO). 
• 
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b) Raney-Ni 
or 
------lE-------
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Scheme 68 
NH2 0 ~(139) 
A 0 18% 
(140) 
.47% 
(141) 
Based on the information from compounds with an non-substimted phenyl group, we 
have made available the o-substimted phenylisoxazole bnilding blocks, with different 
o-substituents, like hydroxyl, allyl and benzyl. We have looked at alkylation of the 
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hydroxyl group for approach I, and an unexpected cyclised product was obtained. 
Nevertheless, this lactone might still be potentially useful for further synthesis. 
For approach 2, we have applied our alkylation experience to the 
o-hydroxyphenylisoxazole building block to yield a precursor for an ll-membered 
macrocycle. However, the ring-closing metathesis by Grubbs II catalyst was 
unsuccessful. 
6.4 Bis-o-Substituted Phenyl Group as Isoxazole Substituent 
(Attempted Synthesis towards Colephomones A, Band C) 
6.4.1 Formation of Building Blocks 
Further to reactions using an ortho-substituted phenyl group as the aromatic isoxazole 
substituent, we decided also to investigate other substituted aromatic groups, which 
have the same aromatic substitution pattern as our target molecules, coleophomones A, 
B and C. We have chosen a bis-ortho-substituted phenyl derivative, 
2-brorno-6-methoxybenzaldehyde oxime (142) as the aromatic precursor. The OMe 
group acted as a protected form of OH, and the Br would be used for coupling to 
carbon substituents. 
We could not fmd a suitable bis-ortho-substituted oxime commercially available, 
therefore, we prepared 2-bromo-6-methoxybenzaldehyde oxime (142) from 
o-anisaldehyde (143). o-Anisaldehyde (143) was reacted with 
N,N'-dimethylethylenediamine in ethanol to yield 
2-(2-methoxyphenyl)-1,3-dimethylimidazolidine (144) in 72 %. I-BuLi was added to 
freshly distilled imidazolidine product (144), which was then treated with 
dibromotetrachloroethane after stirring in room temperature for 6 hours. 
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2-Bromo-6-methoxybenzaldehyde (145) was obtained in 35 % as a yellow solid after 
acidic aqueous work-up. This aldehyde (145) was converted into oxime in the 
presence of hydroxylamine hydrochloride and sodium acetate to give 100 % crude 
yield of2-bromo-6-methoxybenzaldehyde oxime (142) (Scheme 69). 
&e l I~ --::; 
(143) 
MeNH(CH2)2NHMe 
• 
e
e(OH 
NH,oHHCI 
I ~ -.----------
.0 Br NaCOOCH3 
100 % crude (142) 
Scheme 69 
6.4.2 Approach 1 
6(e l I~ 
--::; Br 
35% 
(145) 
2-Bromo-6-methoxybenzaldehyde oxime (142) was heated at reflux in chloroform 
with NCS and pyridine then extracted by DCM. Without purification, 
2-bromo-6-methoxyphenylhydroximoyl chloride (146) was treated with 6 equiv. of 
pyrrolidine enamine (8) and triethylamine to yield methyl 
5-methoxycarbonylmethyl-3-(2-bromo-6-methoxyphenyl)isoxazole-4-carboxylate 
(147) in just 5 % (Scheme 70). The only reason for this low yield that we can propose 
is the steric effect of the two ortho substituents hindering 1,3-dipolar cycloaddition. 
Due to the time limitations, we decided not to carry forward as the yield was not yet 
good enough. 
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For the second approach, 2-bromo-6-methoxybenzaldehyde oxime (142) was brought 
to reflux with NCS and pyridine in chloroform. The extracted crude material was 
stirred with 5-methylcyclohexane-l,3-dione (10) in sodium isopropoxide to give 
3-(2-bromo-6-methoxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one 
(148) in a decent 75 % yield (based on 5-methylcyclohexane-l,3-dione) (Scheme 71). 
OMe rOH 
(142) ~ 
llABr 
NCsl 
rte5:~ + 
lABr 
100 % crude (146) 
O~ 
(10) 
Sodium 
Isopropoxide 
Scheme 71 
OMe N-O ~ BrO 
75 % (148) 
Allyl and 3-methylbut-2-enyl chains were incorporated at the CS position by the 
method developed earlier. 
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3-(2-Bromo-6-methoxyphenyl)-6-methyl-4,5,6,7-tetrahydrobeDZo[dJisoxazol-4-one 
(148) was reacted with allyl bromide or I-bromo-3-methylbut-2-ene in LDA with 
DMPU as a co-solvent to yield the products shown in the table below (Table 7). In the 
IH NMR spectra of alkylated products, the disappearance of the more downfield 
signals between 2.66-3.16 ppm, which represent protons next to the ketone group, 
suggested CS alkylations. 
Starting materal & Co-solvent reagents Products Yield 
alkylating reagent 
DMPU LDA 18% 
2.10 equiv. 
BrO 
(148) (149) 
~Br Alkylating 17% 
reagent 
1.20 equiv. 
~(150) 
DMPU LDA 22% 
2.10 equiv. 
BrO 
(148) 
(151) 
~Br Alkylating 23% 
reagent 
2.00equiv. 
(152) 
Table 7 
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To synthesise the natural products coleophomones A, B and C, we needed to generale 
a double bond between the C6 and C7 positions. The di-alkylated product, 
3-(2-bromo-6-methoxyphenyl)-6-methyl-S,S-bis-(3-methylbut-2-enyl)-4,S ,6, 7 -tetra-
hydrobenzo[dlisoxazol-4-one (152) was chosen because the carbon chains are closest 
to those required in the final product. (152) was deprotonated by LDA in the presence 
of DMPU and then treated with phenylselenium bromide to yield 
3 -(2-bromo-6-methoxyphenyl )-6-methyl-S,S-bis-(3 -methylbut-2-eny 1)-7 -phenyl-
selenyl-4,S,6,7-tetrahydrobenzo[dlisoxazol-4-one (153) in 41 % (Scheme 72). 
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22% 
(151) 
23% 
(152) 
isoxazole of 
3-(2-bromo-6-methoxyphenyl )-6-methyl-5,5-bis-(3 -methy lbut -2-eny 1 )-7 -phenyl-
selenyl-4,5,6,7-tetrahydrobenzo[djisoxazol-4-one (153), and then oxidise the 
phenylselenyl group to give double bond in one-pot. However, no ring-opened 
product was resulted. It was assumed the MO(CO)6 failed to ring-open the isoxazole. 
Smh has been tried but failed as well. We have reversed the sequence of ring-opening 
and oxidation, i.e. an initial oxidation, but again no product was obtained. Lack of 
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time prevented further study along this route. 
6.4.4 Conclusion 
A bis-artha-substituted isoxazole building block was made for both approach 1 and 2. 
Carbon chains and a phenylselenyl group were added on the CS and C7 carbons 
respectively in approach 2 towards the structure of coleophomones. However, the 
isoxazole ring opening by MO(CO)6, Raney nickel and Sm12 was unsuccessful. 
Therefore, we were unable to advance the synthesis towards coleophomones A, B and 
C. Deprotection-alkenylation of the phenolic group, and elaboration of the bromo 
substituent by coupling, remain to be studied. 
6.5 o,m-Substituted Phenyl Group as Isoxazole Substituent 
(Attempted Synthesis towards Coleophomone D) 
6.5.1 Formation of Building Blocks 
.To syntheses coleophomone D, an artha-meta-disubstituted benzaldehyde oxime was 
needed. 2-Acetoxymethyl-3-methoxybenzaldehyde oxime (154) was selected as a 
suitable 1,3-dipole precursor carrying substituents appropriate to coleophomone D. 
Oxime (154) was made from 2,3-dimethylanisole (155) by an initial photolytic 
brominationY4 2,3-Dimethylanisole (155) and freshly recrystallised NBS in CC4 
was stirred under nitrogen, while being exposed to a 300 watt high intensity tungsten 
lamp. The reaction mixture was heated to reflux by the lamp. After S hours, 93 % of 
the desired tri-brominated product, 2-bromomethyl-3-( dibromomethyl)anisole (156) 
was obtained. A range of brominated products were collected with different 
equivalents ofNBS and reaction conditions (Scheme 73), as demonstrated in the table 
below (Table 8). 
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NBS (equiv.) Solvent Lamp (watt) Time (h) Product· 
2.1 cyclohexane 150 2 mono 
3.0 cyclohexane 150 overnight mono+di 
3.0 CCI4 150 3 Mono+di 
3.0 CC4 150 overnight Di 
3.0 cyclohexane (10 mol % 300 overnight Di 
AIBN) 
3.0 CCI4 300 5 Tri 
4.0 CCI4 300 overnight Tetra 
* mono (157), di (158), tri (156) and tetra (159) bromo derivatives 
Table 8 
6: NBS 
(155) 
25%(157) 30%(158) 
~~ 
Br Br 
.. 
~Br 
~Br 
Br 
93 %(156) 
Scheme 73 
pBr 
~Br 
Br 
90 %(159) 
This photolytic bromination method was developed by BOX'S1l4 group in 1990, using 
NBS in CC4 under a 250 W outdoor spot light. Due to a delay with restrictions on . 
purchasing CC4, we started initially to perform the bromination in a less toxic solvent, 
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cyclohexane (instead of CC4) with NBS under a 150 W high intensity tungsten lamp. 
However, only mono (157) and di (158) brominated products were observed, with 2.1 
equiv. and 3.0 equiv. NBS respectively. No further product beyond di-bromination 
was achieved under this condition. Once we received the CC4, we attempted the same 
bromination again. However, surprisingly, a same result was observed even when we 
used CC4 with NBS under a 150 W high intensity tungsten lamp. We have contacted 
Box, the original author, regarding the conditions they used. He agreed with our 
observation of mono (157) and di (158) brominated products formation, and could not 
find any significant error in our reactions. We decided to use a higher intensity 
tungsten lamp with extended reaction time as our last trial. A 300 W high intensity 
tungsten lamp was shone onto the reaction mixture in CC4, and the tetra brominated 
compound was finally obtained. 
We found that tri- and tetra- brominated products (156) and (159) could only be made 
by reactions with CC4 and 300 watt tungsten lamp. Any other conditions only 
produced mono- and di- brominated products (157) and (158). Tetrabromo (159) is 
crystalline, and we were able to obtain an X-ray crystal structure (Figure 26). 
Figure 26 [X-ray crystal structure of (159) Appendix Ill] 
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The desired oxime (154) was made from tri-brominated product, 
2-bromomethyl-3-(dibromomethyl)anisole (156). The tribromo compound was stirred 
with anhydrous sodium acetate in glacial acetic acid to yield 
2-acetoxymethyl-3-methoxybenzaldehyde (160) in 65 %. Further reaction with 
hydroxylamine hydrochloride and sodium acetate resulted in a 100 % crude yield of 
2-acetoxymethyl-3-methoxybenzaldehyde oxime (154) (Scheme 74). 
(155) 
3.0 equiv NBS, cq, 
300 W tungsten lamp 
• ~~.:, 
Br 
CH,COONa ! acetic acid 
AijCO N .... OH AcOij . 
MeO I NH.,OHHCI MeO I 65 % I ~ .... ------ '<::: (160) 
~ NaCOOCf! I .& 
100 % crude (154) 
Scheme 74 
Approach 1 was not tried on the ortho-meta-disubstituted benzaldehyde oxime, as the 
yield from the previous reactions with bis-artha-substituted oxime was not 
satisfactory. Therefore, we moved on to Approach 2. 
6.5.2 Approach 2 
2-Acetoxymethyl-3-methoxybenzaldehyde oxime (154) was treated with NCS and 
pyridine in chloroform. The extracted crude product was stirred with 
5-methy1cyclohexane-l,3-dione (10) in sodium isopropoxide to yield 
3-(2-acetoxymethyl-3-methoxyphenyl}-6-methyl-4,5,6,7-tetrahydrobenzo[d]isoxazol-
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4-one (162) in 38 % yield (based on 5-methylcyc1ohexane-l,3-dione) (Scheme 75). 
Me:~l j~OH 0" (154) 
! NCS 
AijCO N~OH 
MeD I 
I "'" Cl + 
d' 
100 % crude (161) 
Sodium 
isopropoxide MeD 
• 
Scheme 75 
38 % (162) 
3-(2-Acetoxymethyl-3-methoxyphenyl)-6-methyl-4,5,6, 7 -tetrahydrobenzo[ djisoxazol-
4-one (162) was deprotonated by LDA with DMPU as co-solvent and then reacted 
with I-bromo-3-methylbut-2-ene to yield mono-alkylated product, 
3-(2-acetoxymethyl-3-methoxyphenyl)-6-methyl-5-(3-methylbut-2-enyl)-4,5,6,7-tetra 
hydrobenzo[djisoxazol-4-one (163) and di-alkylated product, 
3-(2-acetoxymethyl-3-methoxyphenyl)-6-methyl-5,5-bis-(3-methylbut-2-enyl)-4,5,6,7 
-tetrahydrobenzo[djisoxazol-4-one (164) in 15 % and 23 % respectively. Evidence of 
CS alkylations was shown by disappearance of the CS proton signals in the IH NMR 
spectrum of (162). The more deshielded CS protons next to the ketone at 2.62 ppm (J 
9.7 & 16.9 Hz) and 3.10 ppm (J 5.0 & 16.9 Hz) were absent after alkylations, 
showing the protons at CS were replaced by a1kylating groups. 
After the carbon chains addition, we next attempted double bond generation at C-6 
and C-7, which again was needed for the coleophomone D. Di-alkylated product (164) 
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was treated with LDA and phenylselenium bromide in DMPU to yield 
3-(2-acetoxymethyl-3-methoxyphenyl)-6-methyl-5,5-bis-(3-methyIbut-2-enyl)-7-phen 
ylselenyl-4,S,6,7-tetrahydrobenzo[dJisoxazol-4-one (165) in 39 %. The isoxazole ring 
was opened by MO(CO)6, without purification, and the crude product was further 
treated with H202 to oxidise the phenylselenyl group which then underwent 
elimination to produce the double bond. 
2-[ 1-Amino-l-[3-methoxy-2-(2-oxo-propoxy )-phenyl]-meth-(E)-ylidene ]-5-methyl-6, 
6-bis-(3-methyl-but-2-enyl)-cyciohex-4-ene-I,3-dione (166) was obtained in 20 % 
(Scheme 76). Due to the time limitations, we have not been able to continue to 
coleophomone D. 
114 
(162) MeO 
39 % MeD 
(165) 
I 
Mo(CO~ 
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20% 
(166) 
However, the steps left should be very straightforward. According to Nicolaou's 
research, the carbonyl group at the ortho position of (166) can be· made by simple 
removal of the acetyl group using K2C03 in MeOH followed by oxidation with Mn02. 
Hydrolysis of the enaminoketone at some stage should yield coleophomone D 
(Scheme 77). 
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6.5.3 Conclusion 
K"C03 
---- --..-
MeOH 
... --------
Scheme 77 
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i Mno, 
• 
An o,p-disubstituted phenylisoxazole building block was made for approach 2. We 
successfully performed reactions, such as alkylation, isoxazole ring opening and 
phenylselenyl group elimination to generate a double bond on the building block. 
These work well and developed an isoxazole route towards the natural tatget molecule, 
coleophomone D. 
7.0 Final Conclusion 
Two approaches to syntheses of the coleophomones A, B, C and D have been tried. 
Although we have not completed the total synthesis, we have made the precursors for 
the coleophomone family by an isoxazole route. A precursor (166) for coleophomone 
D was made in a overall yield of 0.41 % from 
2-acetoxymethyl-3-methoxybenzaldehyde oxime (154) with 
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5-methy1cyclohexane-I,3-dione (10). According to Nicolaou's work, we will be able 
to make the final product easily by deprotecting our precursor (166) to generate the 
hydroxyl group and oxidise to aldehyde. 
The isoxazole ring-opening of (153) was unsuccessful using MO(CO)6, Raney nickel 
and 8mb However, we are confident that the cleavage can be achieved by another 
suitable reagent. As long as the ring opening is successful, coleophomones A, B and C 
could be synthesed from it. The compound (153) was made in an overall yield of 1.78 
%. 
(166) (153) 
Figure 27 
Comparing the two approaches we have tried, we concluded that route 2 is more 
effective than route 1. Route 1) was through the isoxazole ring with ketone or ester 
substituents and route 2) through a reduced benzisoxazole. The attempts at formation 
of a six -membered ring between the two esters for route 1 were not successful, and a 
low yield was obtained from the 1,3-dipolar cycloaddition. 
Although the natural target molecules were not achieved, we have made available 
several analogues of the coleophomone family, which could be very valuable 
compounds. 
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8.0 Experimental- General 
Infrared spectra were recorded on a Perkin Elmer Paragon 1000 FT-IR spectrometer 
as liquid films, nujol mulls, chloroform solutions, neat (from evaporation of an 
acetonitrile or dichloroinethane solution) or in KBr discs as stated. 
NMR spectra were measured on either a Bruker AC Broadband HX 5mm probe 250 
MHz or 400 MHz Avance 5mm B.B. dual gradients probe FlNMR spectrometer 
using CDCh, <4-methanol, ~-acetone or ~-DMSO as the solvent as indicated. 
Coupling constant (J) values are given in Hz. 
Mass spectra were measured by JEOL SX 102 high resolution spectrometer, and 
EPSRC National Mass Spectrometry Service Centre (University of Wales Swansea). 
Flash column chromatography was performed with silica gel 60 (40-63 J,t,230-400 
mesh, 60 A), unless stated otherwise. TLC analyses were performed on Merck UV 
active aluminium plates coated with 0.2 mm silica 60 F254 or on alumina plastic 
plates. 
Melting point measurement was performed on Gallenkamp hot stage or Stuart 
Scientific (SMP3) melting point apparatus and they are mostly uncorrected. 
Combustion microanalysis was performed on a Perkin Elmer Analyser 2400 CRN 
and by Warwick Analytical Service. Results are given as percentages. 
Commercial reagents were normally used without further purification, unless stated. 
Dry tetrahydrofuran (THF) was freshly distilled from sodium over pre-dried THF 
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with benzophenone. Dichloromethane, ethyl acetate and petroleum ether (40-60 0c) 
were distilled according to standard methods for general use. ll5 Reagents were 
purified when necessary using standard procedures. ll5 Standard techniques were 
employed for handling air-sensitive reagents and all air-sensitive reaction were carried 
out under a nitrogen atmosphere. 
8.1 Experimental 
Methyl 5-methoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5) 
~OH 
aY 
~_CI 
o 
• 
+ 
o Et,N 
MeOUJOMe-
(8) 
OMe 
Benzaldehyde oxime (1.36 g, 11.24 mmol) in chloroform (50 ml) was added to 
N-chlorosuccinimide (1.64 g, 12.36 mmol) in chloroform (50 ml). The mixture was 
then heated under reflux in a 3-necked flask under an atmosphere of nitrogen for 1.5 h. 
The solution was checked by TLC to confirm that no N-chlorosuccinimide was 
present. After cooling to room temperature, dimethyl 
3-(I-pyrrolidino)pent-2-ene-l,5-dioate (8) (15.33 g, 67.44 mmol) was added in one 
portion, followed by triethylamine (1.70 ml, 12.36 mmol) in chloroform (5 ml) 
dropwise over 45 min. The reaction mixture was heated under reflux at an atmosphere 
of nitrogen for 3 h and then left to stir at room temperature for 16 h. The reaction 
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mixture was concentrated in vacuo to yield a yellow oil, which was purified by flash 
column chromatography on silica gel using petroleum ether:ethyl acetate (5:3 v/v) as 
eluent to yield methyl 5-methoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5) 
(1.32 g, 43 %) as a yellow oil; MS (EI+) found 275.0798, CI4HI3NOS; requires 
275.0794; Vrnax (neat)/cm-1 1741 (C=O), 2848, 2873 and 2953 (CH2, CH3); 15H 
(250MHz; CDCb) 3.75 (s, 6H, 2 x CH3), 4.19 (s, 2H, CH2) and 7.40-7.44 (m, 3H, 3 x 
Ar-H), 7.62-7.65 (m, 2H, 2 x Ar-H); 15c (lOOMHz; CDCb) 33.5 (2 x CH3), 37.6 (CH2), 
109.8 (c), 128.1 (2 x Ar-CH), 129.4 (2 x Ar-CH), 121.0 (Ar-CH), 132.4 (Ar-C), 161.4 
(C), 161.8 (C), 167.3 (C), and 171.3 (C). 
Product in 55 % was obtained ifDCM extracted chlorinated oxime was used. 
6-Methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) 
~OH o Cl 
(83) 
+ o~ 
(10) 
Sodium 
isopropoxide 
(6) 
To a solution of sodium isopropoxide prepared from sodium (0.45 g, 19.60 mmol) in 
isopropyl alcohol (100 ml), were added successively 5-methylcyc1ohexane-l,3-dione 
(10) (2.47 g, 19.60 mmol) and phenylhydroximoyl chloride (83) (1.47 g, 9.37 mmol). 
After stirring for 1 h at room temperature, the reaction mixture was poured into water 
(50 ml), and extracted with ethyl acetate (1 x 300 ml, 2 x 50 ml). The combined 
organic layer was washed with brine (2 x 100 ml), dried over sodium sulfate, filtered 
and concentrated under reduced pressure. The crude product was purified by.flash 
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column chromatography using petroleum ether:diethyl ether (2:1 v/v) as eluent to 
yield 6-methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) (1.30 g, 61 %) 
as a white solid; mp 105-106 cC; MS (EI+) found 227.0947, CI.JI13N02; requires 
227.0946; Vmax (CHCb)/cm-1 1687 (C=N), 1720 (C=O), 2872, 2927 and 2958; liH 
(400MHz; CDCb) 1.17 (d, J 6.6, 3H, CH3), 2.30 (dd, J 11.1 and 16.0, lH,OCCH2), 
2.46-2.50 (m, lH, CH), 2.61 (dd, J 3.8 and 16.0, lH, OCCH2), 2.64 (dd, J 10.0 and 
17.4, lH, O=CCH2), 3.13 (dd,J4.8 and 17.4, lH, 0=CCH2) and 7.37-7.43 (m, 3H, 3 
x Ar-H), 7.97-8.01 (m, 2H, 2 x Ar-H); lie (lOOMHz; CDC13) 20.8 (CH3), 30.3 (CH), 
31.3 (CH2), 47.2 (CH2), 114.0 (C), 128.4 (2 x Ar-CH), 129.2 (2 x Ar-CH), 130.6 
(Ar-CH), 132.4 (Ar-C), 159.9 (C), 182.0 (C) and 191.6 (C). 
DimethyI3-(1-pyrrolidino)pent-2-ene-l,5-dioate (8) 
000 MeO~oMe Dean Stark • ~ 
(8) 
Dimethyl 1,3-acetonedicarboxylate (17.00 g, 97.61 mmol) and pyrrolidine (8.22 ml, 
98.89 mmol) were heated in dry toluene (165 ml) at reflux under a Dean-Stark trap for 
2 h. Water was separated (1.77 ml, 97.61 mmol) and the solvent was evaporated in 
vacuo to give dimethy13-(1-pyrrolidino)pent-2~ene-l,5-dioate (8) (22.10 g, 100 %) as 
a yellow oil, which was used without purification, MS (FAB+) found 228.1233 
[M+H], CIIHI7N04; requires 228.1236 [M+H]; Vmax (neat)/cm·1 1740 (C=O), 2870 
and 2949 (CH2, CH3); liH(250MHz; CDCb) 1.88-1.94 (m, 4H, CH2CH2), 3.18-3.35 
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(m, 4H, CH2NCH2), 3.57 (s, 3H, CH3), 3.69 (s, 3H, CH3), 4.12 (s, 2H, CH2) and 4.56 
(s, lH, CH); lie (100MHz; CDCh) 25.1 (CH2CH2), 35.5 (CH2), 48.0 (CH2NCH2), 
49.8 (CH3), 50.1 (CH3), 52.2 (CH), 154.6 (C), 169.3 (C) and 170.2 (C). 
5-Carboxymethyl-3-phenylisoxa1.o1e-4-carboxylic acid (78) 
2.5 equiv. NaOH 
OMe OH 
MethyI5-methoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5) (4.46 g, 16.21 
mmol) was heated at reflux with sodium hydroxide (1.62 g, 40.53 mmol) in water (30 
ml) and methanol (10ml) for 16 h. After reflux, the solution was cooled, filtered and 
acidified by concentrated hydrochloric acid to pH 1. The resultant white solid was 
filtered and washed with dry ether (5 ml) to yield 
5-carboxymethyl-3-phenylisoxazole-4-carboxylic acid (78) (0.75 g, 81 %) as a light 
yellow solid; mp 192-193 °C; MS (FAB+) found 248.0565 [M+H], C'2H~05; 
requires 248.0559 [M+H]; Vmax (Nujol)/cm-' 1642 (C=N), 1728 (C=O), 2863 and 
2944 (CH2); liH(250MHz; d6-DMSO) 4.20 (5, 2H, CH2), 7.49-7.53 (m, 3H, 3 x Ar-H), 
7.62-7.65 (m, 2H, 2 x Ar-H) and 13.18 (broad peak, 2H, 2 x OH); lie (lOOMHz; 
~-DMSO) 36.8 (CH2), 109.7 (C), 128.1 (2 x Ar-CH), 129.2 (2 x Ar-CH), 129.9 
(Ar-CH), 132.3 (Ar-C), 161.1 (C), 161.7 (C), 167.2 (C) and 171.1 (C). 
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Methyl 
5-(I-methoxycarbonyl-4-methylpent-3-enyl)-3-phenylisoxazole-4-carboxylate (79) 
(Method A) 
2.0 equiv. LOA 
OMe • 
)=yBr COOMe 
Methyl 5-methoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5) (0.10 g, 0.36 
mmol) in dry THF (2 ml) at -78 °C was added dropwise to a freshly prepared solution 
of LDA (2.0 equiv.; 0.72 mmol), which was prepared from n-butyllithium (2.5 M 
solution in hexanes; 0.29 ml, 0.73 mmol) and diisopropylamine (0.12 ml, 0.84 mmol) 
in dry THF (2 ml) at 0 °C. The resulting mixture was allowed to stir at -78 °C for 30 
min. I-Bromo-3-methyl-2-butene (0.04 ml, 0.36 mmol) was added at -78 °C, and the 
mixture was allowed to warm to room temperature and stirred overnight. Saturated 
sodium hydrogen carbonate solution (5 ml) was added and the mixture was extracted 
with diethyl ether (3 x 15 ml). The combined extracts were washed with brine (1 x 30 
ml). The organic extracts were dried over sodium sulfate, filtered and the solvent was 
evaporated under reduced pressure. The crude product was purified by flash column 
chromatography using petroleum ether:ethyl acetate (2: 1 v/v) as eluent to yield 
methyl 5-(I-methoxycarbonyl-4-methylpent-3-enyl)-3-phenylisoxazole-4-carboxylate 
(79) (0.09 g, 70 %) as a yellowish oil; MS (EI+) found 343.1419 [M+Hj, CI9H21NOS; 
requires 343.1420 [M+H]; Vmax (neat)/cm-1 1734 (C=O), 2336 and 3012 (CH2, CH3); 
liH(400MHz; CDCb) 1.51 (s, 3H, CH3), 1.57 (s, 3H, CH3), 2.70-2.80 (m, 2H, CH2), 
3.65 (s, 3H, CH3), 3.67 (s, 3H, CH3), 4.48 (dd, J 6.4 and 8.9, lH, CHCOOMe), 
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5.00-5.04 (m, IH, CH) and 7.34-7.42 (m, 3H, 3 x Ar-H), 7.53-7.57 (m, 2H, 2 x Ar-H); 
lie (100MHz; CDCh) 17.7 (CH3), 25.7 (CH3), 28.7 (CH2), 44.8 (CH), 51.5 (CH3), 
52.6 (CH3), 58.7 (CH), 109.3 (C), 119.2 (C), 128.1 (2 x Ar-CH), 129.3 (2 x Ar-CH), 
129.9 (Ar-CH), 135.6 (Ar-C), 161.9 (C), 162.4 (C), 169.8 (C) and 174.6 (C). 
Methyl 
5-(1-methoxycarbonyl-4-methylpent-3-enyl)-3-phenylisoxazole-4-carboxylate (79) 
(Method B) 
2.5 equlv. n-BuU 
2.2 equlv.)=yBr. 
--------
h 
MeO 0 
(80) 
COOMe 
Methyl 5-methoxycarbonyImethyl-3-phenyIisoxazole-4-carboxylate (5) (0.12 g, 0.45 
mmol) in dry THF (5 mI) was added to l1-butyIIithium (2.5 M in hexane) (2.5 equiv., 
0.45 mI, 1.12 mmol) at -78 °C. The reaction was stirred for 15 min before 
I-bromo-3-methyl-2-butene (0.11 mI, 0.98 mmol) was added also at -78 °C. The 
reaction mixture was allowed to warm to room temperature and stirred overnight. 
Saturated sodium hydrogen carbonate solution (5 mI) was added, the reaction mixture 
was then extracted with diethyl ether (3 x 15mI) and the combined extracts were 
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washed with brine (1 x 30 ml). The organic extract was dried over magnesium sulfate, 
filtered and evaporated under reduced pressure. The crude product was purified by 
flash column chromatography using petroleum ether:ethyl acetate (3:1 v/v) as eluent. 
Only mono-a1kylated product, methyl 
5-(I-methoxycarbonyl-4-methylpent-3-enyl)-3 -phenylisoxazole-4-carboxylate (79). 
was obtained (0.06 g; 47 %) as a yellowish oil. Spectroscopic data as reported above. 
Methyl 
5-[1-methoxycarbonyl-4-methyl-l-(3-methylbut-2-enyl)pent-3-enyIJ-3-phenylisoxaz 
ole-4-carboxylate (80) 
(Method A) 
o COO Me 
(79) 
1.5 equiv. n-BuLi 
• 
1.0 equiv)=yBr o cOOMe 
(80) 
Methyl 5-( l-methoxycarbonyl-4-methylpent-3-enyl)-3-phenylisoxazole-4-carboxylate 
(79) (0.11 g, 0.32 mmol) in dry THF (5 ml) was added to n-butyllithium (2.5 M in 
hexane) (1.5 equiv., 0.19 ml, 0.48 mmol) at -78°C. The reaction was stirred for 30 
min before I-bromo-3-methyl-2-butene (0.04 ml, 0.38 mmol) was added also at -78 
QC. The reaction mixture was allowed to warm to room temperature and stirred 
overnight. Saturated sodium hydrogen carbonate solution (5 ml) was added, the 
reaction mixture was then extracted with diethyl ether (3 x lO ml) and the combined 
extracts were washed with brine (1 x 30 ml). The organic extract was dried over 
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magnesium sulfate, filtered and evaporated under reduced pressure. The crude product 
was purified by flash column chromatography using petroleum ether:ethyl acetate (2:1 
v/v) as eluent to yield methyl 
5-[I-methoxycarbonyl-4-methyl-l-(3-methylbut-2-enyl )pent-3-enyl]-3-phenylisoxazo 
le-4-carboxylate (80) (0.03 g, 23 %) as a yellow oil; MS (FAB+) found 412.2130 
[M+H], C2.JI29NOS; requires 412.2124 [M+H]; Vmax (neat)/cm'\ 1734 (C=O), 2363 
and 3052 (CH2, CH3); /lH(400MHz; CDCh) 1.48 (5, 6H, 2 x CH3), 1.60 (5, 6H,2 x 
CH3), 2.75-2.84 (m, 4H, 2 x CH2), 3.60 (5, 3H, CH3), 3.62 (5, 3H, CH3), 4.89-4.94 (m, 
2H, 2 x CH) and 7.36-7.41 (m, 3H, 3 x Ar-H), 7.52-7.54 (m, 2H, 2 x Ar-H); /le 
(100MHz; CDCh) 17.8 (2 x CH3), 26.0 (2 x CH3), 30.3 (2 x C), 32.7 (2 x CH2), 44.7 
(2 x CH), 51.5 (CH3), 52.1 (CH3), 53.7 (C), 117.6 (C), 128.1 (2 x Ar-CH), 129.3 (2 x 
Ar-CH), 129.8 (Ar-CH), 136.0 (Ar-C), 162.1 (C), 162.9 (C), 172.0 (C) and 177.7 (C). 
Methyl 
5-fl-methoxycarbonyl-4-methyl-l-(3-methylbut-2-enyl)pent-3-enyIJ-3-phenylisoxaz-
ole-4-carboxylate (80) . 
(Method B) 
h COOMe 
MeO 0 
(79) 
1.2 equiv. n-BuLi, 
Pd(O) 10% 
• 
1.2 equiV)=-yBr 
Methyl 5-(I-methoxycarbonyl-4-methylpent-3-enyl)-3-phenylisoxazole-4-carboxylate 
(79) (0.19 g, 0.55 nlmol) in dry THF (5 ml) was added to n-butyllithium (2.5 M in 
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hexane) (1.2 equiv., 0.26 ml, 0.65 mmol) at -78°C. The reaction was stirred for 30 
min before Pd(PPh3)4 (10 %; 0.06 g, 0.05 mmol) was added. After stirring for further 
5min, I-bromo-3-methyl-2-butene (0.08 ml, 0.65 mmol) was added also at -78°C. 
The reaction mixture was allowed to warm to room temperature and stirred overnight. 
Saturated sodium hydrogen carbonate solution (5 ml) was added, the reaction mixture 
was then extracted with diethyl ether (3 x 15 ml) and the combined extracts were 
washed with brine (1 x 30 ml). The organic extract was dried over magnesium sulfate, 
filtered and evaporated under reduced pressure. The crude product was purified by 
flash column chromatography using petroleum ether:ethyl acetate (2: 1 v/v) as eluent 
to yield methyl 
5-[ I-methoxycarbonyl-4-methyl-l-(3-methylbut-2-enyl)pent-3-enyl]-3-phenylisoxaz-
0Ie-4-carboxylitte (80) (0.06 g, 25 %) as a yellow oil. Spectroscopic data as reported 
above. 
5-[(N-methoxy-N-methylcarbamoyl)methylj-3-phenylisoxazole-4-carboxylic acid 
N-methoxy-N-methylamide (81) 
(Method A) 
o N,O-Oimethylhydroxylamine 
hydrochloride ~ 
OH N"MethYlmorphol~ne, I h 
EOCI 
o 
7 
..... OMe 
(81) 
5-Carboxymethyl-3-phenylisoxazole-4-carboxylic acid (78) (0.04 g, 0.13 mmol) was 
dissolved in dry DCM (10 ml). N,O-Dimethylhydroxylamine hydrochloride in dry 
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DCM (2 ml) and N-methylmorpholine (0.03 ml, 0.27 mmol) were added to the 
reaction at 0 °C followed by EDCI (0.05 g, 0.27 mmol) in dry DCM (1 ml) again at 0 
QC. The mixture was stirred at 0 °C for 1 h. Cold hydrochloric acid (1 M; 3 ml) was 
added to the reaction mixture, and the mixture was extracted with DCM (10 ml). The 
organic layer was washed with saturated sodium hydrogencarbonate solution (3 ml) 
and then dried by magnesium sulfate, filtered and evaporated to dryness under 
reduced pressure. The crude material was purified by flash colunm chromatography 
using methanol (10 %) in DCM as eluent to yield 
5-[(N-methoxy-N-methylcarbamoyl)methyl]-3-phenylisoxazole-4-carboxylic acid 
N-methoxy-N-methylamide (81) (0.23 g, 48 %) as a yellowish brown oil; MS (EH) 
found 334.1394 [M+H], C\6H\9N30S; requires 334.1397 [M+H]; Vmax (neat)/cm-\ 
1574, 1614 (amide) and 1754; IiH(400MHz; CDCh) 3.13 (s, 3H, CH3), 3.22 (s, 3H, 
CH3), 3.78 (s, 3H, OCH3), 4.16 (s, 3H, OCH3), 5.07 (s, 2H, CH2), 7.41-7.48 (m, 3H, 3 
x Ar-H) and 7.64-7.68 (m, 2H, 2 x Ar-H); lie (100MHz; CDC13) 30.5 (CH2), 32.4 (2 x 
CH3), 61.6 (2 x OCH~), 112.4 (C), 127.5 (2 x Ar-C), 127.5 (C), 128.1 (C), 128.7 (2 x 
Ar-C), 129.3 (C), 130.0 (Ar-C) and 167.3 (2 x C=O). 
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5-{(N-methoxy-N-methylcarbamoyl)methylj-3:phenylisoxazole-4-carboxylic acid 
N-methoxy-N-methylamide (8J) 
(Method B) 
OMe 
N,O-Dimethylhydroxylamine 
hydrochloride 
AIMe3 
I 
..... OMe 
N,o-Dimethylhydroxylamine hydrochloride (12.76 g, 130.79 mmol) was dissolved in 
dry DCM (lOO ml) under an atmostphere of nitrogen at -10°C. Trimethylaluminium 
(2.0 M in hexane) (65.39 ml, 130.79 mmol) was added dropwise at -10°C, and the 
reaction was stirred for 1 h. Methyl 
5-methoxycarbonylmethyl-3-phenylisoxazole-4-carboxylate (5) (6.00 g, 21.80 mmol) 
in dry DCM (20 ml) was added at -10°C over 1 h by syringe. The mixture was then 
left to stir at room temperature overnight. Water (100 ml) was added at 0 °C to quench 
the reaction. It was then extracted with DCM (3 x 100 ml). The combined organic 
fractions were dried by sodium sulfate, filtered and evaporated under reduced pressure. 
The crude material was purified by flash colunm chromatography using petroleum 
ether:ethyl acetate (1:1 v/v) as the eluent to yield the product 
5-[(N-methoxy-N-methylcarbamoyl)methyl]-3-phenylisoxazole-4-carboxylic acid 
N-methoxy-N-methylarnide (81) (0.32 g, 4 %) as a brown oil. Spectroscopic data as 
reported above. 
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Phenylhydroximoyl chloride (83) 
• 
Benzaldehyde oxime (3.73g, 30.82 mmol) in chlorofonn (30 ml) and pyridine (0.25 
ml, 3.07 mmol) were mixed in a reaction flask. The mixture was stirred under the 
atmosphere of nitrogen and the temperature was raised to 50°C. 
N-Chlorosuccinimide (4.53 g, 33.90 mmol) was added to the mixture and stirred at 50 
°C for 3 h. The reaction mixture was diluted by DCM (200 ml). The organic layer was 
washed with water (2 x 100 ml) and brine (100 ml), dried over sodium sulfate, filtered 
and concentrated under reduced pressure to yield the phenylhydroximoyl chloride (83) 
(3.90 g, 81 %) as greenish-yellow crystals. The solid was unstable, unless stored 
under nitrogen in a refrigerator. Vrnax (CHCh)/cm·1 785 (CCI), 1526,3147 and 3316 
(OH broad peak); 3H (250MHz; CDCh) 7.30-7.35 (m, 3H, 3 x Ar-H), 7.71-7.74 (m, 
2H, 2 x Ar-H) and 9.06 (broad peak, H, OH). Unstable compound, decomposed 
, during MS and carbon NMR studies. 
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5-Bromo-6-methyl-3-phenyl-4,5,6, 7-tetrahydrobenzo{dJisoxazol-4-one (85) 
(6) 
o ~+ 
H 
.. 
(85) 
Pyridinium hydrobromide perbromide (0.17 g, 0.53 mmol) was added to 
6-methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) (0.10 g, 0.44 mmol) 
in DCM (10 rnl). Glacial acetic acid (1.2 rnl) was added and the mixture was warmed 
slightly. The colour of the reaction changed to pale yellow. The reaction was stirred at 
room temperature for 3 h. It was then extracted with diethy1 ether (1 x 15 rnl). The 
combined extracts were washed with water (2 x 15 rnl), dried over sodium sulfate, 
filtered and evaporated under reduced pressure. The crude product was purified by 
flash column chromatography using petroleum ether:ethyl acetate (2:1 v/v) as eluent 
to yield 5-bromo-6-methyl-3 -phenyl-4,5,6,7 -tetrahydrobenzo[ dJisoxazol-4-one (85) 
(0.09 g, 66 %) as a pale yellow solid; mp 133-134 cC; MS (EI+) found 305.0050 
(Br7!), CI4HI2N02Br; requires 305.0051 (Br7!); Vrnax (CHCh)/cm-1 738 (CBr), 1697 
(C=O) and 2985 (CH2,CH3); liH(400MHz; CDCh) 1.32 (d, J 4.0, 3H, CH3), 2.43-2.45 
(m, lH, MeCH), 2.86 (dd,J10.6 and 17.7, lH, OCCH2), 3.00 (dd, J 4.9 and 17.7, lH, 
OCCH2), 4.41 (d, J2.7, 1H, CH) and 7.46-7.50 (m, 3H, 3 x Ar-H), 8.01-8.03 (m, 2H, 
2 x Ar-H); lie (100MHz; CDCI3) 18.6 (CH3), 27.9 (CH2), 34.4 (CH), 58.3 (CH), 111.4 
(C), 128.5 (2 x Ar-CH), 129.1 (2 x Ar-CH), 130.8 (Ar-CH), 132.1 (Ar-C), 160.7 (C), 
180.8 (C) and 185.2 (C). 
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6-Methyl-3-phenylbenzo[dJisoxazol-4-o1 (84) 
Br 
(85) 
DBU, DMF 
Experimental 
5-Bromo-6-methyl-3-phenyl-4,5,6, 7-tetrahydrobenzo[ dJisoxazol-4-one (85) (0.05 g, 
0.22 mmol) was dissolved in dry DMF (3 ml). The solution was heated to 50°C under 
, an atmosphere of nitrogen and 1,5-diazabicyclo[4.3.0]non-5-ene (0.04 ml, 0.26 mmol) 
was added dropwise. The mixture was stirred at 50°C for 1 h. Saturated sodium 
hydrogencarbonate solution (5 ml) was added to quench the reaction mixture. Diethyl 
ether (10 ml) was added and the mixture was washed with brine (4 x 10 ml). The 
organic layer was dried over magnesium sulfate, filtered and evaporated under 
reduced pressure. The crude product was purified by flash column chromatography 
using petroleum ether:ethyl acetate (1: 1 v/v) as eluent to yield 
6-methyl-3-phenylbenzo[dJisoxazol-4-ol (84) (0.02 g, 41 %) as a white powder; mp 
176-177 cC; MS (FAB+) found 226.0874 [M+H], CIJfl1N02; requires 226.0868 
[M+H]; Vmax (CHCh)/cm-1 1633, 1650, 1693 (C=N), 1712, 1731 (C=O), 2356, 2985 
(CH3), 3053 and 3416; oH(400MHz; <4-MeOH) 2.33 (s, 3H, CH3), 6.45 (s, lH, CH), 
6.81 (s, lH, CH) and 7.38-7.40 (m, 3H, 3 x Ar-H), 7.88-7.90 (m, 2H, 2 x Ar-H); Oc 
(lOOMHz; <4-MeOH) 22.0 (CH3), 101.7 (CH), 108.9 (C), 110.8 (CH), 129.2 (2 x 
Ar-CH), 130.4 (2 x Ar-CH), 130.7 (Ar-CH), 130.8 (Ar-C), 144.6 (C), 154.0 (C), 159.1 
(C) and 167.9 (C); Found C, 74.44; H, 4.77; N, 5.93; CI4Hl1N02 requires C, 74.65; H, 
4.92; N, 6.22. 
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4-Acetoxy-6-methyl-3-phenylbenzo[dJisoxazole (86) 
• 
Pyridine 
(84) (86) 
6-Methyl-3-phenylbenzo[dJisoxazol-4-o1 (84) (0.04 g, 0.06 mmol) was dissolved in 
DCM (5 ml). Acetic anhydride (0.01 ml, 0.06 mmol) and pyridine (0.01 ml, 0.06 
mmol) were added. The reaction mixture was heated at reflux' for 4 h. Solvent was 
evaporated under reduced pressure. The crode product was purified by flash column 
chromatography using petroleum ether:ethyl acetate (4: 1 v/v) as eluent to yield 
4-acetoxy-6-methyl--3-phenylbenzo[dJisoxazole (86) (0.02 g, 100 %) as a white 
powder; mp 94 QC; MS (EI+) found 267.0898, CI6H13N03; requires 267.0895; Vmax 
(CHCh)/cm-1 1685, 1701 (C=O), 2358 and 2988 (CH3); IiH (400MHz; CDCh) 1.87 (s, 
3H, CH3), 2.47 (s, 3H, OCOCH3), 6.81 (s, lH, CH), 7.27 (s, lH, CH) and 7.44-7.45 
(m, 3H, 3 x Ar-H), 7.65-7.68 (m, 2H, 2 x Ar-H); lie (100MHz; CDCh) 19.9 (CH3), 
20.5 (CH3), 100.9 (C), 107.6 (CH), 116.7 (CH), 127.9 (C), 129.1 (2 x Ar-CH), 130.8 
(2 x Ar-CH), 131.2 (Ar-CH), 131.3 (Ar-C), 144.3 (C), 153.9 (C), 159.0 (C) and 167.7 
(C); Found C, 72.19; H, 5.12; N, 5.29; Cl~13N03 requires C, 71.90; H, 4.90; N, 5.24. 
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5-Bromo-6-methyl-3-phenylbenzo{dJisoxazol-4-01 (87) 
or 7-bromo-6-methyl-3-phenylbenzo{dJisoxazol-4-o1 (88) 
Br. 
AcOH 
(84) 
• 
Br 
(87) 
Experimental 
OR 
(88) 
Bromine (0.02 ml, 0.36 mmol) was added dropwise to a mixture of 
6-methyl-3-phenylbenzo[dJisoxazol-4-01 (84) (0.08 g, 0.36 rmnol) in methanol (5 ml), 
glacial acetic acid (0.5 ml) and water (5 ml). The reaction vessel was cooled in ice 
throughout the addition. After stirring the mixture vigorously over a period of 3.5 h, 
brine (10 ml) was added to saturate the reaction mixture. The two layers were 
separated and the aqueous layer was extracted with diethyl ether (2 x 30 ml). The 
combined organic phase was washed with saturated sodium hydrogen carbonate 
solution (3 x 30 ml) and brine (1 x 30 ml), dried over magnesium sulfate, filtered and 
concentrated in vacuo to yield the crude product. The crude product was purified by 
flash column chromatography using petroleum ether:diethyl ether (1:1 v/v) as eluent 
to yield the bromo-derivative (87) or (88) (0.02 g, 18 %); mp 195-196 °C; MS (FAB+) 
found 302.9889 (Br79), C14HION02Br79; requires 302.9895 (Br7~; Vmax (CHCh)/cm'\ 
731 (CBr), 1687, 1720 (C=O) and 2895 (CH3); liH (250MHz; CDCh) 2.73 (s, 3H, 
CH3), 6.34 (s, lH, Ar-CH) and 7.49-7.54 (m, 3H, 3 x Ar-H), 7.92-7.96 (m, 2H, 2 x 
Ar-H); lie (100MHz; CDCh) 22.0 (CH3), 101.9 (CH), no.O(C), 115.4 (CBr), 129.7 (2 
x Ar-CH), 130.8 (2 x Ar-CH), 131.0 (Ar-CH), 131.2 (Ar-C), 144.8 (C), 154.2 (C), 
159.3 (C) and 168.0 (C); Position ofbromination cannot be identified by nOe. 
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6-Methyl-4-(3-methylbut-2-enyloxy)-3-phenylbenzo[dJisoxazole (89) 
3.0 equiv. LOA, THF 
.. 
1.3 equiv. ~Br 
(84) 
(89) 
6-Methyl-3-phenylbenzo[dJisoxazol-4-o1 (84) (0.02 g, 0.07 mmol) in dry THF (2 ml) 
at -78 DC was added dropwise to a freshly prepared solution ofLDA (3.0 equiv.; 0.21 
mmol), which was prepared from n-butyllithium (2.5 M solution in hexanes; 0.09 ml, 
0.21 mmol) and diisopropylamine (0.04 ml, 0.26 mmol) in dry THF (2 ml) at 0 DC. 
The resulting mixture was allowed to stir at -78 DC for 15 min. 
I-Bromo-3-methyl-2-butene (0.01 ml, 0.09 mmol) was added at -78 DC, the mixture 
was allowed to warm to room temperature and stirred overnight. Saturated sodium 
hydrogen carbonate solution (5 ml) was added and the mixture was extracted with 
DCM (3 x 15 ml). The combined organic layer was washed with brine (1 x 30 ml), 
dried over sodium sulfate, filtered and the solvent was evaporated under reduced 
pressure. The crude material was purified by flash column chromatography using 
petroleum ether:diethyl ether (10: 1 v/v) as eluent to yield 
6-methyl-4-(3-methylbut-2-enyloxy)-3-phenylbenzo[dJisoxazole (89) (0.01 g, 58 %) 
as a yellow oil; MS (FAB+) found 294.1498 [M+H], Ct9Ht9N02; requires 294.1494 
[M+H]; Vmax (neat)/cm,t 1617,1672 and 2919 (CH2, CH3); lIH(250MHz; CDCh) 1.61 
(s, 3H, CH3), 1.70 (s, 3H, CH3), 2.42 (s, 3H, CH3), 4.51 (d, J 6.8, 2H, OCH2), 
5.34-5.38 (m, lH, CHC), 6.43 (s, lH, ArH), 6.92 (s, IH, Ar-H), 7.36-7.40 (m, 3H, 3 x 
Ar-H), 7.89-7.91 (m, 2H, 2 x Ar-H); lie (100MHz; CDCh) 18.1 (CH3), 18.3 (CH3), 
22.4 (CH3), 25.7 (Me2C), 65.3 (CH), 102.5 (CH), 106.3 (C) 118.8 (CH), 127.9 (2 x 
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Ar-C), 129.1 (Ar-C), 129.6 (Ar-C), 129.9 (2 X Ar-C) 138.4 (CH20), 142.7 (C), 153.5 
(C), 157.8 (C) and 166.3 (C). 
4-Methoxy-6-methyl-3-phenylbenzo{dJisoxazole (90) 
3.0 equiv. LDA, THF 
1.3 equiv. dimethyl sulfate 
(84) 
6-Methyl-3-phenylbenzo[dJisoxazol-4-01 (84) (0.02 g, 0.Q7 mmol) in dry THF (2 ml) 
at -78°C was added dropwise to a freshly prepared solution ofLDA (3.0 equiv; 0.21 
mmol), which was prepared from n-butyllithium (2.5 M solution in hexanes; 0.09 ml, 
0.21 mmol) and diisopropylamine (0.04 ml, 0.26 mmol) in dry THF (2 ml) at 0 °C. 
The resulting mixture was allowed to stir at -78°C for 15 min, Dimethyl sulfate (0.12 
ml, 0.09 mmol) was added at -78°C, and the mixture was allowed to warm to room 
temperature and stirred overnight. Saturated sodium hydrogen carbonate solution (5 
ml) was added and the mixture was extracted with DCM (3 x 15 ml). The combined 
orgauic layer was washed with brine (1 x 30ml), dried over sodium sulfate, filtered 
and the solvent was evaporated under reduced pressure. The crude product was 
purified by flash column chromatography using petroleum ether:diethyl ether (10:1 
v/v) as eluent to yield 4-methoxy-6-methyl-3-phenyl-benzo[dJisoxazole (90) (0.06 g, 
36 %) as a yellow oil, MS (EI+) found 239.0948, CIsHI3N02; requires 239.0946; Vmax 
(neat)/cm-1 1621, 1669 (C=N) and 2939 (CH2, CH3); 1iH(250MHz; CDCh) 2.43 (s,3H, 
CH3), 4.45 (s, 3H, OCH3), 6.42 (s, \H, ArH), 6.90 (s, \H, Ar-H), 7.36-7.40 (m, 3R, 3 
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x Ar-H), 7.89-7.90 (m, 2H, 2 x Ar-H); .se (lOOMHz; CDCh) 22.5 (CH3); 102.3 (C), 
127.5 (2 x Ar-C), 129.5 (Ar-C), 129.8 (Ar-C), 129.9 (2 x Ar-C) 139.2 (CH30), 143.4 
(C), 153.5 (C), 157.8 (C) and 166.3 (C). 
5-Bromo-6-methyl-7-(3-methylbut-2-enyl)-3-phenyl-benzo{dJisoxazol-4-o1 (91) 
or 7-bromo-6-methyl-5-(3-methylbut-2-enyi)-3-phenyl-benzo{dJisoxazol-4-o1 
2.0 equiv. LDA 
• 
1.2equiv~Br 
Br Br (87) (91) 
5-Bromo-6-methyl-3-phenylbenzo[ dJisoxazol-4-01 (87) or 
7-bromo-6-methyl-3-phenylbenzo[dJisoxazol-4-01 (88) (0.03 g, 0.11 mmol) in dry 
THF (2 rnl) at -78°C was added dropwise to a freshly prepared solution of LDA (2.0 
equiv.; 0.21 mmol), which was prepared from n-butyllithium (2.5 M solution in 
hexane) (0.09 rnl, 0.21 mmol) and diisopropylamine (0.04 ml, 0.26 mmol) in dry THF 
(2 rnl) at 0 cC. The resulting mixture was allowed to stir at -78°C for 30 min. 
1-Bromo-3-methyl-2~butene (0.01 rnl, 0.13 mmol) was added at -78°C, the mixture 
was allowed to warm to room temperature and stirred overnight. Saturated sodium 
hydrogen carbonate solution (3 rnl) was added and the mixture was extracted with 
DCM (3 x ID rnl). The combined organic layer was washed with brine (1 x 30 rnl), 
dried over sodium sulfate, filtered and the solvent was evaporated under reduced 
pressure. The crude material was purified by flash column chromatography using 
petroleum ether:ethyl acetate (10:1 v/v) as eluent to yield 
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5-brorno-6-rnethyl-7-(3-rnethylbut-2-enyl)-3-phenylbenzo[dJisoxazol-4-o1 (91) or 
7-brorno-6-rnethyl-5-(3-rnethylbut-2-enyl)-3-phenyl-benzo[dJisoxazol-4-o1 (0.01 g, 
30 %) as yellow crystals; rnp 137 - 138°C; MS (EI+) found 371.0531 (Br79), 
C19HlsN02Br79; requires 371.0521 (Br7\ Vrnax (nujol)/crn·1 736 (CBr), 1651, 2252, 
2978 (CH2, CH3) and 3153 (OH); liH(400MHz; CDCb) 1.25 (s, 3H, CH3), 1.54 (s, 3H, 
CH3), 2.70 (s, 3H, CH3), 4.04 (d, J7.2, 2H, CH2), 4.95-4.99 (rn, IH, CH), 7.43-7.48 
(rn, 3H, 3 x Ar-H) and 7.84-7.86 (rn, 2H, 2 x Ar-H); lie (lOOMHz; CDCb) 17.7 (CH3), 
24.0 (CH3), 25.8 (CH3), 72.l (CH2), 100.0 (CMe2), 114.l (Ar-C), 115.7 (Ar-C), 118.4 
(CH), 127.9 (Ar-C), 128.6 (2 x Ar-C), 129.6 (2 x Ar-C), 130.4 (Ar-C), 140.0 (CBr), 
140.8 (COH), 149.2 (C), 158.2 (C) and 162.0 (C); Found C, 61.11; H, 4.89; N, 3.96; 
C19H18N02Br requires C, 61.30; H, 4.87; N, 3.76. 
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6-Methyl-5-(3-methylbut-2-enyl)-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one 
(92) and 
6-Methyl-5,5-bis-(3-methylbut-2-enyl)-3-phenyl-4,5,6, 7-tetrahydrobenzo[dJisoxazol-
4-one(93) 
(Method A) 
N-O 
I 
(6) 
2.0 equiv. LOA, 
THF:HMPA (6:1) 
• 
1.0eqUiv~Br· 
N-O 
I 
+ 
(92) 
(93) 
n-Butyllithium (2.5 M solution in hexanes; 0.18 ml, 0.45 mmol) and diisopropylamine 
(0.07 ml, 0.54 mmol) were added to dry THF (3 ml), followed by HMPA (0.5ml) at 0 
°C to make a LDA solution. The mixture was left to stir at 0 °C for 15 min. 
6-Methyl-3-phenyl-4,5,6,7-tetrahydrobenzo[dJisoxazole-4-one (6) (0.05 g, 0.22 mmol) 
in dry THF (2 ml) at -78°C was added dropwise to this freshly prepared solution of 
LDA (2.0 equiv.; 0.45 mmol). The resulting rnixture was allowed to stir at -78°C for 
15 min. 1-Bromo-3-methyl-2-butene (0.03 ml, 0.22 mmol) was added at -78°C, the 
mixture was allowed to warm to room temperature and. stirred overnight. Saturated 
ammonium chloride solution (5 ml) was added and the mixture was extracted with 
DCM (3 x 10 ml). The combined organic fraction was washed with water (3 x 30 ml) 
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and brine (1 x 30 ml), dried over sodium sulfate, filtered and the solvent was 
evaporated under reduced pressure. The crude material was purified by flash colunm 
chromatography using petroleum ether:diethyl ether (2: 1 v/v) as eluent to yield the 
mono-alkylated product, 
6-methyl-5-(3-methylbut-2-enyl)-3 -phenyl-4,5 ,6, 7 -tetrahydrobenz[ d]isoxazol-4-one 
(92) (0.02 g,21 %) as a yellow oil; MS (EH) found 295.1573, C19H21N02; requires 
295.1572; Vrnax (neat)/cm·1 1689 (C=O), 2304, 2985 and 3053 (CH2, CH3); ~ 
(400MHz; CDC13) 1.11 (d, J 6.1, 3H, CH3), 1.60 (s, 3H, CH3), 1.64 (s, 3H, CH3), 
2.31-2.41 (m, lH, MeCH), 2.34 (dd, J 11.2 and 16.1, lH, OCCH2), 2.52-2.66 (m, 2H, 
CH2), 2.65 (del, J 3.9 and 16.1, IH, OCCH2), 2.84-2.86 (m, lH, O=CCH), 5.02-5.05 
(m, lH, CHCMe2), 7.39-7.42 (m, 3H, 3 x Ar-H) and 7.98-8.01 (m, 2H, 2 x Ar-H); 3c 
(100MHz; CDCh) 18.0 (CMe), 19.3 (CMe), 25.9 (CMe), 28.1 (CH2), 33.1 (Ar-C), 
42.2 (Ar-C), 46.0 (Ar-C), 53.5 (CMe2), 113.7 (C=O), 119.3 (CCH), 128.5 (2 x Ar-C), 
129.2 (2 x Ar-C), 130.5 (Ar-C), 135.3 (Ar-C), 159.9 (C), 181.0 (C) and 184.3 (C); and 
the di-alkylated product, 
6-Methyl-5,5-bis-(3-methylbut-2-enyl)-3-phenyl-4,5,6, 7-tetrahydrobenzo[d]isoxazol-
4-one (93) (0.02 g, 21 %) as a yellow oil; MS (EI+) found 363.2201, CWh9N02; 
requires 363.2198; Vrnax (neat)/cm·1 1682 (C=O), 2305, 2986 and 3052 (CH2, CH3); 3H 
(400MHz; CDCh) 1.03 (d, J 6.6, 3H, CH3), 1.42 (s, 3H, CH3), 1.52 (s, 3H, CH3), 1.57 
(s, 3H, CH3), 1.61 (s, 3H, CH3), 2.37-2.78 (m, 5H, CH and 2 x CH2), 2.45 (dd, J 11.1 
and 16.0, lH, OCCH2), 2.73 (del, J 3.8 and 16.0, lH, OCCH2), 4.72-4.76 (m, IH, 
CCH), 5.03-5.07 (m, lH, CCH), 7.38-7.42 (m, 3H, 3 x Ar-H) and 7.98-8.00 (m, 2H, 2 
x Ar-H); 3c (100MHz; CDCh) 14.6 (CH3), 17.7 (CH3), 18.0 (CH3), 26.1 (2 x CH3), 
32.5 (CH2), 33.2 (CH2), 34.8 (CH), 44.8 (CH2), 44.9 (C), 114.5 (C=O), 118.2 (CH), 
118.6 (CH), 127.6 (Ar-C), 128.4 (2 x Ar-C), 129.3 (2 x Ar-C), 130.5 (Ar-C), 135.6 
(CMe2), 135.6 (CMe2), 159.9 (C), 186.9 (C) and 192.0 (C). 
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6-Methyl-5-(3-methylbut-2-enyl)-3-phenyl-4,5,6, 7-tetrahydrobenzfdJisoxazol-4-one 
(92) and 
6-Methyl-5,5-bis-(3-methylbut-2-enyl)-3-phenyl-4,5,6,7-tetrahydrobenzofdJisoxazol-
4-one (93) 
(Method B) 
LOA 1.5 equiv .• 
THF:OMPU (6:1) 
• 
1.0 equiv.)=/'Br 
(92) 
+ 
n-Butyllithium (2.5 M solution in hexanes; 2.83 ml, 7.07 mmol) and diisopropylamine 
(1.01 ml, 7.21 mmol) were added in dry THF (9 ml) at 0 °C, followed by DMPU (1.5 
ml) to make a LDA solution. It was stirred for 20 min. 
6-Methyl-3-phenyl-4,5,6,7-tetrahydrobenzo[d]isoxazole-4-one (6) (1.07 g, 4.71 mmol) 
in dry THF (5 ml) was added dropwise to this solution ofLDA (1.5 equiv.; 7.07 mmol) 
at -78°C. The resulting mixture was allowed to stir at -78 °C for 90 min. 
I-Bromo-3-methyl-2-butene (0.56 ml, 4.80 mmol) was added at -78°C, and the 
mixture was allowed to warm to room temperature and stirred overnight. Saturated 
ammonium chloride solution (10 ml) was added and the mixture was extracted with 
DCM (3 x 20 ml). The combined extracts were washed with water (3 x 30 ml) and 
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then brine (1 x 30 ml). The organic extracts were dried over sodium sulfate, filtered 
and the solvent was evaporated under reduced pressure. The crude product was 
purified by flash column chromatography using petroleum ether:diethyl ether (2:1 v/v) 
as eluent to yield mono-alkylated product, 
6-methyl-S-(3-methylbut-2-enyl)-3-phenyl-4,S,6,7-tetrahydrobenz[dJisoxazol-4-one 
(92) (0.08 g, 6 %) and di -alkylated product, 
6-methyl-S,S-bis-(3-methylbut-2-enyl)-3-phenyl-4,S,6,7-tetrahydrobenzo[dJisoxazol-4 
-one (93) (0.30 g, 17 %). Spectroscopic data as reported above. 
6-Methyl-5,5-bis-(3-methylbut-2-enyl)-3-phenyl-7-phenylselenyl-4,5,6,7-tetrahydro-
benzo{dJisoxazol-4-one (94) 
(Method A) 
(93) 
LOA 1.5 equlv .• 
THF:HMPA (6:1) 
1.2 equlv. PhSeBr 
.' 
"Se-Ph 
• 
(94) 
6-Methyl-S,S-bis-(3-methylbut-2-enyl)-3-phenyl-4,S,6,7-tetrahydrobenzo[dJisoxazol-
4-one (93) (0.02 g, 0.05 mmol) in dry THF (2 ml) at -78°C was added dropwise to a 
freshly prepared solution of LDA (1.5 equiv.; 0.07 mmol) and HMPA, which was 
prepared from n-butyllithium (2.5 M solution in hexanes; 0.03 ml, 0.07 mmol) and 
diisopropylamine (0.01 ml, 0.09 mmol) in dry THF (3 ml) at 0 cC, followed by HMPA 
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(0.5 rol). The resulting mixture was allowed to stir at -78°C for 10 min. 
Pheny1selenium bromide (0.02 g, 0.06 mmol) was added at -78°C, the mixture was 
allowed to warm to room temperature and stirred overnight. Saturated ammonium 
chloride solution (5 ml) was added and the rnixture was extracted with DCM (3 x 10 
m1). The combined organic fraction was washed with water (3 x 30 rol) and brine (1 x 
30 rol), dried over sodium sulfate, filtered and the solvent was evaporated under 
reduced pressure. The crude material was purified by flash colunm chromatography 
using petroleum ether:ethyl acetate (8:1 v/v) as eluent to yield 
6-methyl-5,5-bis-(3-methylbut-2-enyl)-3-phenyl-7-phenylselenyl-4,5,6, 7-tetrahydro-
benzo[dJisoxazol-4-one (94) (0.01 g, 50 %) as a brown oil; MS (EI+) found 520.1750 
(Se80) [M+H], C30H33N02Se80; requires 520.1749 (Se80) [M+H]; Vrnax (neat)/cm·1 1651, 
1672 (C=O), 2335, 2974 and 3001 (CH2, CH3); IlH (400MHz; CDCh) 1.24 (d, J 0.8, 
3H, CH3), 1.50 (s, 12H, 4 x CH3), 2.32-2.44 (m,2H, CH2), 2.51-2.61 (m, 2H, CH2), 
2.72-2.80 (m, lH, CHMe), 3.74 (d, J 11.3, 1H, CHSe), 4.86-4.87 (m, lH, CH), 
5.20-5.23 (m, 1H, CH), 7.11-7.25 (m, 3H, 3 x Ar-H), 7.39-7.42 (m, 3H, 3 x Ar-H), 
7.47-7.58 (m, 2H, 2 x Ar-H) and 7.95-7.97 (m, 2H, 2 x Ar-H); lie (100MHz; CDCh) 
14.6 (CH3), 17.7 (CH3), 18.0 (CH3), 26.1 (2 x CH3), 32.5 (CH2), 33.2 (CH2), 34.8 
(CH), 51.5 (CH), 44.9 (C), 114.5 (C=O), 118.2 (CH), 118.6 (CH), 127.6 (Ar-C), 128.4 
(2 x Ar-C), 129.3 (2 x Ar-C), 129.5 (2 x Ar-C), 130.5 (Ar-C), 131.6 (Ar-C), 135.6 
(CM~), 135.6 (CMe2), p8.2 (2 x Ar-C), 159.9 (C), 186.9 (C) and 192.0 (C). 
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6-Methyl-5,5-bis-(3-methylbut-2-enyl)-3-phenyl-7-phenyIselenyl-4,5,6,7-tetrahydro-
benzo[dJisoxazol-4-one (94) 
(Method B) 
(93) 
LDA 2.0 equiv., 
THF:DMPU (6:1) 
1.0 equiv. PhSeBr 
.' 
"Se-Ph 
• 
(94) 
n-Butyllithiwn (2.5 M solution in hexanes; 1.45 ml, 3.63 rnrnol) and diisopropylarnine 
(0.52 rnI, 3.70 rnrnol) was added in dry TIIF (12 ml) at 0 ~C, followed by DMPU (2 
rnI) to make a LDA solution. It was stirred for 20 min. 
6-Methyl-S,S-bis-(3-methylbut-2-enyl)-3-phenyl-4,S,6,7-tetrahydrobenzo[dJisoxazol-
4-one (93) (0.66 g, 1.81 rnrnol) in dry THF (5 rnI) was added dropwise to this solution 
ofLDA(2.0 equiv.; 3.63 rnrnol) at -78°C. The resulting mixture was allowed to stir at 
-78 °C for 60 min. Phenylseleniwn bromide (0.44 g, 1.85 rnrnol) was added at -78 °C, 
and the mixture was allowed to warm to room temperature and· stirred overnight. 
Saturated arnrnoniwn chloride solution (10 rnI) was added. The mixture was extracted 
with DCM (3 x 20 rnI), and the combined extracts were washed with water (3 x 30 ml) 
and then brine (1 x 30 rnI). The organic extracts were dried over sodiwn sulfate, 
filtered and the solvent was evaporated under reduced pressure. The crude product 
was purified by flash column chromatography using petrolewn ether:ethyl acetate 
(10:1 v/v) as eluent to yield 
6-methyl-5,S-bis-(3-methylbut -2-enyl)-3-phenyl-7 -phenylselenyl-4,5,6, 7 -tetrahydrobe 
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nzo[dJisoxazol-4-one (94) (0.36 g, 39 %) as a brown oil. Spec1roscopic data as 
reported above. 
2-[I-Amino-l-phenyl-meth-(E)-ylideneJ-5-methyl-6,6-bis-(3-methyl-but-2-enyl)-cycl 
ohex-4-ene-I,3-dione (95) 
(94) 
.•• Se-Ph 
Mo(CO). 
-
° 
H20 2 
-
(95) 
6-Methyl-5,5-bis-(3-methylbut-2-enyl)-3-phenyl-7 -phenylselenyl-4,5,6, 7 -tetrahydro-b 
enzo[dJisoxazol-4-one (94) (6.90 g, 13.31 mmol) waS dissolved in acetonitrile (30 ml) 
and water (10 ml). Molybdenum hexacarbonyl (3.51 g, 13.31 mmol) was added to the 
reaction and the rnixture was refluxed for 3 h. After cooling to room temperature, the 
reaction mixture was treated with hydrogen peroxide (3 ml) dropwise at 0 ·C. It was 
then left to stir at room temperature overnight. The reaction was filtered through celite 
and charcoal bath and then poured into ice (20 g). The mixture was extracted with 
DCM (30 ml). The organic layer was washed with water (3 x 20 ml) and then treated 
• 
with sodium sulphite solution (10 %) (10 ml). The extracted organic layer was dried 
over sodium sulfate, filtered and evaporated to· dryness under reduced pressure to 
yield a residue. This crude product was purified by flash column chromatography 
using DCM as eluent to yield the product, 
2-[I-amino-l-phenyl-meth-(E)-ylidene ]-5-methyl-6,6-bis-(3-methyl-but-2-enyl)-cyclo 
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hex-4-ene-l,3-dione (95) (1.45 g, 30 %) as a light yellow viscous oil. MS (FAB+) 
found 364.2271 [M+H], C2JI29NOi; requires 364.2277 [M+H]; Vrnax (CHCh)/cm-1 
1617, 1620 (NH2), 2936, 3403 (C=O); IiH(400MHz; CDCh) 1.21 (d, J3.1, 3H, CH3), 
1.51 (d, J 2.5, 12H, 4 x CH3), 2.11-2.25 (m, 4H, 2 x CH2), 4.71-5.01 (m, 2H, CH), 
5.74 (s, lH, NH2), 6.41 (s, lH, NH2), 7.32-7.41 (m, 3H, 3 x Ar-H), 7.46 (s, lH, CH) 
and 7.74-7.78 (m, 2H, 2 x Ar-H); lie (400MHz; CDCh) 15.5 (CH3), 18.1 (2 x CH3), 
18.9 (2 x CH3), 47.9 (2 x CH2), 114.7 (C), 127.5 (2 x Ar-C), 128.2 (C), 128.6 (3 x 
Ar-C), 130.1 (CH), 130.2 (CH), 131.9 (CH), 135.8 (C), 135.9 (C), 156.9 (C),160.7 
(C), 185.8 (C) and 191.6 (C). 
6-Methyl-3-phenyl-5-phenylselenyl-4,5,6,7-tetrahydrobenzo{dJisoxazol-4-one (96) 
(6) 
1.2 equiv. LOA, 
THF:HMPA6:1 
.. 
1.2 equiv. PhSeBr 
N-O 
I 
o 
0-(se 
V 
(96) 
6-Methyl-3-phenyl-4,5,6,7-tetrahydrobenzo[d]isoxazole-4-one (6) (0.05 g, 0.24 mmol) 
in dry THF (2 ml) at -78°C was added dropwise to a freshly prepared solution of . 
LDA (1.2 equiv.; 0.29 mmol) and HMPA, which was prepared from n-butyllithium 
(2.5 M solution in hexanes; 0.11 ml, 0.29 mmol) and diisopropylamine (0.04 ml, 0.35 
mmol) in dry THF (3 ml) at 0 QC, followed by HMPA (0.5 ml). The resulting mixture 
was allowed to stir at -78°C for 15 min. Phenylse1enium bromide (0.07 g, 0.29 mmol) 
was added at -78°C, the mixture was allowed to warm to room temperature and 
stirred overnight. SatUrated ammonium chloride solution (5 ml) was added and the 
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mixture was extracted with DCM (3 x 10 ml). The combined organic fraction was 
washed with water (3 x 30 ml) and brine (1 x 30 ml), dried over sodium sulfate, 
filtered and the solvent was evaporated under reduced pressure. The crude material 
was purified by flash column chromatography using petroleum ether:ethyl acetate (8: 1 
v/v) as eluent to yield 
6-methyl-3-phenyl-5-phenylselenyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (96) 
(0.02 g, 25 %) as a brown oil; MS (EI+) found 384.0496 (Se8~ [M+H], 
C2oH17N02Se80; requires 384.0497 (Se8~ [M+H]; Vrnax (neat)/cm-1 1685 and 1685 
(C=O); 15H (400MHz; CHCh) 1.34 (d, J 6.6, 3H, CH3), 2.58-2.74 (m, lH, CHMe), 
2.85 (dd, J 11.1 and 16.0, lH, OCCH2), 2.95 (dd, J3.9 and 16.0, lH, OCCH2), 3.89 (d, 
J 3.2, lH, SeCH), 7.18-7.22 (m, 3H, 3 x Ar-H), 7.36-7.38 (m, 3H, 3 x Ar-H), 
7.50-7.52 (m, 2H, 2 x Ar-H) and 7.84-7.86 (m, 2H, 2 x Ar-H); 15c (lOOMHz; CDCh) 
20.8 (CH3), 30.3 (CH), 31.3 (CH2), 50.1 (CH), 114.0 (C), 128.4 (2 x Ar-CH), 129.2 (2 
x Ar-CH), 129.5 (2 x Ar-C), 130.6 (Ar-CH), 131.5 (Ar-C), 138.2 (2 x Ar-C), 132.4 
(Ar-C), 159.9 (C), 182.0 (C) and 191.6 (C); 
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6-Methyl-3-phenyl-5-phenylselenyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (96) 
(Method B) 
(6) 
LOA 1.5 equiv., 
THF:OMPU' (6:1) 
1.0 equiv. PhSeBr 
(96) 
n-Butyllithium (2.5 M solution in hexanes; 2.83 ml, 7.07 mmol) and diisopropylamine 
(1.01 ml, 7.21 mmol) was added in dry THF (9 ml) at 0 cC, followed by DMPU (1.5 
ml) to make a LDA solution. It was stirred for 20 rnin. 
6-Methyl-3-phenyl-4,5,6,7-tetrahydrobenzo[d]isoxazole-4-one (6) (1.Q7 g, 4.71 mmol) 
in dry THF (5 ml) was added dropwise to this solution ofLDA(I.5 equiv.; 7.07 mmol) 
at -78 cC. The resulting mixture was allowed to stir at -78 cC for 90 min. 
Phenylselenium bromide (1.13 g, 4.80 mmol) was added at -78 cC, and the mixture 
was allowed to warm to room temperature and stirred overnight. Saturated ammonium 
chloride solution (10 ml) was added. The mixture was extracted with DCM (3 x 20 
ml). The combined extracts were washed with water (3 x 30 ml) and then brine (I x 
30 ml). The organic extracts were dried over sodium sulfate, filtered and the solvent 
was evaporated under reduced pressure. The crude product was purified by flash 
column chromatography using petroleum ether:ethyl acetate (8: 1 v/v) as eluent to 
yield 6-methyl-3-phenyl-5-phenylselenyl-4,5 ,6, 7 -tetrahydrobenzo[ dJisoxazol-4-one 
(96) (0.36 g, 20 %) as brown oil. Spectroscopic data as reported above. 
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2-BenT,Yloxybenzaldehyde oxime (105) 
(104) 
BnBr. KzC03• Acetone 
• 
Experimental 
I~ 
I~ 
~ 
(105) 
2-Hydroxybenzaldehyde oxime (104) (5.00 g, 36.46 mmol) was dissolved in dry 
acetone (50 ml) under an atmosphere of nitrogen. Potassium carbonate (5.04 g, 36.46 
mmol) was added, followed by benzyl bromide (4.34 g, 36.46 mmol). The reaction 
mixture was heated under reflux for 16 h. After the reaction was cooled to room 
temperature, the solvent was evaporated. The residue was dissolved in ethyl acetate 
(100 ml), and then washed with saturated sodium hydroxide solution (IM; 3 x 50 ml) 
and brine (50 ml). The organic layer was dried by sodium sulfate, filtered and 
evaporated to dryness under reduced pressure. The crude oil was purified by flash 
column chromatography using petroleum ether:ethyl acetate (3:1 v/v) as eluent to 
yield 2-benzyloxybenzaldehyde oxime (105) (0.05 g, 1 %) as a yellow oil; MS (EI+) 
found 227.0943, C14H13N02; requires 227.0946; Vmax (neat)/cm-1 1620 (C=N), 2877 
and 3280 (OH); liH (400MHz; CDCb) 5.02 (s, 2H, CH2Ph), 6.87-6.79 (m, 2H, 2 x 
Ar-H), 7.23-7.32 (m, 6H, 5 x Ar-H, OAr-H), 7.65 (d, J7.6, !H, Ar-H), 8.50 (s, !H, 
N=CH) and 9.73 (broad peak, !H, NOH); lie (100MHz; CDCb) 70.5 (CH2) 112.6 
(NCH), 120.9 (Ar-C), 121.2 (Ar-C), 127.4 (Ar-C), 128.1 (Ar-C), 128.2 (Ar-C), 128.46 
. , 
(Ar-C), 128.7 (Ar-C), 128.7 (Ar-C), 131.3 (Ar-C), 136.6 (Ar-C), 146.5 (C) and 157.4 
(OC). 
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2-Ben'lSloxybenzaldehyde oxime (105) 
N~OHHCI 6i: • NaCOOCI1 
(105) 
To a solution of hydroxylamine hydrochloride (3.21 g, 46.24 mmol) and sodium 
acetate (7.59 g, 92.52 mmol) in water (50 ml), 2-benzyloxybenzaldehyde (110) (4.91 
g, 23.13 mmol) in ethanol (50 ml) was added. The reaction mixture was heated to 70 
'C for 10 min and then cooled down to room temperature. The reaction was stored in 
a refrigerator overnight. If crystals were not formed, the solution was extracted with 
ethyl acetate (3 x 100 ml). The combined organic layer was dried by sodium sulfate, 
filtered and evaporated to dryness under reduced pressure to yield the crude product, 
2-benzyloxybenzaldehyde oxime (105) (6.30 g crude) as a yellow oil; MS (EI+) 
found 227.0943, C14HI3N02; requires 227.0946; Vmax (neat)!cm·1 1620 (C=N), 2877 
and 3280 (OH); IiH (400MHz; CDCh) 5.02 (s, 2H, CH2Ph), 6.87-6.79 (m, 2H, 2 x 
Ar-H), 7.23-7.32 (m, 6H, 5 x Ar-H, OAr-H), 7.65 (d, J 7.6, lH, Ar-H), 8.50 (s, 1H, 
N=CH) and 9.73 (broad peak, lH, NOH); lie (100MHz; CDCh) 70.5 (CH2) 112.6 
(NCH), 120.9 (Ar-C), 121.2 (Ar-C), 127.4 (Ar-C), 128.1 (Ar-C), 128.2 (Ar-C), 128.5 
(Ar-C), 128.7 (Ar-C), 128.7 (Ar-C), 131.3 (Ar-C), 136.6 (Ar-C), 146.5 (C) and 157.4 
(OC). 
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2-Allyloxybenzaldehyde oxime (106) 
Allyl bromide, ~C03' Acetone 
• 
l ,OH 
& (106) (104) 
2-Hydroxybenzaldehyde oxime (104) (5.00 g, 36.46 mmol) was dissolved in dry 
acetone (50 ml) under an atmosphere of nitrogen. Potassium carbonate (5.04 g, 36.46 
mmol) was added, followed by allyl bromide (3.16 ml, 36.46 mmol). The reaction 
mixture was heated under reflux for 16 h. After the reaction was cooled to room 
temperature, the solvent was evaporated. The residue was dissolved in ethyl acetate 
(100 ml), and then washed with saturated sodium hydroxide solution (IM, 3 x 50 ml) 
and brine (50 ml). The organic layer was dried by sodium sulfate and evaporated to 
dryness under reduced pressure. The crude oil was purified by flash column 
chromatography using petroleum ether:ethyl acetate (3: 1 v/v) as eluent to yield 
2-allyloxybenzaldehyde oxime (106) (0.19 g, 3 %) as a yellow oil; MS (EI+) found 
177.0789, CIOHnN02; requires 177.0790; Vrnax (neat)/cm'\ 1649 (C=N), 2887 and 
3283 (OH); OH (400MHz; CDCh) 4.44 (d, J 8.3, 2H, OCH2), 5.16 (d, J 10.6, lH, 
=CH2), 5.28 (d, J 10.6, lH, =CH2), 5.88-5.93 (rn, lH, CH), 6.75-6.85 (m, 2H, 2 x 
Ar-H), 7.17-7.20 (m, lH, Ar-H), 7.59-7.61 (rn, lH, Ar-H), 8.47 (s, lH, N=CH) and 
9.62 (broad peak, IH, NOH); oe (100MHz; CDCh) 13.1 (CH2), 20.0 (CH), 68.1 
(OCH2),111.4 (N=CH), 119.8 (Ar-C), 125.8 (Ar-C), 130.4 (Ar-C), 131.8 (Ar-C), 
145.5 (C) and 155.6 (OC). 
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2-Allyloxybenzaldehyde oxime (106) 
lO 0 
~H 
(111) 
NH;PHHCI 
NaCOOCI1 
Experimental 
~ /OH ~O N 
• (0H 
V(106) 
To a solution of hydroxylamine hydrochloride (4.20 g, 60.42 mmol) and sodium 
acetate (9.91g, 120.84 mmol) in water (50 ml), 2-allyloxybenzaldehyde (111) (4.90 g, 
30.21 mmol) in ethanol (50 ml) was added. The reaction mixture was heated to 70 'C 
for 10 min and then cooled down to room temperature. The reaction was stored in a 
refrigerator overnight. If crystals were not formed, the solution was extracted with 
ethyl acetate (3 x 100 ml). The combined organic layers was dried by sodium sulfate, 
filtered and evaporated to dryness under reduced pressure to yield the crude product, 
2-allyloxybenzaldehyde oxime (106) (6.48 g crude) as a yellow oil. Spectroscopic 
data as reported above. 
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2-Hydroxyphenylhydroximoyl chloride (120) 
oJ~ ~WCI o 
• 
x;t°H l) I Cl 
(104) (120) 
2-Hydroxybenzaldehyde oxime (104) (3.00 g, 21.88 mmol) was dissolved in 
chlorofonn (100 ml), followed by addition of pyridine (0.22 ml, 2.74 mmol). The 
mixture was stirred under an atmosphere of nitrogen, when the temperature was raised 
to 50 °C. N-Chlorosuccinimide (2.98 g, 22.31 mmol) was added to the mixture which 
was stirred at 50 °C for 2 h. The reaction mixture was diluted by DCM (60 ml). The 
organic layer was washed by water (2 x 40 ml) and brine (50 ml), dried over sodium 
sulfate, filtered and concentrated under reduced pressure to yield the crude product, 
2-hydroxyphenylhydroximoyl chloride (120) (4.28 g crude) as a crude yellow oil; MS 
(EI+) found 171.0079 (CI3s), C7~N02Ces; requires 171.0087; Vmax (neat)/cm-1 758 
(CC1), 1606,3047 and 3306 (OH board peak); liH (400MHz; CDCh) 6.92-6.84 (m, 2H, 
2 x Ar-R), 7.28-7.17 (m, lH, Ar-R), 7.72 (d, J8.4, lH, Ar-H), 8.71 (s, broad peak, lH, 
NOR) and 10.13 (s, broad peak, lH, OH); lie (100MHz; CDC13) 115.8 (C), 117.0 
(Ar-C), 120.4 (Ar-C), 129.4 (Ar-C), 132.2 (Ar-C). 142.4 (C) and 156.2 (C). 
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Methyl 5-methoxycarbonylmethyl-3-(2-hydroxyphenyl)isoxazole-4-carboxylate 
(107) 
OH N/ OH Cfe! 
(120) 
+ Q MeO~oMe 
(8) 
Et,N 
-
Dimethyl 3-(I-pyrrolidino)pent-2-ene-l,5-dioate (8) (5.40 g, 23.78 mmol) and 
2-hydroxyphenylhydroximoyl chloride (120) (0.68 g, 3.96 mmol) was dissolved in 
chloroform (50 ml). Triethylamine (0.55 ml, 3.96 mmol) was added dropwise over 30 
min. The reaction mixture was heated under reflux at an atmosphere of nitrogen for 3 
h and then left to stir at room temperature for 16 h. The reaction mixture was 
concentrated in vacuo to yield a yellow oil, which was purified by flash column 
chromatography on silica gel using petroleum ether:ethyl acetate (5:3 v/v) as eluent to 
yield methyl 5-methoxycarbonylmethyl-3-(2-hydroxyphenyl)isoxazole-4-carboxylate 
(107) (0.08 g, 7 %) as a yellow oil; MS (FAB+) found 292.0818 [M+H], CIJI13N06; 
requires 292.0821 [M+H]; Vmax (neat)/cm·1 1740 (C=O), 2360, 2955 (CH2, CH3) and 
3410 (OH); OH (400MHz; CDCh) 3.75 (s, 3H, CH3), 3.79 (CH3), 4.35 (s, 2H, CH2), 
. 7.40-7.36 (m, lH, Ar·H), 7.61-7.59 (m, lH, Ar-H), 8.10 (d, J8.0, lH Ar-H) and 9.82 
(s, lH, OH); oe (100MHz; CDCb) 30.2 (CH2), 40.7 (CH3), 49.9 (CH3), 105.2 (C), 
111.0 (C), 118.0 (Ar-C), 124.5 (Ar-C), 125.4 (Ar-C), 133.2 (Ar-C), 153.4 (C), 156.2 
(c), 156.4 (C), 166.1 (C) and 171.7 (C). 
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3-(2-Hydroxyphenyl)-6-methyl-4,5,6, 7-tetrahydroben'l.ofdJisoxa'l.ol-4-one (108) 
XjOH Q Cl 
(120) 
+ o~ 
(10) 
Sodium 
isopropoxide 
• 
(108) 
To a solution of sodium isopropoxide prepared from sodium (0.09 g, 3.96 mmol) in 
isopropyl alcohol (50 ml), were added successively 5-methylcyc1ohexane-I,3-dione 
(10) (0.50 g, 3.96 mmol) and 2-hydroxyphenylhydroximoyl chloride (120) (0.68 g, 
3.96 mmol). After stirring for 4 h at room temperature, the reaction mixture was 
poured into water (30 ml), and extracted with ethyl ac~tate (3 x 50 ml). The combined 
organic layer was washed with brine (2 x 50 ml), dried over sodium sulfate, filtered 
and concentrated under reduced pressure. The crude product was purified by flash 
column chromatography using ethyl acetate:petroleum ether (1:1 v/v) as eluent to 
yield 3-(2-hydroxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazo1-4-one (108) 
(0.50 g, 52 %) as yellow crystals; mp 125-126 cC; MS (FAB+) found 244.0968 
[M+H], CIJI13N03; requires 244.0974 [M+H]; Vmax (nujol)/cm-I 1692 (C=O), 2952 
and 3118 (OH); liH(400MHz; CDCh) 1.22 (d, J 6.4, 3H, CH3), 2.38 (del, J 11.2 and 
16.0, lH, OCCH2), 2.43-2.55 (m, IH, CCH), 2.69 (dd, J3.6 and 16.0, lH,OCCH2), 
2.70 (dd, J 10.4 and 16.7, lH, O=CCH2), 3.18 (dd, J 4.8 and 16.7, lH, O=CCH2), 
7.07-7.00 (m, 2H, 2 x Ar-H), 7.38-7.35 (m, lH, Ar-H), 8.61 (d, J8.0, lH, Ar-H) and 
9.49 (s lH, OH); lie (100MHz; CDCh) 20.6 (CH3), 29.8 (CHMe), 31.0 (CH2), 47.4 
(CH2), 112.8 (C), 114.5 (C), 117.4 (Ar-C), 119.8 (Ar-C), 132.2 (Ar-C), 132.5 (Ar-C), 
156.6 (C), 159.4 (C), 181.6 (C) and 191.8 (C); Found C, 69.01; H, 5.43; N, 5.81; 
CI4H13N03 requires C, 69.12; H, 5.39; N, 5.76. 
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2-Bem,y/oxybenza/dehyde (11 0)116 
~ • B'" BnBr, K,CO. reflux (109) (110) 
2-Hydroxybenzaldehyde (109) (3.81 ml, 36.46mmol) in dry THF was treated with 
anhydrous potassium carbonate (5.04 g, 36.46mmol). The slurry was stirred under 
nitrogen for 10 min at room temperature and was treated with benzyl bromide (4.78 
ml, 40.11 mmol). The reaction mixture was warmed at reflux for 16 h and allowed to 
cool to room temperature. Water (200 ml) was added to dilute the reaction and then 
extracted with ethyl acetate (3 x 100 ml). The combined organic layer was washed 
with water (200 ml) and then brine (200 ml). The organic layer was dried by sodium 
sulfate, filtered and evaporated to dryness under reduced pressure. The crude product 
was purified by flash colmnn chromatography using petroleum ether:ethyl acetate (8: 1 
v/v) as eluent to yield 2-benzyloxybenzaldehyde (110) (5.6 g, 75 %) as yellow 
crystals; mp 48-49 ·C (lit1l6 m.p. 48 - 49 ·C); MS (EI+) found 212.0836, C14H1202; 
requires 212.0837; Vrnax (CHC13)/cm·1 1600, 1708 (C=O), 2911, 3033, 3062 (CH2); IiH 
(400MHz; CDCh) 5.01 (s,2H, CH2), 6.90-6.87 (m, 2H, 2 x Ar-H), 7.30-7.21 (m,6H, 
6 x Ar-H), 7.71 (d, J7.6, lH, Ar-H) and 10.42 (s, lH, CHO); lie (100MHz; CDCh) 
70.4 (CH2), l13.1 (Ar-C), 121.0 (Ar-C), 125.2 (C), 127.4 (Ar-C), 127.6 (Ar-C), 128.3 
(Ar-C), 128.4 (Ar-C), 128.8 (Ar-C), 129.2 (Ar-C), 136.2 (Ar-C), 161.1 (C),189.7 
(CHO) and 196.7 (C). 
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2-Ally/oxybenza/dehyde (111) 
Allyl bromide, ~C03. ~ AA, ~ 0 H 
reflux V 
(111) 
2-Hydroxybenzaldehyde (109) (3.81 ml, 36.46mmol) in dry THF was treated with 
anhydrous potassium carbonate (5.04 g, 36.46mmol). The slurry was stirred un:der 
nitrogen for 10 min at room temperature and was treated with allyl bromide (3.48 ml, 
40.11 mmol). The reaction mixture was warmed at reflux for 16 h and allowed to cool 
to room temperature. Water (200 ml) was added to dilute the reaction mixture which 
was then extracted with ethyl acetate (3 x 100 ml). The combined organic layer was 
washed with water (200 rnl) and then brine (200 rnl). The organic layer was dried by 
sodium sulfate, filtered and evaporated to dryness under reduced pressure. The crude 
product was purified by flash column chromatography using petroleum ether:ethyl 
acetate (9:1 v/v) as eluent to yield the product 2-allyloxybenzaldehyde (111) (5.6 g, 93 
%) as a yellow oil; MS (EI+) found 162.0683, CIOHIO02; requires 162.0681; Vmax 
(neat)/cm·1 1647, 1688 (C=O), 2862, 3076 (CH2); oH(400MHz; CDCh) 4.65 (dd, J 
3.2 and 5.2, 2H, OC~), 6.00 (d, J 10.6, lH, =CH2), 6.13 (d, J 10.6, lH, =CH2), 
6.13-6.00 (m, lH, CH), 7.03-6.96 (rn, 2H, 2 x Ar-H), 7.54-7.50 (m, lH, Ar-H), 7.83 (d, 
J7.6, lH, Ar-H) and 10.53 (CHO); Oc (IOOMHz; CDCh) 69.1 (CH2), 112.9 (Ar-C), 
118.0 (OCH2), 120.8 (Ar-C), 125.0 (C), 128.4 (Ar-C), 132.4 (CH), 135.9 (Ar-C), 
160.9 (C) and 189.7 (CHO). 
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2-Ben1,Yloxyphenylhydroximoyl chloride (112)'1 
I~ 
c$-a ~ ~ .... OH 0 Y .. I~ I: Cl ~ 
(105) (112) 
2-Benzyloxybenzaldehyde oxime (105) (6.70 g, 29.48 mmol) was dissolved in 
chlorofonn (50 ml), and pyridine (0.25 ml, 3.07 mmol) was added. The solution was 
then heated to 50°C, while N-chlorosuccinimide (4.33 g, 32.43 mmol) was added. 
The reaction mixture was heated under reflux for 16 h. After the mixture was cooled 
to room temperature, DCM (100 ml) was added. The mixture was then washed with 
water (2 x 50 ml) and brine (50 ml). The combined organic layer was dried by sodium 
sulfate and evaporated to dryness under reduced pressure to yield 
2-benzyloxyphenyJhydroximoyl chloride (112) (7.60 g, lOO %) as a crude yellow oil; 
MS (EH) found 261.0552, C)4H12NChCI3S; requires 261.0557; Vmax (neat)!cm') 752 
(CCI) and 3028 (OH); BH(400MHz; CDCb) 5.12 (s, 2H, CH2), 6.87-7.58 (m, 9H, 9 x 
Ar-H), 8.49 (s, broad peak, lH, NOH) and 10.41 (s, broad peak, lH, OH); Bc 
(lOOMHz; CDCh) 70.3 (CH2), 127.8 (Ar-C), 128.4 (Ar-C), 128.6 (Ar-C), 128.7 
(Ar-C), 128.8 (Ar-C), 129.0 (Ar-C), 131.0 (Ar-C), 131.9 (Ar-C), 133.9 (Ar-C), 136.6 
(C), 153.1 (C), 156.0 (C) and 156.7 (C). The crude product was used without 
purification as it is very reactive. 
158 
Experimental 
·Methyl 5-methoxycarbonylmethyl-3-(2-ben~loxyphenyl)isoxazole-4-carboxylate 
(113) 
BnO N"-OH 
cYC1 + 
(112) 
rl Q Cd 
MeO~OMe 
(8) 
-
o 0Me 
(113) 
0Me 
Dimethyl 3-(I-pyrrolidino)pent-2-ene-l,5-dioate (8) (1.70 g, 7.50 mmol) and 
2-benzyloxyphenylhydroximoyl chloride (112) (0.33 g, 1.25 mmol) was dissolved in 
chloroform (30 ml). Triethylamine (0.21 ml, 1.50 mmol) was added dropwise over 15 
min. The reaction mixture was heated under reflux at an atmosphere of nitrogen for 3 
h and then left to stir at room temperature for 16 h. The reaction mixture was 
concentrated in vacuo to yield a yellow oil, which was purified by flash colwnn 
chromatography on silica gel using petroleum ether:ethyl acetate (5:3 v/v) as eluent to 
yield methyl 5-methoxycarbonylmethyl-3-
(2-benzyloxyphenyl)isoxazole-4-carboxylate (113) (0.04 g; 8 %) as a yellow oil; MS 
(EI+) found 381.1231, C21H19N06; requires 381.1212; Vmax (neat)/cmo1 1696 (C=N), 
1718,1743 (C=O), 2344, 2360, 2950, 3031 (CH2, CH3); IiH(400MHz; CDCb) 3.48 (s, 
3H, COOCH3), 3.67(s, 3H, COOCH3), 4.09 (s, 2H, CH2COOMe), 4.99 (s, 2H, 
CH2Ph), 7.00-6.96 (m, 2H, 2 x Ar-H), 7.20-7.18 (m, 3H, 3 x Ar-H), 7.25-7.23 (m, 3H, 
3 x Ar-H) and 7.40-7.37 (m, 2H, 2 x Ar-H); lie (IOOMHz; CDCb) 33.2 (CH2), 51.6 
(CH3), 52.7 (CH3), 70.3 (CH2Ph), 111.6 (C), 112.3 (Ar-C), 118.1 (C), 120.9 (Ar-C), 
126.8 (Ar-C), 127.7 (Ar-C), 128.4 (Ar-C), 128.6 (Ar-C), 128.6 (Ar-C), 130.5 (Ar-C), 
131.5 (Ar-C), 136.7 (C), 156.8 (C), 160.4 (C), 161.8 (C), 167.4 (C) and 169.6 (C). 
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3-(1-Ben;.yloxyphenyl)-6-methyl-4,5,6, 7-tetrahydrobenzo[dJisoxazol-4-one (114) 
BnO fOH 0.& Sodium 
BnO 
isopropoxide ~ + • 
(112) (10) 
To a solution of sodium isopropoxide prepared from sodium (0.03 g, 1.25 mmol) in 
isopropyl alcohol (20 ml), were added successively 5-methylcycIohexane-l,3-dione 
(10) (0.16 g, 1.25 mmol) and 2-benzyloxyphenylhydroximoyl chloride (112) (0.33 g, 
1.25 mmol). After stirring for 16 h at room temperature, the reaction mixture was 
poured into water (30 ml), and extracted with ethyl acetate (3 x 50 ml). The combined 
organic layer was washed with brine (2 x 50 ml), dried over sodium suIfate, filtered 
and concentrated under reduced pressure. The crude product was purified by flash 
column chromatography using petroleum ether:diethyl ether (5:1 v/v) gradually 
changed to petroleum ether:diethyl ether (1: 1) as eluent to yield 
3-(2-benzyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[djisoxazo1-4-one (114) 
(0.02 g, 5 %) as a yellow oil; MS (FAB+) found 334.1436 [M+H], C2IHI9N03; 
requires 334.1443 [M+H]; Vrnax (neat)/cm·\ 1701 (C=O), 2247, 2872, 2958, 3032, 
3064 (CH2, CH3); SH(400MHz; CDCh) 1.05 (d, J6.8, 3H, CH3), 2.06 (dd, J11.1 and 
15.9, IH, OCCH2), 2.35-2.24 (m, lH, CHMe), 2.33 (dd, J3.5 and 15.9, lH,OCCH2), 
2.54 (dd, J9.6 and 16.9, lH, O=CCH2), 3.06 (dd, J 4.8 and 16.9, lH, O=CCH2), 4.97 
(s, 2H, CH2), 6.99-6.97 (m, 2H, 2 x Ar-H), 7.23-7.18 (m, 3H, 3 x Ar-H), 7.28-7.24 (m, 
3H,3 x Ar-H) and 7.39-7.37 (m, 2H, 2 x Ar-H); Se (lOOMHz; CDCI3) 20.7 (CH3), 
30.4 (CHMe), 31.0 (CH2), 46.6 (CH2), 70.4 (CH2Ph), 112.4 (Ar-C), 117.3 (C), 120.7 
(Ar-C), 127.1 (Ar-C), 127.9 (Ar-C), 127.9 (Ar-C), 128.3 (Ar-C), 128.6 (Ar-C), 130.5 
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(Ar-C), 131.7 (Ar-C), 136.9 (C), 157.2 (C), 157.5 (C), 171.2 (C), 180.2 (C) and 191.1 
(C). 
3-(2-Allyloxyphenyl}-6-methyl-4,5,6, 7-tetrahydrobenzo[dJisoxazol-4-one (117) 
K,C03• allyl bromide 
• 
reflux 
3-(2-Hydroxyphenyl)-6-methyl-4,5,6,7 -tetrahydrobenzo[ dJisoxazol-4-one (108) (0.27 
g, 1.09mmol) was dissolved in dry THF (20 ml). Potassium carbonate (0.15 g, 1.11 
mmol) was added to the mixture and then stirred for 10 min. After that, the allyl 
bromide (0.10 ml, 1.20 mmol) was added and the reaction mixture was heated under 
reflux for 16 h. Water (50 ml) was added after the reaction was cooled to room 
temperature, then ethyl acetate (3 x 30 ml) was added to extract the solution. The 
combined organic layer was extracted with water (50 ml) and then brine (50 ml). The 
organic layer was dried by sodium sulfate, filtered and evaporated to dryness under 
reduced pressure. The crude product was purified by flash column chromatography 
using petroleum ether:ethyl acetate (2: 1 v/v) as eluent to yield 
3-(2-allyloxyphenyl)-6-methyl-4,5,6, 7 -tetrahydrobenzo[ dJisoxazol-4-one (117) (0.13 
g, 43 %) as yellow crystals; mp 111-112 cC; MS (FAB+) found 284.1287 [M+H], 
C17H17N03; requires 284.1287 [M+H]; Vrnax (nujol)!cm·1 1603, 1689 (C=O) and 2956; 
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/lH(400MHz; CDCh) 1.22 (d, J6.5, 3H, CH3), 2.39 (dd, J11.0 and 15.9, lH,OCCH2), 
2.46-2.62 (m, lH, CHMe), 2.65 (dd, J3.6 and 15.9, lH, OCCH2), 2.70 (dd, J9.7 and 
17.0, lH, O=CCH2), 3.08 (dd, J 5.2 and 17.0, lH, O=CCH2), 4.65-4.67 (m,2H, 
OCH2), 5.31 (d, J 10.1, IH, =CH2), 5.57 (d, J 16.8, lH, =CH2), 6.04-6.08 (m, lH, 
=CH), 6.99-7.04 (m, 2H, 2 x Ar-H), 7.39-7.43 (m, lH, Ar-H) and 8.06 (d, J 8.0, lH, 
. Ar-H); /le (100MHz; CDCh) 21.0 (CH3), 30.2 (CH2), 30.8 (CHMe),46.3 (CH2),69.2 
(=CH2), 113.3 (Ar-C), 115.9 (C), 117.1 (OCH2), 118.3 (Ar-C), 131.1 (Ar-C), 132.4 
(Ar-C), 132.7 (=CH), 134.6 (C), 156.8 (C), 160.9 (C), 163.7 (C) and 191.2 (C); Found 
C, 71.95; H, 5.82; N, 5.09; C17H17N03 requires C, 72.07; H, 6.05; N, 4.94. 
(4-Oxo-4H-chromeno[4,3-cJisoxazol-3-yl)acetic acid methyl ester (121) 
o 
'Sca.. allyl bromide 
OMe • OMe 
reflux 
(1D7) 
Methyl 5-methoxycarbonylmethyl-3-(2-hydroxyphenyl)isoxazole-4-carboxylate (107) 
(0.08 g, 0.29 mmol) was dissolved in dry THF (20 ml). Potassium carbonate (0.04 g, 
0.29 mmol) was added to the mixture and then stirred for 10 min. After that, the ally 
bromide (0.03 ml, 0.31 mmol) was added and the reaction mixture was heat under 
reflux for 16 h. Water (50 ml) was added after the reaction was cooled to room 
temperature. Ethyl acetate (3 x 30 ml) was added to extract the solution and the 
combined organic layer was extracted with water (50 ml) and then brine (50 ml). The 
organic layer was dried by sodium sulfate, filtered and evaporated to dryness under 
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reduced pressure. The crude product was purified by flash column chromatography 
using petroleum ether:ethyl acetate (8:1 v/v) as eluent to yield 
(4-oxo-4H-chromeno[4,3-c]isoxazol-3-yl)acetic acid methyl ester (121) (0.02 g, 27 %) 
as a viscous yellow 'oil (solidified in refrigerator); MS (EI+) found 259.0483, 
C13H9NOs; requires 259.0481; Vrnax (CHCb)/cm-1 1635,1741 (C=O) and 2934 (CH2, 
CH3); oH(400MHz; CDCb) 2.99 (s, 2H, CH2), 3.76 (s, 3H,CH3), 4.72-4.76 (m, lH, 
OCCH), 5.02-5.13 (m, 2H, =CH2), 5.68-5.81 (m, lH, CH), 7.36-7.39 (m, 2H, 2 x 
Ar-H), 7.58-7.62 (m, lH, Ar-H) and 8.08-8.11 (m, lH, Ar-H); oe (100MHz; CDCI3) 
34.0 (CH2), 42.8 (CH), 53.1 (CH3), 104.7 (C), 111.1 (C), 118.0 (Ar-C), 118.9 (CH2), 
124.4 (Ar-C), 125.3 (Ar-C), 132.8 (=CH), 133.2 (Ar-C), 153.3 (C), 156.1 (C), 156.2 
(C), 168.3 (C) and 175.4 (C). 
3-Acetyl-4-amino-chromen-2-ane (123) 
i) 5M Hel, glacial acid 
OMe ------'.~ 
ii) I<:!C03 
Methyl 5-methoxycarbonylmethyl-3-(2-hydroxyphenyl)isoxazole4-carboxylate (107) 
(0.08 g, 0.29 mmol) was treated with hydrochloric acid (5M; 3 rn\) in glacial acetic 
acid (15 rn\). The mixture was heated at reflux for 3 h. The reaction was evaporated 
under reduced pressure to yield the crude product. The residue was dissolved in dry 
acetone (20 ml) and heated under reflux with potassium carbonate (0.04 g, O.29mmol) 
for 3 h_ After the reaction was cooled to room temperature, the solvent was evaporated 
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and the residue was dissolved in ethyl acetate (30 ml). This mixture was washed with 
saturated sodium hydroxide solution (lM; 3 x 30 ml) and brine (50 ml). The organic 
layer was dried by sodium sulfate, filtered and evaporated to dryness under reduced 
pressure. The crude oil was purified by flash column chromatography using petroleum 
ether:ethyl acetate (1:1 v/v) as eluent to yield 3-acetyl-4-amino-chromen-2-one (123) 
(0.04 g, 59 %) as a pale yellow solid; mp 70 - 71°C; MS (EI+) found 204.0658 
[M+H], CllH9N03; requires 204.0655 [M+H]; Vmax (CDCh)/cm-1 1734,2921 (C=O) 
and 3329 (NH2); IIH (400MHz; CDCh) 2.72 (s, 3H, CH3), 6.95-6.99 (m, 1H, Ar-H), 
7.05 (dd, J 1.0 & 8.0, m, Ar-H), 7.35-7.39 (m, m, Ar-H), 7.82 (dd, J 1.0 & 8.0, m, 
Ar-H), 10.72 (s, lH, NH2) and 10.85 (s, m, NH2); lie (400MHz; CDCI3) 12.1 (CH3), 
110.7 (c), 117.2 (Ar-C), 119.7 (Ar-C), 126.0 (Ar-C), 129.8 (C), 132.5 (Ar-C), 153.5 
(C), 156.8 (C), 157.9 (C) and 160.8 (C); Found C, 65.21; H, 4.63; N, 6.82; CllH9N03 
requires C, 65.02; H, 4.46; N, 6.89. 
164 
Experimental 
5-Allyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one 
(124) and 
5,5-Diallyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one 
(125) 
(Method A) 
(117) 
LOA 1.2 equiv .• 
THF:HMPA (6:1) 
1.0 equiv. allyl bromide 
(124) 
• 
(125) 
n-Butyllithium (2.5 M solution in hexanes; 0.22 ml, 0.54 mmol) and diisopropylamine 
(0.08 ml, 0.55 mmol) was added in dry THF (6 ml) at 0 °C, followed by HMPA (1 ml) 
to make a LDA solution. The mixture was then stirred for 10 min. 
3-(2-Allyloxyphenyl)-6-methyl-4,5,6, 7-tetrahydrobenzo[dJisoxazol-4-one (117) (0.13 
g, 0.45 mmol) in dry THF (2 ml) was added dropwise to this solution of LDA (1.2 
equiv.; 0.54 mmol) at -78 °C. The resulting mixture was allowed to' stir at -78 °C for 
30 min. Allyl bromide (0.04 ml, 0.45 mmol) was added at -78 °C, and the mixture was 
allowed to warm to room temperature and stirred overnight. Saturated ammouium 
chloride solution (10 ml) was added and the mixture was extracted with DCM (3 x 30 
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ml). The combined extracts were washed with water (3 x 50 ml) and then brine (1 x 
50 ml). The organic extracts were dried over sodium sulfate, filtered and the solvent 
was evaporated under reduced pressure. The crude product was purified by flash 
column chromatography using petroleum ether:ethyl acetate (1:1 v/v) as eluent to 
yield, mono-allylated • product 
5-allyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (124) 
(0.02 g, 11 %) as a yellow oil; MS (EI+) found 324.1594 [M+H], C20H21N03; requires 
324.1594 [M+H]; Vmax (neat)/cm-1 1676,1680 (C=O), 2919 and 2976; aH (400MHz; 
CDCh) 1.19 (d, J 6.4, 3H, CH3), 2.38-2.50 (rn, 2H, CH2), 2.41 (dd, J 11.0 and 16.0, 
m, OCCH2), 2.59-2.76 (m, m, CHMe), 2.77 (dd, J3.6 and 16.0, m, OCCH2), 3.18 
(m, m, O=CCH), 4.65-4.68 (m, 2H, CH2), 5.05-5.10 (m, 2H, OCH2), 5.33 (dd, J 10.2, 
1H, =CH2), 5.59 (dd, J 16.7, 1H, =CH2), 5.72- 5.88 (m, 1H, CH), 6.06-6.13 (m, m, 
CH), 7.00-7.07 (rn,2H, 2 x Ar-H), 7.41-7.47 (rn, m, Ar-H) and 8.07-8.10 (rn, m, 
Ar-H); ac (100MHz; CDCh) 19.9 (CH3), 28.4 (CH2), 30.1 (CH2), 32.4 (CHMe), 53.3 
(CH), 60.4 (CH2), 113.3 (Ar-C), 116.0 (C), 117.2 (=CH2), 117.3 (=CH2), 121.0 (Ar-C), 
131.1 (Ar-C), 132.7 (Ar-C), 133.1 (CH), 133.8 (C), 136.0 (CH), 156.8 (C), 161.1 (C), 
162.0 (C) and 192.7 (C); and di-allylated product, 
5 ,5-diallyl-3-(2-allyloxyphenyl)-6-rnethyl-4,5,6, 7 -tetrahydrobenzo[ dJisoxazol-4-one 
(125) (0.01 g, 7 %) as a yellow oil; MS (EI+) found 364.1905 [M+H], C23H2SN03; 
requires 364.1907 [M+H]; Vmax (neat)/crn-1 1686 (C=O), 2919 and 2977; aH (400MHz; 
CDCI3) 1.16 (d, J6.9, 3H, CH3), 2.11-2.23 (rn, 2H, CCH2), 2.26-2.31 (rn, 2H, CCH2), 
2.28 (dd, Jl1.0 and 16.0, m, OCCH2), 2.51-2.62 (m, m, CHMe), 2.86 (dd,J3.6 and 
16.0, m, OCCH2), 4.67-4_69 (rn, 2H, OCH2), 5.04-5.07 (rn, 4H, 2 x =CH2), 5.33 (d, J 
10.0, m, =CH2), 5.60 (d, J 16.8, m, =CH2), 5.62- 5.78 (rn, 2H, 2 x CH), 6.02-6.12 
(m, m, CH), 6.99-7.05 (rn, 2H, 2 x Ar-H), 7.38-7.43 (rn, m, Ar-H) and 8.08-8_10 (m, 
m, Ar-H); ac (lOOMHz; CDCh) 15.3 (CH3), 27.8 (CH2), 35.2 (CHMe), 35.4 (CH2), 
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37.1 (CH2), 52.9 (C), 69.3 (CH2), 113.4 (Ar-C), 116.0 (C), 117.4 (CH2),118.1 (=CH2), 
118.4 (=CH2), 120.9 (Ar-C), 131.1 (Ar-C), 132.4 (Ar-C), 132.7 (CH), 133.1 (CH), 
133.9 (C), 134.2 (CH), 156.8 (C), 161.1 (C), 162.3 (C) and 194.2 (C). 
5-Alyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo{dJisoxazol-4-one 
(124) 
(Method B) 
(117) 
LOA 2.5 equiv .• 
THF:OMPU (6:1) 
1.0 equiv. allyl bromide 
• 
(124) 
n-Butyllithium (2.5 M solution in hexanes; 2.5 equiv., 14.02 rnl, 35.05 mmol) and 
diisopropylamine (5.02 ml, 35.75 mmol) was added in dry THF (30 ml) at 0 °C, 
followed by DMPU (5 ml) to make a LDA solution. It was stirred for 30 min .. 
3-(2-Allyloxyphenyl)-6-methyl-4,5,6, 7 -ietrahydrobenzo[ d]isoxazol-4-one (117) (4.00 
g, 14.02 mmol) in dry THF (5 rnl) was added dropwise to this solution of LDA and 
DMPU at -78 °C. The resulting mixture was allowed to stir at -78 °C for 90 min. Allyl 
bromide (1.21 ml, 14.30 mmol) was added at -78 °C, and the mixture was allowed to 
warm to room temperature and stirred overnight. Saturated sodium 
hydrogencarbonate solution (60 ml) was added and the mixture was extracted with 
DCM (3 x 60 rnl). The combined extracts were washed with water (4 x 60 rnl) and 
then brine (1 x 100 ml). The organic extracts were dried over sodium sulfate, filtered 
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and the solvent was evaporated under reduced pressure. The crude product was 
purified by flash column chromatography uSing petroleum ether:ethyl acetate (2: 1 v/v) 
as eluent to yield 
5-allyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (124) 
(0.91 g, 20 %) as a yellow oil. Spectroscopic data as reported before. 
3-(2-Allyloxypheny/)-6-methyl-S-(3-methylbul-2-eny/)-4,S,6,7-tetrahydrobenzo[dJiso 
xazol-4-one (126) and 
3-(2-Allyloxyphenyl)-6-methyl-S,S-bis-(3-methylbut-2-enyl)-4,S,6,7-tetrahydrobenzo 
[dJisoxazol-4-one (127) 
(117) 
LOA 2.5 equiv., 
THF:OMPU (6:1) 
• 
1.1 equiv. ~Br 
(126) 
(127) 
n-Butyllithium (2.5 M solution in hexanes; 2.5 equiv., 0.21 ml, 0.53 mmol) and 
diisopropylamine (0.08 ml, 0.54 mmol) was added in dry THF (6 ml) at 0 cC, 
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followed by DMPU (1 ml) to make a LDA solution. It was then stirred for 15 min. 
3-(2-Allyloxyphenyl)-6-methyl-4,5 ,6, 7 -tetrahydrobenzo [dJisoxazol-4-one (117) (0.06 
g, 0.21 mmol) in dry THF (2 ml) was added dropwise to this solution of LDA at -78 
QC. The resulting mixture was allowed to stir at _78°C for 10 miD. 
1-Bromo-3-methylbut-2-ene (0.03 ml, 0.22 mmol) was added at -78°C, and the 
mixture was allowed to warm to room temperature and stirred overnight. Saturated 
sodium hydrogencarbonate solution (10 ml) was added and the mixture was extracted 
with DCM (3 x 20 ml). The combined extracts were washed with water (4 x 20 ml) 
and then. brine (l x 30 ml). The organic extracts were dried over sodium sulfate, 
filtered and the solvent was evaporated under reduced pressure. The crude product 
was purified by flash column chromatography using petroleum ether:ethyl acetate (1: 1 
v/v) as eluent to yield both mono-a\kylated product, 
3-(2-allyloxyphenyl)-6-methyl-5-(3-methylbut-2-enyl)-4,5,6,7-tetrahydrobenzo[dJiso 
xazol-4-one (126) (0.02 g, 23 %) as a yellow oil; MS (EI+) found 352.1917 [M+H], 
C22H2SN03; requires 352.1913 [M+H]; Vmax (neat)/cm-I 1693, 1698 (C=O), 2927 and 
2963; IiH (400MHz; CDCb) 1.18 (d, J 6.5, 3H, CH3), 1.70 (s, 3H, CH3), 1.71 (s, 3H, 
CH3), 2.35-2.46 (m, 3H, OCCHH & CH2), 2.71-2.77 (m, lH, CHMe), 2.79 (dd, J 3.6 
and 15.9, lH, OCCH2), 3.21 (m, lH, O=CCH2), 4.67-4.70 (m, 2H, OCH2), 5.08-5.27 
(m, lH, =CH), 5.32 (d, J 10.0, lH, =CH2), 5.58 (d, J 16.5, lH, =CH2), 6.03-6.13 (m, 
lH, CH=), 7.00-7.07 (m, 2H, 2 x Ar-H), 7.42-7.44 (m, lH, Ar-H) and 8.06-8.10 (m, 
lH, Ar-H); lie (lOOMHz; CDCb) 19.9 (CH3), 25.9 (CH3), 26.0 (CH3), 28.4 (CH2), 
30.1 (CH2), 32.4 (CHMe), 53.3 (CH), 60.4 (CH2), 113.3 (Ar-C), 116.0 (c), 117.5 
(OCH2), 117.5 (C), 121.0 (Ar-C), 131.2 (Ar-C), 132.8 (Ar-C), 133.7 (CH), 133.8 (C), 
136.2 (CH), 156.9 (C), 161.4 (C), 162.2 (C) and 192.8 (C). and di-alkylated product, 
3-(2-allyloxyphenyl)-6-methyl-5,5-bis-(3-methylbut-2-enyl)-4,5,6,7-tetrahydrobenzo[ 
dJisoxazol-4-one (127) (0.01 g, 10 %) as a yellow oil; MS (EI+) found 420.2540 
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[M+HJ, C27H33N03; requires 420.2539 [M+H]; Vmax (neat)!cm'\ 1675, 1684 (C=O), 
2915 and 2962; IiH(400MHz; CDCh) 1.17 (d,J6.9, 3H, CH3), 1.68 (s, 3H, CH3), 1.69 
(s, 3H, CH3), 1.70 (s, 3H, CH3), 1.71 (s, 3H, CH3), 2.40-2.51 (m, 4H, 2 x CH2), 
2.69-2.73 (m, lH, CHMe), 2.78 (dd,J11.0 and 16.0,lH, OCCH2), 3.22 (dd,J3.6 and 
16.0, lH, OCCH2), 4.65-4.71 (m, 2H, OCH2), 5.03-5.19 (m, 2H, 2 x =CH), 5.31 (d, J 
10.0, lH, =CH2), 5.59 (d, J 16.8, lH, =CH2), 6.02-6.14 (m, lH, =CH), 7.00-7.07 (m, 
2H, 2 x Ar-H), 7.38-7.45 (m, lH, Ar-H) and S.OS-S.l1 (m, lH, Ar-H); lie (100MHz; 
CDCI3) 18.0 (CH3), 25.9 (CH3), 26.0 (CH3), 26.1 (CH3), 26.2 (CH3), 29.4 (CH2), 32.S 
(CHMe), 35.3 (CH2), 37.3 (CH2), 52.7 (C), 69.1 (CH2), 113.4 (Ar-C), 116.3 (C), 117.3 
(CH2), 11S.0 (C), 11S.1 (C), 120.S (Ar-C), 131.3 (Ar-C), 132.5 (Ar-C), 132.7 (CH), 
133.2 (CH), 133.7 (C), 134.2 (CH), 156.8 (C), 161.3 (C), 161.3 (C) and 194.7 (C). 
5-Spirocyclopentene-3-(2-allyloxyphenyl)-6-methyl-4,5,6, 7-tetrahydrobenzo[dJisoxa 
zol-4-one (134) 
~. 
o ~ o 
Grubbs 11 cat. 20 mol% 
(125) (134) 
. 5,5-Diallyl-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-one 
(125) (0.13 g, 0.36 mmol) was dissolved in dry DCM under an atmosphere of 
nitrogen. Grubbs II catalyst (20 mol%, 0.06 g, 0.07 mmol) was added and the reaction 
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was heated to 40 'C for 3.5 h. The reaction mixture was then filtered through celite 
and charcoal. Water (10 ml) was added to the filtrate and the mixture was extracted by 
DCM (3 x 10 ml). The combined organic layer was washed with brine (30 ml), dried 
by sodium sulfate, filtered and evaporate under reduced pressure. The crude material 
was purified by flash colunm chromatography using petroleum ether:ether acetate (2: 1 
v/v) as eluent to yield the product 
5-spirocyclopentene-3-(2-allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxaz 
ol-4-one (134) (0.03 g, 27 %) as a yellow oil; MS (EI+) found 336.1595 [M+H] , 
C21H21N03; requires 336.1600 [M+H]; Vrnax (neat)/cm-1 1684 (C=O) and 2925; liH 
(400MHz; CDCb) 1.03 (d, J 6.8, 3H, CH3), 2.39 (dd, J 11.0 and 16.0, lH, OCCH2), 
2.50-2.56 (m, lH, CH), 2.59 (dd, J 3.6 and 15.9, lH, OCCH2), 2.69-2.79 (m, 2H, 
CH2), 3.05-3.14 (m, 2H, CH2), 4.62 (d,JlO.l, lH, =CH2), 4.79 (d, Jl6.8, lH, =CH2), 
5.23-5.27 (m, lH, =CH), 5.51-5.59 (m, 2H, OCH2), 5.98-6.07 (m, IH, =CH), 
6.35-6.41 (m, lH, =CH), 6.93-7.03 (m, 2H, 2 x Ar-H), 7.26-7.31 (m, lH, Ar-H) and 
7.98-8.03 (m, IH, Ar-H); /le (400MHz; CDCh) 15.4 (CH3), 26.6 (CH2), 26.7 (CH2), 
37.6 (CH2), 39.2 (CH2), 68.3 (CH2), 110.5 (C), 112.3 (Ar-C), 112.6 (Ar-C), 116.2 
(CH2), 119.9 (CH), 120.0 (CH), 123.0 (CH), 127.6 (Ar-C), 130.1 (C), 131.3 (Ar-C), 
155.6 (C), 160.2 (C), 161.1 (C), 167.1 (C) and 170.3 (C). 
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3-[2-(Bul-3-enyloxy)phenylj-6-melhyl-4,5,6,7-letrahydrobenzo[djisoxazol-4-one 
(135) 
K,C03• 4-bromobut-1-ene 
.. 
reflux 
3-(2-Hydroxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (108) (6.00 
g, 24.77 mmol) was dissolved in dry THF (50 ml). Potassium carbonate (3.49 g, 25.26 
mmol) was added to the mixture and then stirred for 10 min. After that, the 
4-bromobut-l-ene (2.51 ml, 24.77 mmol) was added and the reaction mixture was 
heated under reflux for 16 h. Water (50 ml) was added after the reaction was cooled to 
room temperature. The mixture was extracted with ethyl acetate (3 x 40 ml), and the 
combined organic layer was extracted with water (50 ml) and then brine (50 ml). The 
organic layer was dried by sodium sulfate, filtered and evaporated to dryness under 
reduced pressure. The crude product was purified by flash column chromatography 
using petroleum ether:ethyl acetate (2:1 v/v) as eluent to yield 
3-[2-(but-3-enyloxy)phenyl]-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (135) 
(0.31 g,4 %) as a oil; MS (EI+) found 297.1360, ClsHI9N03; requires 297.1365; Vmax 
(neat)/cm-1 1601, 1693 (C=O) and 2956; IiH (400MHz; CDCh) 1.08 (d, J 2.4, 3H, 
CH3), 2.41 (dd, J !l.0 and 15.9, lH, OCCH2), 2.52-2.64 (m, lH, CH), 2.62 (dd, J3.6 
& 15.9, lH, OCCH2), 2.70 (dd, J 9.8 and 16.9, lH, O=CCH2), 3.10 (dd, J 5.0 and 
16.9, lH, O=CCH2), 3.85-3.90 (m, 2H, CH2), 5.09-5.22 (m, 3H, CH2 & CH), 
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5.77-5.99 (rn, 2H, OCH2), 6.99-7.05 (rn, 2H, 2 X Ar-H), 7.41-7.43 (rn, lH, Ar-H) and 
8.04-8.06 (rn, lH, Ar-H); (le (400MHz; CDCh) 20.9 (CH3), 30.3 (CH2), 30.8 (CH), 
46.3 (CH2), 68.2 (CH2), 113.0 (Ar-C), 117.2 (CH2), 117.5 (CH), 117.6 (CH2), 120.8 
(Ar-C), 126.8 (Ar-C), 131.1 (Ar-C), 157.2 (C), 163.8 (C), 171.2 (C), 177.5 (C), 191.4 
(C) and 200.0 (C). 
5-Allyl-3-[2-(but-3-enyloxy)phenyIJ-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-
one (136) and 
5,5-Diallyl-3-[2-(but-3-enyloxy)phenyIJ-6-methyl-4,5,6,7-tetrahydrobenzo[dJ-
isoxazol-4-one (137) 
LOA 1.2 equiv., 
THF:OMPU (6:1) 
1.0 equiv. allyl bromide 
(136) 
• 
(137) 
n-Butyllithiwn (2.5 M solution in hexanes; 1.2 equiv., 0.61 ml, 1.52 mmol) and 
diisopropylamine (0.22 ml, 1.55 mmol) was added in dry THF (3 ml) at 0 cC, 
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followed by OMPU (1 ml) to make a LOA solution. It was then stirred for 10 min. 
3-[2-(But-3-enyloxy)phenyl]-6-methyl-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-one (135) 
(0.30 g, 1.01 mmol) in dry THF (3 ml) was added dropwise to the solution of LOA 
and OMPU at -78°C. The resulting mixture was allowed to stir at -78 °C for 30 min. 
Allyl bromide (0.09 ml, 1.03 mmol) was added at -78°C, and the mixture was 
allowed to warm to room temperature and stirred overnight. Saturated ammonium 
chloride solution (10 ml) was added, and the mixture was extracted with DCM (3 x 10 
ml). The combined organic extracts were washed with water (3 x 10 ml) and then 
brine (30 ml). The organic extracts were dried over sodium sulfate, filtered and the 
solvent was evaporated under reduced pressure. The crude product was purified by 
flash column chromatography using petroleum ether:ethyl acetate (2:1 v/v) as eluent 
to yield, mono-allylated product, 5-allyl-3-[2-(but-3-enyloxy) 
phenyl]-6-methyl-4,5,6, 7 -tetrahydrobenzo[ d]isoxazol-4-one (136) (0.07 g, 21 %) as a 
yellowish oil; MS (FAB+) found 338.1758 [M+H], C2\H23N03; requires 338.1757 
[M+H]; Vmax (neat)/cm·\ 1603,1693 (C=O) and 2955; /lH(400MHz; CDCh) 1.21 (d, J 
6.8, 3H, CH3), 2.41-2.47 (m, 3H, OCCH2 and CH2), 2.62 (dd, J 3.6 & 15.9, lH, 
OCCH2), 2.72-2.76 (rn, lH, CH), 3.17 (m, lH, O=CCH2), 4.14 (t, J 6.4, 2H, CH2), 
5.05-5.22 (m, 5H, 2 x CH2 & CH), 5.73-5.89 (m, 2H, CH2), 5.90-6.03 (m, lH, =CH), 
6.99-7.05 (m, 2H, 2 x Ar-H), 7.41-7.43 (m, lH, Ar-H) and 8.07-8.09 (m, IH, Ar-H); 
/le (400MHz; CDCh) 19.9 (CH3), 28.4 (CH2), 32.4 (CH2), 32.6 (CH), 53.3 (CH), 68.2 
(CH2), 101.3 (C), 102.0 (CH), 112.6 (CH), 113.0 (Ar-C), 116.0 (C), 116.3 (CH2), 
117.2 (CH2), 117.3 (CH2), 120.8 (Ar-C), 131.1 (Ar-C), 132.4 (Ar-C), 157.2 (C), 162.0 
(C), 184.2 (C) and 192.7 (C); and di-allylated product, 5,5-diallyl-3-[2-(but-3-enyloxy) 
phenyl]-6-methyl-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-one (137) (0.08 g, 21 %) as a 
yellowish oil; MS (FAB+) found 378.2066 [M+H], C24H27N03; requires 378.2069 
[M+H]; Vmax (neat)/cm·\ 1609, 1690 (C=O) and 2928; /lH (400MHz; CDCh) 1.09 (d, J 
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6.4, 3H, CH3), 2.04-2.21 (m, 2H, CH2), 2.38-2.49 (m, lH, CH), 2.48 (m, 2H, CH2), 
2.62 (m, 2H, CH2), 4.14 (t, J 6.8, 2H, CH2), 5.05-5.16 (m, 7H, 3 x CH2 & CH), 
5.63-5.86 (m, 3H, CH2 & CH), 5.87-6.02 (m, lH, CH), 6.99-7.05 (m, 2H, 2 x Ar-H), 
7.43-7.45 (m, IH, Ar-H) and 8.08-8.10 (m, lH, Ar-H); 5c (400MHz; CDCh) 19.5 
(CH3), 27.8 (CH2), 30.7 (CH2), 32.1 (CH2), 32.9 (CH2), 68.2 (CH2), 101.3 (C), 102.0 
(2 x CH), 113.0 (Ar-C), 116.7 (CH2), 116.3 (C), 116.5 (C), 117.2 (CH2), 117.4 (CH), 
117.6 (CH2), 118.4 (CH2), 120.8 (Ar-C), 131.2 (Ar-C), 132.3 (Ar-C), 157.2 (C), 162.1 
(C), 175.5 (C) and 200.6 (C). 
2-(Aminophenylmethylene)-S-methylcyclohexane-1,3-dione (139) 
(Method A) 
Mo(CO)" 
• 
6-Methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) (0.03 g, 0.12 mmol) 
was dissolved in acetonitrile (3 ml), molybdenum hexacarbonyl (0.03 g, 0.12 mmol) 
was added and the reaction was heated at reflux overnight. After cooling to room 
temperature, the reaction mixture was filtered through celite, and then washed with 
ethyl acetate (30 ml). The organic layer was evaporated under reduced pressure to 
give the crude product. The crude material was purified by flash column 
chromatography with or with Fluka aluminium oxide (basic type pH 9.5 ± 0.5, 50-150 
Il) using MeOH (2 %) in DCM as the eluent to yield the product, 
2-(arninophenylmethylene)-5-methylcyclohexane-l,3-dione (139) (O.Olg, 35 %) as a 
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yellow solid; mp 104 ·C; MS (EI+) found 230.1185 [M+H], CI4H1SN02; requires 
230.1181 [M+H]; Vmax (DMSO)/cm'l 1664 (NH bending), 2124, 2250 and 3450 (NH2); 
/lH(400MHz; DMSO) 0.99 (s, 3H, CH3), 2.09-2.18 (m, 3H, CH2 & CH), 2.33-2.41 (m, 
2H, CH2), 7.24-7.27 (m, 2H,2 x Ar-H), 7.36-7.45 (m, 3H, 3 x Ar-H), 9.19 (s, lH, NH2) 
and 11.61 (s, IH, NH2); /le (400MHz; DMSO) 20.7 (CH3), 25.9 (CH), 46.6 (2 x CH2), 
114.2 (C), 127.2 (2 x Ar-C), 127.8 (2 x Ar-C), 129.2 (Ar-C), 133.6 (C), 153.8 (C), 
173.2 (C) and 175.6 (C); Found C, 72.94; H, 6.65; N, 6.32; Cl~ISN02 requires C, 
73.34; H, 6.59; N, 6.11. 
2-(Aminophenylmethylene)-5-methylcyclohexane-1,3-dione (139) 
(Method B) 
H". PdlC 10 % 
ethanol 
Palladium on carbon (10 %) was added carefully to dry ethanol (10 ml) in a flask 
under an atmosphere of nitrogen. 
6-Methyl-3-phenyl-4,5,6,7-tetrahydrobenz[dJisoxazol-4-one (6) (0.03 g, 0.12 mmol) 
in ethanol (10 ml) was added to the palladium/carbon slurry whilst stirring vigorously. 
The reaction vessel was evacuated and then purged with nitrogen three times, then 
evacuated and purged with hydrogen three times, eventually being left under an 
atmosphere of hydrogen. The reaction mixture was left stirring vigorously for 24 h at 
room temperature. The reaction vessel was then evacuated and purged with nitrogen 
three times, and the reaction mixture was filtered using a celite pad. The solvent was 
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removed under reduced pressure to yield the crude product, which was passed through 
or with Fluka aluminium oxide (basic type pH 9.5 ± 0.5, 50-150 Il) using MeOH (2 %) 
in DCM as the eluent to yield the product 
2-(aminophenylmethylene)-5-methylcyclohexane-l,3-dione (139) (O.Olg, 35 %) as a 
yellow solid. Spectroscopic data as reported above. 
2-[(2-Allyloxyphenyl)aminomethyleneJ-5-methylcyc1ohexane-1,3-dione (140) 
Mo(CO~ 
• 
3-(2-Allyloxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[djisoxazol-4-0ne (99) (0.06 g, 
0.23 mmol) was dissolved in moist acetonitrile (10 ml), molybdenum hexacarbonyl 
(0.06 g, 0.23 mmol) was added and the reaction was heated at reflux overnight. After 
cooling to room temperature, the reaction mixture was filtered through celite and then 
washed with ethyl acetate (30 ml). The organic layer was then evaporated under 
reduced pressure to give a crude product. The crude material was purified by flash 
column chromatography with or with Fluka aluminium oxide (basic type pH 9.5 ± 0.5, 
50-150 Il) using petroleum ether:ether acetate (1:1 v/v) as the eluent to yield the 
product 2-[(2-allyloxyphenyl)aminomefuylene]-5-niefuylcyclohexane-l,3-dione (140) 
(0.03 g, 47 %) as a yellow solid, mp 72 -73 ·C; MS (FAB+) found 286.1451 [M+H], 
C\7H\9N03; requires 286.1443 [M+H]; Vmax (CHCh)/cm'\ 1667 (NH bending), 1733 
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(C=O), 2358, 2949 and 3459 (NH2); liH (400MHz; CDCh) 1.65-1.69 (rn, 3H, CH3), 
2.34-2.39 (rn, lH, CH), 3.68-3.70 (rn, 2H, CH2), 4.22-4.24 (rn, 2H, CH2), 4.69-4.71 
(rn, 2H, OCH2), 5.38 (d, J 10.2, lH, =CH2), 5.46 (d, J 16.4, lH, =CH2), 5.84 (s, IH, 
NH2), 6.01-6.13 (rn, lH, =CH), 6.98 (d, J 8.4, lH, Ar-H), 7.09-7.11 (rn, IH, Ar-H), 
7.44-7.46 (rn, lH, Ar-H), 7.81 (s, lH, NH2) and 8.22 (dd, J2.0 & 8.0, lH, Ar-H); lie 
(400MHz; CDCh) 24.3 (CH3), 33.7 (CH), 63.3 (CH2), 69.1 (CH2), 69.9 (=CH2), 112.7 
(Ar-C), 116.3 (C), 119.4 (OCH2), 121.5 (Ar-C), 124.1 (C), 132.1 (=CH), 132.7 (Ar-C), 
133.3 (Ar-C), 134.6 (C), 156.3 (C), 158.1 (C) and 184.1 (C); Found C, 71.85; H, 6.70; 
N, 4.91; C17H19N03 requires C, 71.56; H, 6.71; N, 4.91. 
2-(2-Methoxyphenyl)-1,3-dimethylimidazolidine (144)117 
• 
o-Anisaldehyde (3.00 g, 22.04 mmol) and N,N'-dirnethylethylenediamine (2.33 g, 
26.44 mmol) in ethanol (100 ml) was stirred at room temperature overnight. 
Magnesium sulfate (ca. 4.50 g) was added, and the resulting mixture was stirred for a 
further 15 min. The reaction mixture was filtered and washed with diethyl ether and 
the solvent was removed under reduced pressure. The crude product was distilled (h.p. 
98-102 'C/3mbar) (lit. b.p. 96-100 'C!2mbar) to yield the product 
2-(2-rnethoxyphenyl)-1,3-dimethylimidazolidine (144) (3.28 g, 72 %) as a solid; mp 
41-42 'C; MS (EI+) found 207.1494 [M+H], C12HlSN20; requires 207.1497 [M+H]; 
178 
Experimental 
Vrnax (CHCh)/cm-1 1600,2777 and 2940; lIH(400MHz; CDCh) 2_11 (s, 6H, 2 X NCH3), 
2.50-2.54 (m, 2H, 2 x CffH), 3.23-3.27 (m, 2H, 2 x CHH), 3.72 (s, 3H, OCH3), 3.98 
(s, IH, CH), 6.79 (d, J 8.3, lH, Ar-H), 6.87-9.30 (m, lH, Ar-H), 7.15-7.19 (m, lH, 
Ar-H) and 7.58-7.60 (m, lH, Ar-H); lie (400MHz; CDCh) 39.6 (2 x CH3), 53.5 (2 x 
CH2), 55.4 (OCH3), 82.7 (CH), 110.3 (Ar-C), 121.1 (Ar-C), 127.5 (C), 128.8 (Ar-C), 
129.2 (Ar-C) and 158.9 (C). 
2-Bromo-6-methoxybenzaldehyde (145/ 17 
i) t-BuLi 
.. 
ii) BrCC~CC~Br 
(14S) 
To a solution of freshly distilled 2-(2-methoxyphenyl)-1,3-dimethylimidazolidine 
(144) (1.00 g, 4.85 mmol) in dry THF (40 ml) was added t-BuLi (2.5 M in hexanes) 
(5.82 ml, 14.54 mmol) dropwise by syringe over 1 h. The mixture was stirred under 
nitrogen at room temperature for 6 h. A solution of 1,2-dibromotetrachloroethane 
(5.00 g, 14.54 mmol) in dry THF (10 ml) was then slowly added, and the mixture was 
stirred at room temperature overnight. Hydrochloric acid (2M; 150 ml) was added to 
quench the reaction, which was stirred for 30 min at room temperature. The organic 
layer was separated and the aqueous layer extracted with chloroform (2 x 50 ml). The 
combined organic extract was washed with aqueous ammonia chloride (100 ml), and 
the aqueous layer was extracted with chloroform (2 x 50 ml). The organic layers were 
again combined, dried by magnesium sulfate, filtered and evaporated under reduced 
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pressure. The crude product was purified by flash column chromatography using 
petroleum ether:diethyl ether (7:3 v/v) as eluent to yield the product 
2-bromo-6-methoxybenzaldehyde (145) (0.36 g, 35 %) as a yellow solid; mp 57-58 
'C (lit. 57.5-58 'C); MS (EI+) found 214.9712 (Br79) [M+H], CSH70ZBr; requires 
214.9708 (Br79) [M+H]; Vrnax (CHCh)/cm-1 785 (C-Br), 1691 (C=O), 2882 and 3075; 
IIH(400MHz; CDCh) 3.83 (s, 3H, OCH3), 6.85 (dd, J 8.4 & 14.0, IH, Ar-H), 7.04 (cl, 
J8.4, lH, Ar-H), 7.28 (m, lH, Ar-H) and 10.41 (s, lH, CHO); lie (400MHz; CDCh) 
55.2 (CH3), 110.0 (Ar-C), 125.4 (Ar-C), 123.7 (C), 133.8 (Ar-C), 135.4 (C), 161.0 (C) 
and 189.3 (C). 
2-Bromo-6-methoxybenzaldehyde oxime (142) 
NH.zOHHCI 
• 
NaCOOCf! 
To a solution of hydroxylamine hydrochloride (0.31 g, 4.46 mmol) and sodium 
acetate (0.72 g, 8.78 mmol) in water (50 ml), 2-bromo-6-methoxybenzaldehyde (145) 
(0.47 g, 2.19 mmol) in ethanol (20 ml) was added. The reaction rnixture was heated to 
70 'C for 10 rnin and then cooled down to room temperature. The reaction was stored 
in a refrigerator overnight. If crystals were not formed, the solution was extracted 
with ethyl acetate (3 x 30 ml). The combined organic layer was dried by sodium 
sulfate, filtered and evaporated to dryness under reduced pressure to yield 
2-bromo-6-methoxybenzaldehyde oxime (142) (0.61 g, 100 %) as a pale yellow 
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crude solid (the crude product was further purified by recrysta11ization with 
DCMlMeOH. for combustion analysis); mp 186-187 ·C; MS (ES+) found 229.9812 
(Br79) [M+H), CsHsN0V3r79; requires 229.9811 (Br7~ [M+H]; Vmax (CHCh)/cm-' 721 
(C-Br) and 2958 (OH); IiH (400MHz; CDCh) 3.92 (s, 3H, OCH3), 6.88-6.94 (m, IH, 
Ar-H), 7.05-7.20 (m, lH, Ar-H), 7.24-7.28 (m, lH, Ar-H), 8.56 (s, IH, NCH) and 
10.05 (s, lH, OH); lie (400MHz; CDCh) 56.1 (OCH3), 109.8 (Ar-C), 114.3 (C), 122.4 
(C), 130.9 (Ar-C), 135.0 (C), 145.5 (NCH) and 158.9 (C); Found C, 41.66; H, 3.60; N, 
6.05; CsHsN02Brrequires C, 41.77; H, 3.51; N, 6.09. 
2-Bromo-6-methoxyphenylhydroximoyl chloride (146) 
Be roOH \"'" ,-::; Br 
(142) 
o 
C{N-CI 
o 
• 
2-Bromo-6-methoxybenzaldehyde oxime (142) (0.61 g, 2.65 mmol) was dissolved in 
chloroform (50 ml), followed by addition of pyridine (0.21 ml, 2.65 mmol). The 
mixture was stirred under an atmosphere of nitrogen, when the temperature was raised 
to 50°C. N-Chlorosuccinimide (0.36 g, 2.70 mmol) was added to the mixture which 
was stirred at 50°C for 2 h. The reaction mixture was diluted by DCM (50 rnI). The 
organic layer was washed with water (2 x 50 rnI) and brine (50 rnI), dried over sodium 
sulfate, filtered and concentrated under reduced pressure to yield the crude product, 
2-bromo-6-methoxyphenylhydroximoyl chloride (146) (0.72 g, 100 %) as a yellow 
crude oil; MS (El+) found 263.9431 (Br79, Ces) [M+H), CsH7N02Br79Ctls; requires 
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263.9427 (Br7!) [M+R]; Vrnax (neat)/cm·1 1586, 2301 and 3546 (OH); liH (400MHz; 
CDCh) 3.90 (s, 3R, OCR3), 6.87-6.89 (m, lH, Ar-H), 7.19-7.30 (m, lH, Ar-H), 
7.43-7.46 (m, lH, Ar-H) and 8.67 (s, lH, OH); lie (400MHz; CDCh) 56.3 (OCH3), 
109.6 (Ar-C), 124.7 (Ar-C), 126.4 (C), 131.6 (C), 132.3 (Ar-C), 136.2 (C) and 162.7 
(C). 
Methyl 5-methoxycarbonylmethyl-3-(2-bromo-6-methoxy 
phenyl)isoxazole-4-carboxylate (147) 
Et,N 
+ 
-
OMe 
(147) 
Dimethyl 3-(I-pyrrolidino)pent-2-ene-l,5-dioate (8) (1.80 g, 7.94 mmol) and 
2-bromo-6-methoxyphenylhydroximoyl chloride (146) (0.35 g, 1.32 mmol) were 
dissolved in chloroform (50 ml). Triethylamine (0.18 ml, 1.32 mmol) was added 
dropwise over 30 min. The reaction mixture was heated under reflux at an atmosphere 
of nitrogen for 3 h and then left to stir at room temperature for 16 h.The reaction 
mixture was concentrated in vacuo to yield a yellow oil, which was purified by flash 
column chromatography on silica gel using petroleum ether:ethyl acetate (1:1 v/v) as 
eluent to yield methyl 5-methoxycarbonylmethyl-3-(2-bromo-6-methoxy 
phenyl)isoxazole-4-carboxylate (147) (0.03 g, 5 %) as a yellow oil; MS (EI+) found 
383.0002 (Br7!), ClsRl<tN06Br79; requires 383.0004 (Br7!); Vmax (neat)/cm·1 1629, 
1708, 1752 (C=O), 2846 and 2951; liH(400MHz; CDCh) 3.68 (s, 3R, OCR3), 3.72 (s, 
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3H, OCH3), 3.84 (s, 3H, OCH3), 5.20 (s, 2H, CH2), 6.85-6.93 (m, lH, Ar-H) and 
7.27-7.28 (m, 2H, 2 X Ar-H); ac (400MHz; CDCI3) 38.2 (CH2), 51.1 (CH3), 52.2 
(CH3), 56.0 (OCH3), 110.7 (Ar-C), 116.4 (C), 123.9 (C), 124.5 (Ar-C), 132.2 (Ar-C)? 
158.8 (C), 161.4 (C), 161.7 (C), 171.2 (C), 181.1 (C) and 190.1 (C). 
3-(2-Bromo-6-methoxyphenyl}-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one 
(148) 
&0" 0& Sodium 
OMe 
I ~ I Cl isopropoxide + • 
~ Br (10) (146) 
To a solution of sodium isopropoxide prepared from sodium (0.03 g, 1.02 mmol) in 
isopropyl alcohol (50 ml), were added successively 5-methylcyciohexane-I,3-dione 
(10) (0.13 g, 1.02 mmol) and 2-bromo-6-methoxyphenylhydroximoyl chloride (146) 
(0.27 g, 1.02mmol). After stirring overnight at room temperature, the reaction mixture 
was poured into water (50 ml), and extracted with DCM (3 x 50 ml). The combined 
organic layer was washed with brine (2 x 100 ml), dried over sodium sulfate, filtered 
and concentrated under reduced pressure. The crude product was purified by flash 
column chromatography using ethyl acetate:petroleum ether (1:1 v/v) as eluent to 
yield 3-(2-bromo-6-methoxyphenyl)-6-methyl-4,5,6,7-
> 
tetrahydrobenzo[d]isoxazol-4-one (148) (0.26 g, 75 %) as a yellow viscous oil; MS 
(nanospray) found 335.0164 (Br79), ClsHI4N03Br79; requires 335.0163 (Br7~; Vrnax 
(DCM)/cm·1 713 (C-Br), 1692 (C=O) and 2959; aH(400MHz; CDCh) 1.21 (dd, J 6.4, 
183 
Experimental 
3H, CH3), 2.26-2.31 (m, lH, OCCH2), 2.43-2.57 (m, lH, CH), 2.52 (dd, J2.S & 16.0, 
IH, OCCH2), 2.66-2.72 (m, lH, O=CCH2), 3.16 (d, J 4.S & 17.2, lH, O=CCH2), 3.71 
(s, 3H, OCH3), 6.90-6.93 (m, lH, Ar-H) and 7.24-7.27 (m, 2H, 2 x Ar-H); oe 
(400MHz; CDCh) 20.S (CH3), 30.4 (CH), 31.0 (CH2), 46.4 (CH2), 56.2 (OCH3), 
110.1 (Ar-C), 115.4 (C), 123.9 (C), 124.S (Ar-C), 131.S (Ar-C), 134.5 (C), 156.0 (C), 
15S.9 (C), IS0.S (C) and 191.0 (C). 
5-Allyl-3-(2-bromo-6-methoxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo/d/isoXllzol-
4-one (149) and 
5,5-Diallyl-3-(2-bromo-6-methoxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo/dJisoxa 
zol-4-one (150) 
OMe 
BrO 
(148) 
2.1 equiv. LOA. 
THF:OMPU (6:1) 
• 
1.2 equiv. allyl bromide 
(149) 
+ 
(150) 
n-ButylIithium (2.5 M solution in hexanes; 2.1 equiv., 1.10 ml, 2.75 mmol) and 
diisopropylamine (0.40 ml, 2.S1 mmol) was added in dry TIIF (26 ml) at 0 cC, 
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followed by DMPU (6 ml) to make a LDA solution. It was stirred for 10 min. 
3-(2-Bromo-6-methoxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one 
(148) (0.44 g, 1.31 mmol) in dry THF (10 ml) was added dropwise to this solution of 
LDA and DMPU at -78 °C. The resulting mixture was allowed to stir at -78 °C for 30 
min. Allyl bromide (0.13 ml, 1.57 mmol) was added at -78 °C, and the mixture was 
allowed to warm to room temperature and stirred overnight. Saturated ammonium 
chloride solution (30 ml) was added and the mixture was extracted with DCM (3 x 50 
ml). The combined extract was washed with water (3 x 30 ml) and then brine (1 x 100 
ml). The organic extract was dried over sodium sulfate, filtered and the solvent was 
evaporated under reduced pressure. The crude product was purified by flash column 
chromatography using petroleum ether:ethyl acetate (1: 1 v/v) as eluent to yield, 
mono-allylated product 
5-allyl-3-(2-bromo-6-methoxyphenyl)-6-methyl-4,5,6, 7 -tetrahydrobenzo[ dJisoxazol-4 
-one (149) (0.09 g, 18 %) as a yellow oil; MS (FAB+) found 376.0544 (Br79) [M+H], 
ClsH1SN03Br79; requires 376.0548 (Br7~ [M+H]; Vmax (neat)/cm-1 778 (C-Br), 1693 
(C=O) and 2963; IiH (400MHz; CDCh) 1.18 (d, J 6.4, 3H, CH3), 2.28-2.42 (m, 3H, 
OCCHH & CH2), 2.45-2.53 (m, lH, CH), 2.55 (dd, J 2.8 & 16.0, lH, OCCH2), 
2.95-3.03 (m, lH, O=CCH), 3.73 (s, 3H, OCH3), 5.16-5.24 (m, 2H, =CH2), 5.71-6.01 
(m, lH, =CH), 6.91-6.93 (m, lH, Ar-H) and 7.24-7.31 (m, 2H, 2 x Ar-H); lie 
(400MHz; CDCI3) 19.0 (CH3), 33.6 (CH), 41.5 (CH), 45.2 (CH2), 45.6 (CH2), 56.2 
(OCH3), 110.0 (Ar-C), 115.2 (C), 118.5 (=CH2), 124.1 (C), 124.1 (C), 124.9 (Ar-C), 
131.8 (Ar-C), 134.3 (=CH), 156.1 (C), 158.9 (C), 182.4 (C) and 190.8 (C); and 
di-allylated product, 
5,5-diallyl-3-(2-bromo-6-methoxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxaz 
ol-4-one (150) (0.09 g, 17 %) as a yellow oil; MS (FAB+) found 416.0864 (Br79) 
[M+H], C21H22N03Br79; requires 416.0861 (Br7~ [M+H]; Vmax (neat)/cm-1 779 (C-Br), 
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1693 (C=O) and 2964; oH(400MHz; CDCb) 1.02 (d, J2.0, 3H, CH3), 2.21-2.41 (m, 
3H, OCCHH & CH2), 2.45-2.61 (m, 4H, CH, OCCHH & CH2), 3.68 (s, 3H, OCH3), 
5.03-5.09 (m, 4H, 2 x =CH2), 5.41-5.79 (m, 2H, 2 x =CH), 6.83-6.87 (m, IH, Ar-H) 
and 7.18-7.22 (m, 2H, 2 x Ar-H); oe (400MHz; CDCb) 12.9 (CH3), 37.2 (CH2), 37.6 
(CH2), 43.0 (CH2), 52.3 (CH), 55.2 (OCH3), 109.0 (Ar-C), 116.2 (C), 118.3 (=CH2), 
118.5 (=CH2), 123.0 (C), 123.1 (C), 123.8 (Ar-C), 131.6 (Ar-C), 131.7 (=CH), 132.0 
(=CH), 157.8 (C), 163.1 (C), 175.8 (C), 189.8 (C) and 191.3 (C). 
3-(2-Bromo-6-methoxyphenyl)-6-methyl-5-(3-methylbut-2-enyl)-4,5,6, 7-tetrahydrob 
enzo{dJuoxazol-4-one (151) and 
3-(2-Bromo-6-methoxyphenyl)-6-methyl-5,5-bu-(3-methylbut-2-enyl)-4,5,6,7-tetrah 
ydrobenzo{dJuoxazol-4-one (152) 
2.1 equiv. LOA, 
THF:DMPU (6:1) 
• 
2.0 equiv.~Br 
BrO 
(148) 
(151) 
+ 
OMe 
(152) 
n-Butyllithium (2.5 M solution in hexanes; 2.1 equiv., 2.30 ml, 5.75 mmol) and 
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diisopropylamine (0.82 ml, 5.86 nunol) was added in dry THF (30 ml) at 0 cC, 
followed by DMPU (8 ml) to make a LDA solution. It was stirred for 15 min. 
3-(2-Bromo-6-methoxyphenyl)-6-methyl-4,5,6, 7 -tetrahydrobenzo[ dJisoxazol-4-one 
(148) (0.92g, 2.74 nunol) in dry THF (18 ml) was added dropwise to this solution of 
LDAand DMPU at -78°C. The resulting mixture was allowed to stir at -78 °C for 10 
min. I-Bromo-3-methyl but-2-ene (0.64 ml, 5.47 nunol) was added at -78°C, and the 
mixture was allowed to warm to room temperature and stirred overnight. Saturated 
sodium hydrogencarbonate solution (40 ml) was added, and the mixture was extracted 
with DCM (3 x 50 ml). The combined organic extract was washed with water (3 x 30 
ml) and then brine (1 x 100 ml). The organic extract was dried over sodium sulfate, 
filtered and the solvent was evaporated under reduced pressure. The crude product 
was purified by flash column chromatography using petroleum ether:ethyl acetate (2:1 
v/v) as eluent to yield both mono-alkylated product, 
3-(2-bromo-6-methoxyphenyl)-6-methyl-5-(3-methylbut-2-enyl)-4,5,6,7-tetrahydro-
benzo[d]isoxazol-4-one (151) (0.24 g, 22 %) as a yellow oil; MS (EI+) found 
403.0780 (Br"), C2oHnN03Br'9; requires 403.0778 (Br'9); Vrnax (neat)/cm·1 731 
(C-Br), 1570, 1694 (C=O) and 2965; /lH (400MHz; CDCh) 1.08 (d, J 5.9, 3H, CH3), 
1.53 (s, 3H, CH3), 1.55 (s, 3H, CH3), 2.11-2.41 (m, 3H, OCCHH & CH2), 2.51-2.63 
(m, 2H, OCCHH & CH), 2.86 (m, lH, O=CCH), 3.64 (s, 3H, OCH3), 5.17-5.21 (m, 
IH, =CH), 6.83-6.86 (m, lH, Ar-H) and 7.16-7.23 (m, 2H, 2 x Ar-H); /le (400MHz; 
CDCh) 20.9 (CH3), 24.6 (2 x CH3), 28.4 (CH2), 34.6 (CH2), 50.9 (CH), 54.5 (CH), 
55.3 (OCH3), 108.2 (Ar-C), 117.1 (C), 121.5 (C), 123.1 (Ar-C), 131.2 (Ar-C), 131.9 
(=CH), 152.1 (C), 153.1 (C), 157.9 (C), 171.2 (C), 183.1 (C) and 191.3 (C); and 
di-alkylated product, 
3-(2-bromo-6-methoxyphenyl)-6-methyl-5,5-bis-(3-methylbut-2-enyl)-
4,S,6,7-tetrahydrobenzo[dJisoxazol-4-one (152) (0.30 g, 23 %) as a yellow oil; MS 
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(FAB+) found 472.1480 [M+H] (Br7\ C2sH3oN03Br79; requires 472.1487 [M+H] 
(Br79); Vrnax (neat)/cmo1 777 (C-Br), 1597, 1698 (C=O) and 2974; liH(400MHz; CDCh) 
1.04 (d, J 6.3, 3H, CH3), 1.49 (s, 3H, CH3), 1.51 (s, 3H, CH3), 1.53 (s, 3H, CH3), 1.55 
(s, 3H, CH3), 2.20-2.51 (m, 3H, OCCHH & CH2), 2.51-2.62 (m, 4H, CH, OCCHH & 
CH2), 3.70 (s, 3H, OCH3), 5.14-5.21 (m, 2H, 2 x =CH), 6.82-6.89 (m, lH, Ar-H) and 
7.19-7.25 (m, 2H, 2 x Ar-H); lie (400MHz; CDCh) 22.0 (CH3), 25.7 (2x CH3), 25.8 
(2 x CH3), 28.5 (CH2), 28.9 (CH2), 34.1 (CH2), 51.2 (CH), 56.2 (OCH3), 108.2 (Ar-C), 
117.0 (C), 121.2 (C), 122.4 (C), 123.9 (Ar-C), 131.6 (Ar-C)" 131.9 (=CH), 132.0 
(=CH), 152.6 (C), 153.1 (C), 157.9 (C), 165.4 (C), 171.1 (C), 182.0 (C) and 192.5 
(C). 
3-(2-Bromo-6-methoxyphenyl)-6-methyl-S,S-bis-(3-methylbut-2-enyl)-7-phenylselen 
yl-4,S,6,7-tetrahydrobenzo[dJisoxazol-4-one (153) 
(152) 
LOA 2.0 equlv., 
THF:OMPU (6:1) 
1.5 equlv. PhSeBr 
• 
(153) 
n-Butyllithium (2.5 M solution in hexanes; 0.51 ml, 1.27 mmol) and diisopropyl amine 
(0.18 ml, 1.30 mmol) was added in dry THF (16 ml) at 0 °C, followed by DMPU (6 
ml) to make an LDA solution. The mixture was stirred for 20 min. 
3-(2-Bromo-6-methoxyphenyl)-6-methyl-5,5-bis-(3-methylbut-2-enyl)-4,5,6,7-tetrahy 
drobenzo[dJisoxazol-4-one (152) (0.30 g, 0.64 mmol) in dry THF (10 ml) was added 
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dropwise to this solution of LDA and DMPU at -78°C. The resulting mixture was 
allowed to stir at -78 °C for 60 min. Phenylselenium bromide (0.22 g, 0.95 mmol) in 
dry THF (10 ml) was added at -78°C, and the mixture was allowed to warm to room 
temperature and stirred overnight. Saturated sodium hydrogen carbonate solution (30 
ml) was added, and the mixture was extracted with DCM (3 x 30 ml). The combined 
extract was washed with water (50 ml) and then brine (50 ml). The organic extracts 
were dried over sodium sulfate, filtered and the solvent was evaporated under reduced 
pressure.· The crude product was purified by flash column chromatography using 
petroleum ether:ethyl acetate (3: 1 v/v) as eluent to yield 
3-(2-bromo-6-methoxyphenyl)-6-methyl-5,5-bis-(3-methylbut-2-enyl)-7-phenylseleny 
1-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-one (153) (0.16 g, 41 %) as a brown oil. MS 
(FAB+) found 628.0959 [M+H] (Br79, Se81), C31H34N03Br79Se80; requires 628.0966 
[M+H] (Br79, Se81); Vmlll( (neat)/cm-1 734 (C-Br), 1573, 1616 (C=O), 2925 and 2963; 
/lH (400MHz; CDCh) 1.03 (cl, J 5.9, 3H, CH3), 1.53 (s, 3H, CH3), 1.55 (s, 3H, CH3), 
1.57 (s, 3H, CH3), 1.59 (s, 3H, CH3), 2.21-2.50 (m, 5H, CH & 2 x CH2), 2.50-2.61 (m, 
m, CH), 3.70 (s, 3H, OCH3), 4.97-5.13 (m, m, =CH), 5.19-5.31 (m, m, =CH), 
6.83-6.71 (m, m, Ar-H), 7.17-7.20 (m, 2H, 2 x Ar-H), 7.28-7.34 (m, 3H, 3 x Ar-H) 
and 7.56-7.61 (m, 2H, 2 x Ar-H); /le (400MHz; CDCh) 22.0 (CH3), 25.7 (2 x CH3), 
25.9 (2 x CH3), 28.7 (CH2), 28.9 (CH2), 48.2 (CH), 51.3 (CH), 56.1 (OCH3), 108.2 
(Ar-C), 117.1 (C), 121.3 (C), 122.4 (C), 123.9 (Ar-C), 129.5 (2 x Ar-C), 131.6 (2 x 
Ar-C), 131.9 (=CH), 132.1 (=CH), 138.1 (2 x Ar-C), 152.4 (C), 153.1 (C), 157.8 (C), 
165.1(C), 171.3 (C), 181.9 (C) and 192.6 (C). 
189 
Experimental 
2-Bromomethyl-3-(dibromomethyl)anisole (156)114 
OMe 3.0 equiv. NBS, CCI4, OMe Br Cc 300 W tungsten lamp • Br 
(156) Br 
2,3-Dimethylanisole (0.20 g, 1.47 nunol) and N-bromosuccinimide (0.78 g ,4.41 
nunol) were dissolved in carbon tetrachloride (75 mJ) and the mixture was stirred 
under nitrogen for 5 h, while being exposed to a 300 watt high intensity tungsten lamp. 
The solution was cooled to room temperature, the suspended succinimide was 
removed by filtration and the solvent was evaporated. The residue was recrystallised 
from hexane:chloroform (5:1 v/v) to yield the product 
2-bromomethyl-3-(dibromomethyl)anisole (156) (0.51 g, 93 %) as a white solid; mp 
84-85 "C (Lit.1I4 84-85 0C); Vrnax (CHCh)/cm,1 797 (C-Br), 1698 and 2836; liH 
(400MHz; CDCh) 3.73 (5, 3H, OCH3), 4.67 (s, 2H, CH2), 6.72 (t, J 7.6, IH, Ar-H), 
6.95 (s, lH, CH), 7.24 (t, J 8.0, lH, Ar-H), 7.43 (d, J 7.8, lH Ar-H); lie (400MHz; 
CDCh) 22.9 (CH2)' 35.8 (CH), 55.4 (OCH3), 110.8 (Ar-C), 121.8 (Ar-C), 123.9 (C), 
129.4 (Ar-C), 140.3 (C) and 156.8 (C). 
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2-Bromomethyl-3-methylanisole (157)114 
1.0 equiv. NBS, 
cyclohexane, 
150 W tungsten lamp 
• 
Experimental 
OMe 
2,3-Dimethylanisole (5.00 g, 36.71 mmol) and N-bromosuccinimide (6.53 g, 36.71 
mmol) were dissolved in cyclohexane (300 ml) and the mixture was stirred under 
nitrogen for 1.5 h, while being exposed to a 150 watt high intensity tungsten lamp. 
The solution was cooled to room temperature, the suspended succinimide was 
removed by filtration and the solvent was evaporated. The residue was recrystallised 
from hexane:diethyl ether (5:1 v/v) to yield the product 
2-bromomethyl-3-methylanisole (157) (2.01 g, 25 %) as a white solid; m.p. 48-50 cC; 
MS (FAB+) found 213.9999 [M-H] (Br7~, C9H110Br79; requires 213.9993 [M-H] 
(Br79); Vmax (CHCh)/cm"1 775 (C-Br), 1586 and 3415; IiH (400MHz; CDCh) 2.31 (s, 
3H, CH3), 3.77 (s, 3H, OCH3), 4.66 (s, 2H, CH2), 6.70 (m, 2H, 2 x Ar-H) and 7.08 (t, 
J8.0, lH, Ar-H); lie (400MHz; CDCh) 18.4 (CH3), 54.4 (OCH3), 56.5 (CH2), 107.2 
(Ar-C), 122.0 (Ar-C), 125.9 (C), 127.5 (Ar-C), 136.9 (C) and 157.0 (C). 
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2,3-Bis(bromomethyl)anisole (158)114 
OMe 2.1 equiv. NBS. OMe Br 
Cc cyclohexane. 150 W tungsten lamp • 
(158) Br 
2,3-Dimethylanisole (2.5 g, 18.36 nunol) and N-bromosuccinimide (6.86 g, 38.55 
mmol) were dissolved in cyc10hexane (150 ml) and the mixture was stirred under 
nitrogen for 3 h, while being exposed to a 150 watt high intensity tungsten lamp. The 
solution was cooled to room temperature, the suspended succinimide was removed by 
filtration and the solvent was evaporated. The residue was recrysta1lised from 
hexane:diethyl ether (5:1 v/v) to yield the product 2,3-bis(bromomethyl)anisole (158) 
(1.62 g, 30 %) as a white solid; mp 69-70 'C (Lit.1l4 69-70 'C); MS (FAB+) found 
291.9100 (Br'!), C9HIO02Br'9; requires 291.9098 (Br'\ Vmax (CHCh)/cm'\ 796 
(C-Br), 2835 and 2960; BH (400MHz; CDCh) 3.76 (s, 3H, OCH3), 4.51 (s,2H, CH2), 
4.68 (s, 2H, CH2), 6.75 (d, J 8.4, lH, Ar-H), 6.85 (d, J 3.8, lH, Ar-H) and 7.15 (1, J 
16.4, lH, Ar-H); Bc (400MHz; CDCI3) 22.8 (CH2),29.1 (CH2), 55.1 (OCH3), 110.4 
(Ar-C), 121.8 (Ar-C), 124.0 (C), 129.0 (Ar-C), 136.9 (C) and 156.8 (C). 
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2,3-Bis(dibromomethyl)anisole (159)114 
OMe 4.0 equiv. NBS, CCI., OMe Br Cc 300 W tungsten lamp Br • Br 
(159) Br 
2,3-Dimethylanisole (0.20 g, 1.47 mmol) and N-bromosuccinimide (1.05 g, 5.88 
mmol) were dissolved in carbon tetrachloride (75 ml) and the mixture was stirred 
under nitrogen overnight, while being exposed to a 300 watt high intensity tungsten 
lamp. The solution was .cooled to room temperature, the suspended succinimide was 
removed by filtration and the solvent was evaporated. The residue was recrysta1lised 
from hexane:chloroforrn (5:1 v/v) to yield the product 2,3-bis(dibromomethyl)anisole 
(159) (0.60 g, 90 %) as a white solid; mp 148-149.5 'C (Lit.114 149-150 'C); MS 
(FAB+) found 370.8082 [M-Br-H] (Br7\ 4HgOBr4; requires 370.8075 [M-Br-H] 
(Br7!); Vmax (CDCh)/cm·1 748 (C-Br), 1902, 1975, 2535 and 3740; IiH (400MHz; 
CDCh) 3.88 (s, 3H, OCH3), 6.78 (dd, JO.8 & 8.4, lH, Ar-H), 7.40 (t, J8.4, lH, Ar-H), 
7.54 (s, lH, CH), 7.68 (dd, JO.8 & 8.0, IH, Ar-H) and 7.77 (s, lH, CH); lie (400MHz; 
CDCI3) 28.8 (CH), 37.0 (CH), 56.41 (OCH3), 111.16 (Ar-C), 124.3 (C), 125.7 (Ar-C), 
131.5 (Ar-C), 144.2 (C) and 151.8 (C). 
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2-Acetoxymethyl-3-methoxybenzaldehyde (160)114 
OMe o 
C,"\COONa O~ 
.. 
Br acetic acid 
(156) Br (160) 
2-Bromomethyl-3-(dibromomethyl)anisole (156) (11.49 g, 30.81 mmol) and 
anhydrous sodium acetate (9.10 g, 110.93 mmol) were dissolved in glacial acetic acid 
(100 ml) and the stirred solution was heated at reflux overnight. The acetic acid was 
evaporated, the residue was dissolved in ethyl acetate, the salts were removed by 
filtration, and the filtrate was stirred with hydrochloric acid (0.5M) (100 ml). After the 
layers were separated, the aqueous layer was extracted with ethyl acetate (3 x 80 ml). 
The combined organic solution was dried over magnesium suIfate, filtered, 
evaporated and the crude material was purified by flash column chromatography 
using petroleum ether:ethyl acetate (3:2 v/v) as the eluent to yield the product 
2-acetoxymethyl-3-methoxybenzaldehyde (160) (4.17 g, 65 %) as a yellow oil; MS 
(FAB+) found 207.0652 [M-H], CIIH1204; requires 207.0657 [M-H];. Vmax 
(CHCh)/cm-11659 and 1737 (C=O); ~(400MHz; CDCh) 2.05 (s, 3H, CH3), 3.90 (s, 
3H, OCH3), 5.57 (s, 2H, CH2), 7.17-7.19 (m, lH, Ar-H), 7.50-7.53 (m, 2H, 2 x Ar-H) 
and 10.29 (s, lH, CHO); Bc (400MHz; CDCI3) 21.0 (CH3), 55.9 (CH2), 56.2 (OCH3), 
116.23 (Ar-C), 122.56 (C), 122.82 (Ar-C), 130.26 (Ar-H), 137.0 (C), 158.5 (C), 171.1 
(C=O) and 191.7 (CHO). 
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2-Acetoxymethyl-3-methoxybenzaldehyde oxime (154) 
NH,OHHCI 
• 
NaCOOCI-j, 
(160) (154) 
To a solution of hydroxylamine hydrochloride (5.70 g, 82.03 mmol) and sodium 
acetate (13.46 g, 164.09 mmol) in water (80 ml), was added 
2-acetoxymethyl-3-methoxybenzaldehyde (160) (8.54 g, 41.02 mmol) in ethanol (80 
ml). The reaction mixture was heated to 70 'C for 10 min, and then cooled down to 
room temperature. The reaction was stored in a refrigerator ovemight. If crystals were 
not formed, the solution was extracted with ethyl acetate (3 x 50 ml). The combined 
organic layer was dried by sodium suIfate, filtered and evaporated to dryness under 
reduced pressure to yield 2-acetoxymethyl-3-methoxybenzaldehyde oxime (154) 
(9.17 g, 100 %) as a pale yellow solid (the crude product was further purified for 
combustion analysis); mp 142-143 'C; MS (ES+) found 223.0838, ClIH13N04; 
requires 223.0839; Vmax (CHCh)/cm·1 1691, 1731 (C=O) and 3370; OH (400MHz; 
CDCI3) 2.07 (s, 3H, CH3), 3.86 (s, 3H, OCH3), 5.33 (s,2H, CH2), 6.94-6.97 (m, m, 
Ar-H), 7.32-7.38 (m, 2H, 2 x Ar-H) and 8.42 (s, m, NCH); Oc (400MHz; CDCh) 
21.1 (CH3), 55.9 (OCH3), 57.3 (CH2), 112.0 (Ar-C), 119.3 (Ar-C), 121.9 (C), 130.1 
(Ar-C), 133.1 (C), 148.6 (CHN), 158.2 (C) and 170.2 (C=O); Found C, 59.38; H, 5.86; 
N, 6.49; ClIH13N04 requires C, 59.19; H, 5.87; N, 6.27. 
195 
Experimental 
2-Acetoxymethyl-J-methoxyphenylhydroximoyl chloride (161) 
• 
To 2-aeetoxymethyl-3-methoxybenzaldehyde oxime (154) (6.64 g, 29.75 mmol) in 
chlorofonn (100 ml) was added pyridine (2.40 ml, 29.75 mmol) in a reaction flask. 
The mixture was stirred under an atmosphere of nitrogen and the temperature was 
raised to 50°C. N-Chlorosuccinimide (4.05 g, 30.34 mmol) was added to the mixture 
and stirred at 50°C for 2 h. The reaction mixture was diluted by DCM (50 ml). The 
organic layer was washed with water (2 x 80 ml) and brine (100 ml), dried over 
sodium sulfate, filtered and concentrated under reduced pressure to yield the crude 
product, 2-acetoxymethyl-3-methoxyphenylhydroximoyl chloride (161) (7.68 g, 100 
%) as a yellow crude oil; MS (EH) found 257.0454 (CI3s), CIIH!2N04Ces; requires 
257.0455; Vmax (neat)!cm'! 667 (C-CI), 1792 (C=O) and 3402; IiH(400MHz; CDCI3) 
2.07 (s, 3H, CH3), 3.85 (s, 3H, OCH3), 5.28 (s, 2H, CH2), 7.01-7.26 (m, lH, Ar-H) 
and 7.32-7.45 (m, 2H, 2 x Ar-H); lie (400MHz; CDCh) 20.0 (CH3), 54.9 (OCH3), 56.6 
(CH2), 110.2 (Ar-C), 120.9 (Ar-C), 121.0 (C), 129.1 (Ar-H), 132.9 (C), 157.8 (C), 
169.5 (C=O) and 169.9 (C). 
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3-(2-Acetoxymethyl-3-methoxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol 
-4-one (162) 
AijcO N .... OH 
MeO I I ~ Cl 
. .0 
+ 
.& 50dium isopropoxide • o 
(161) (10) 
To a solution of sodium isopropoxide prepared from sodium (0.68 g, 29.77 mmol) in 
isopropyl alcohol (150 ml), were added successively 5-methylcyclohexane-l,3-dione 
(10) (5.63 g, 44.64 mmol) and 2-acetoxymethyl-3-methoxyphenylhydroximoyl 
chloride (161) (7.67 g, 29.77 mmol). After stirring overnight at room temperature, the 
reaction mixture was poured into water (150 ml), and extracted with DCM (3 x 60 ml). 
The combined organic layer was wash with brine (2 x 100 ml), dried over sodium 
sulfate, filtered and concentrated under reduced pressure. The crude product was 
purified by flash column chromatography using petroleum ether:ethyl acetate (1:2 v/v) 
as eluent to yield 
3-(2-acetoxymethyl-3-methoxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[d]isoxazol-
4-one (162) (3.73 g, 38 %) as a yellow viscous oil; MS (FAB+) found 330.1350 
[M+H], CJ8Hi9NOs; requires 330.1342 [M+H]; Vmax (CHCh)/clIli 1690 and 1735 
(C=O); aH (400MHz; CDCh) 1.16 (d, J 6.8, 3H, CH3), 1.96 (s, 3H, CH3), 2.21 (dd, J 
11.0 & 15.9, lH, OCCH2), 2.41-2.53 (m,2H, CH & OCCH2), 2.62 (dd, J9.7 & 16.9, 
lH, O=CCH2), 3.10 (dd, J 5.0 & 16.9, lH, O=CCH2), 3.80 (s, 3H, OCH3), 5.19 (s, 2H, 
OCH2), 6.93-6.97 (m, lH, Ar-H) and 7.21-7.34 (m, 2H, 2 x Ar-H); ac (400MHz;· 
CDCI3) 20.9 (CH3), 21.1 (CH3), 30.5 (CH2), 31.08 (CH2), 46.64 (CH), 55.90 (OCH3), 
57.85 (OCH2), 112.5 (Ar-C), 115.0 (C), 121.5 (Ar-C), 130.2 (Ar-C), 137.0 (C), 142.0 
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(C), 158.6 (C), 170.9 (C), 181.1 (C) and 191.5 (C). 
3-(2-Acetoxymethyl-3-methoxyphenyl)-6-methyl-5-(3-methylbut-2-enyl)-4,5,6,7-
tetrahydrobenzo[dJisoxazol-4-one (163) and 
3-(2-Acetoxymethyl-3-methoxyphenyl)-6-methyl-5,5-bis-(3-methylbut-2-enyl)-
4,5,6,7-tetrahydrobenzoJdJisoxazol-4-one (164) 
2.1 equiv. LOA, 
THF:DMPU (6:1) 
• 
2.0 equiv.»=/'sr 
AcO 
o 
(162) MeO 
(163) 
+ 
(164) 
n-Butyllithium (2.5 M solution in hexanes; 2.1 equiv., 9.52 ml, 23.79 mmol) and 
diisopropylamine (3.40 ml, 24.27 mmol) was added in dry THF (30 ml) at 0 °C, 
followed by DMPU (8 ml) to make a LDA solution. It was stirred for 15 min. 
3-(2-Acetoxymethyl-3-methoxyphenyl)-6-methyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-
4-one (162) (3.73g, 11.33 mmol) in dry THF (18 ml) was added dropwise to this 
solution of LDA and DMPU at -78 °C. The resulting mixture was allowed to stir at 
-78 °C for 10 min. 1-Bromo-3-methybut-2-ene (2.64 ml, 22.66 mmol) was added at 
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-78°C, and the mixture was allowed to warm to room temperature and stirred 
overnight. Saturated sodium hydrogencarbonate solution (40 ml) was added and the 
mixture was extracted with DCM (3 x 50 ml). The combined extract was washed with 
water (3 x 30 ml) and then brine (1 x 100 ml). The organic extract was dried over 
sodium sulfate, filtered and the solvent was evaporated under reduced pressure. The 
crude product was purified by flash column chromatography using petroleum 
ether:ethyl acetate (2: 1 v/v) as eluent to yield both mono-alkylated product, 
3-(2-acetoxymethyl-3-methoxyphenyl)-6-methyl-5-(3-methylbut-2-enyl)-4,5,6,7-tetra 
hydrobenzo[dJisoxazol-4-one (163) (0.66 g, 15 %) as a yellow oil; MS (FAB+) found 
397.1891 [M+H], C23H27NOS; requires 397.1889 [M+H]; VIlUlX (neat)/cm·1 1695, 1737 
(C=O) and 2966; SH (400MHz; CDCb) 1.16 (d, J 5.5, 3H, CH3), 1.58 (5, 3H, CH3), 
1.60 (5, 3H, CH3), 2.07 (5, 3H, CH3), 2.24 (dd, J 11.0 and 15.9, lH, CH2), 2.41-2.54 
(m, 4H, CH, CH2 & CH2), 2.97-3.08 (m, lH, CH), 3.75 (5, 3H, OCH3), 5.19 (5, 2H, 
OCH2), 5.24-5.27 (m, lH, CH), 6.83-6.86 (m, IH, Ar-H), 6.94-6.98 (m, lH, Ar-H) 
and 7.25-7.43 (m, lH, Ar-H); Se (400MHz; CDCb) 20.7 (CH3), 21.0 (CH3), 25.8 (2 x 
CH3), 30.1 (CH2), 42.8 (CH2), 43.2 (CH), 51.9 (CH), 55.8 (OCH3), 57.6 (OCH2), 
108.2 (Ar-C), 111.2 (Ar-C), 117.3 (C), 121.9 (C), 129.6 (Ar-C), 130.1 (=CH), 151.2 
(C), 153.1 (C), 158.7 (C), 165.7 (C), 170.7 (C), 181.2 (C) and 190.8 (C); and 
di-alkylated product, 
3-(2-acetoxymethyl-3-methoxyphenyl)-6-methyl-5,5-bis-(3-methylbut-2-enyl)-4,5,6,7 
-tetrahydrobenzo[dJisoxazol-4-one (164) (1.23 g, 23 %) as a yellow oil; MS (FAB+) 
found 465.2514 [M+H], C28H3SNOS; requires 465.2515 [M+H]; Vmax (neat)/cm-1 1589, 
1737 (C=O) and 2968; SH (400MHz; CDCI3) 1.17 (d, J 5.1, 3H, CH3), 1.57 (5, 3H, 
CH3), 1.59 (5, 3H, CH3), 1.62 (5, 3H, CH3), 1.65 (5, 3H, CH3), 2.03 (5, 3H, CH3), 
2.24-2.34 (m, 3H, CH & CH2), 2.41-2.65 (m, 2H, CH & CH2), 3.05-3.11 (rn, 2H, 
CH2), 3.77 (5, 3H, OCH3), 5.19 (5, 2H, OCH2), 5.16-5.23 (m, 2H, 2 x CH), 6.82-6.86 
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(m, IH, Ar-H), 6.92-6.96 (m, lH, Ar-H) and 7.23-7.28 (m, lH, Ar-H); .se (400MHz; 
CDCh) 20.8 (CH3), 21.0 (CH3), 25.7 (2 x CH3), 25.9 (2 x CH3), 29.6 (CH2), 30.1 
(CH2), 43.2 (CH2), 51.9 (CH), 55.6 (OCH3), 57.6 (OCH2), 106.3 (Ar-C), 110.9 (Ar-C), 
117.2 (C), 121.2 (C), 122.6 (C), 129.5 (Ar-C), 130.1 (=CH), 130.2 (=CH), 152.3 (C), 
153.3 (C), 158.6 (C), 163.2 (C), 165.6 (C), 171.1 (C), 181.0 (C) and 191.3 (C). 
3-(2-Acetoxymethyl-3-methoxyphenyl)-6-methyl-5,5-bis(3-methylbut-2-enyl)-7-
phenylselenyl-4,5,6, 7-tetrahydrobenzo[dJisoxazol-4-one (165) 
(164) 
LOA 2.0 equiv., 
THF:OMPU (6:1) 
1.5 equiv. PhSeBr 
MeO 
• 
"Se-Ph 
" 
(165) 
3-(2-Acetoxymethyl-3-methoxyphenyl)-6-methyl-5,5-bis-(3-methylbut-2-enyl)-
4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (164) (1.23 g, 1.81 mmol) in dry THF (10 
ml) was added dropwise to a solution of LDA and DMPU at -78°C, which was 
prepared by adding n-butyllithium (2.5 M solution in hexanes; 2.11 ml, 5.28 mmol) 
and diisopropyl amine (0.76 ml, 5.39 mmol) in dry THF (16 ml) at 0 °C, followed by 
DMPU (6 ml). The resulting mixture was allowed to stir at -78°C for 60 min. 
Phenylselenium bromide (0.94 g, 3.96 mmol) in dry THF (10 ml) was added at -78°C, 
and the mixture was allowed to warm to room temperature and stirred overnight. 
Saturated sodium hydrogencarbonate solution (30 ml) was added and the mixture was 
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extracted with DCM (3 x 30 ml). The combined extract was washed with water (50 ml) 
and then brine (50 ml). The organic extracts were dried over sodium sulfate, filtered 
and the solvent was evaporated under reduced pressure. The crude product was 
purified by flash column chromatography using petroleum ether:ethyl acetate (3:1 v/v) 
as eluent to yield 
3-(2-acetoxymethyl-3-methoxyphenyl)-6-methyl-5,5-bis-(3-methyIbut-2-enyl)-7-
phenylselenyl-4,5,6,7-tetrahydrobenzo[d]isoxazol-4-one (165) (0.64 g, 39 %) as a 
brown oil. MS (FAB+) found 622.2069 (Se80) [M+H] , C34H39NOsSe80; requires 
622.2072 (Se80) [M+H); Vrnax (neat)/cm,l 1731 (C=O), 2912 and 2964; BH (400MHz; 
CDCh) 1.04 (d, J 5.8, 3H, CH3), 1.58 (s, 3H, CH3), 1.60 (s, 3H, CH3), 1.62 (s, 3H, 
CH3), 1.65 (s, 3H, CH3), 2.04 (s, 3H, CH3), 2.22-2.33 (m, 4H, 2 x CH2), 2.41-2.64 (m, 
2H, 2 x CH), 3.83 (s, 3H, OCH3), 4.97-5.12 (m, lH, =CH), 5.20-5.45 (m, lH, =CH), 
5.19 (s, 2H, OCH2), 6.85-6.92 (m, lH, Ar-H), 6.93-7.12 (m, lH, Ar-H), 7.23-7.27 (m, 
3H, 3 x Ar-H), 7.38-7.44 (m, lH, Ar-H) and 7.58-7.62 (m, 2H, 2 x Ar-H); Bc 
(400MHz; CDCh) 20.7 (CH3), 21.2 (CH3), 25.6 (2 x CH3), 25.9 (2 x CH3), 29.5 
(CH2), 30.1 (CH2), 49.2 (CH), 51.8 (CH), 55.5 (OCH3), 57.6 (OCH2), 106.2 (Ar-C), 
117.3 (C), 119.6 (Ar-C), 121.3 (C), 122.5 (C), 129.5 (2 x Ar-C), 130.1 (=CH), 130.2 
(Ar-C), 130.3 (=CH), 131.6 (Ar-C), 138.1 (2 x Ar-C), 151.2 (C), 153.6 (C), 158.7 (C), 
163.1 (C), 165.5 (C), 171.2 (C), 181.2 (C) and 191.3 (C). 
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2-/1-Amino-1-(2-acetoxymethyl-3-methoxyphenyl)-meth-(E)-ylideneJ-5-methyl-6,6-
bis(3-methyl-but-2-enyl)cyclohex-4-ene-1,3-dione (166) 
AcO AcO 
MeO ..• Se·Ph MeO 
.•• Se·Ph MeO 
Mo(eo>. HP2 
-
(165) (166) 
3-(2-Bromo-6-methoxyphenyl)-6-methyl-5,5-bis(3-methylbut-2-enyl)-7-phenyl-
selenyl-4,5,6,7-tetrahydrobenzo[djisoxazol-4-one (165) (7.14 g, 11.50 mmol) was 
dissolved in acetonitrile (30 rnI) and water (10 ml). Molybdenum hexacarbonyl (3.04 
g, 11.50 mmol) was added to the reaction, and the mixture was heated under reflux for 
3 h. After cooling to room temperature, the reaction mixture was treated with 
hydrogen peroxide (27.5 wt % in H20) (3 rnI) dropwise at 0 ·C. It was then left to stir 
at room temperature overnight. The reaction was filtered through celite and charcoal 
bath and then poured into ice (20 g). The mixture was extracted with DCM (30 rnI). 
The organic layer was washed with water (3 x 20 rnI) and then neutralised with 
sodium sulfite (10 %) (20 rnI). The extracted organic layer was dried over sodium 
sulfate, filtered and evaporated to dryness under reduced pressure to give the crude. 
The crude product was purified by flash column chromatography using petroleum 
ether:ethyl acetate (7:1) as eluent to yield the product, 
2-[ l-amino-l-(2-aeetoxymethyl-3-methoxyphenyl ]-meth-(E)-ylidene ]-5-methyl-6,6-
bis(3-methyl-but-2-enyl)cyclohex-4-ene-l,3-dione (166) (1.04 g, 20 %) as a light 
yellow viscous oil. MS (FAB+) found 466.2610 [M+H], C2sH3SNOS; requires 
466.2593 [M+H]; Vrnax (CHCh)/cm-1 1678, 1771 (C=O), 2713 and 3410 (NH2); 3H 
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(400MHz; CDCh) 1.18 (d, J 6.5, 3H, CH3), 1.50 (s, 12H, 4 X CH3), 1.99 (d, J7.4, 2H, 
CH2), 2.00 (s, 3H, CH3), 2.44 (d, J 7.2, 2H, CH2), 3.74 (s, 3H, OCH3), 4.21-4.62 (m, 
2H, 2 x CH), 5.18 (s, Ill, NH2), 5.23 (s, 2H, OCH2), 5.32 (s, Ill, NH2), 6.80-6.84 (m, 
lH, Ar-H), 6.92-6.94 (m, lH, Ar-H), 7.24-7.29 (m, lH, Ar-H) and 7.45 (d, J 1.5, Ill, 
CH); oe (400MHz; CDCI3) 15.0 (CH3), 17.3 (2 x CH3), 17.6 (2 x CH3), 26.0 (CH3), 
47.0 (2 x CH2), 55.6 (OCH3), 64.8 (CH2), 117.8 (C), 125.5 (2 x Ar-C), 127.5 (Ar-C), . 
128.2 (Ar-C), 130.0 (CH), 130.1 (CH), 131.2 (CH), 134.2 (C), 135.3 (C), 158.6 (C), 
161.3 (C), 170.3 (C), 187.2 (C) and 191.5 (C). 
2,3-Bis(acetoxymethyl)anisole (167)114 
OMe Br 
CH.,COONa 
• 
acetic acid 
(158) Br 
2,3-Bis(bromomethyl)anisole (158) (1.64 g, 4.40 mmol) and anhydrous sodium 
acetate (1.30 g, 15.83 mmol) were dissolved in glacial acetic acid (20 ml) and then 
heated under reflux overnight. The acetic acid was evaporated, the residue was 
dissolved in ethyl acetate, the salts were removed by filtration, and the filtrate was 
stirred with hydrochloric acid (0.5 M) (10 ml). After the layers were separated, the 
aqueous layer was extracted with ethyl acetate (3 x 30 ml). The combined organic 
solution was dried over magnesium sulfate, filtered, evaporated and. the crude was 
purified by flash column chromatography using petroleum ether:ethyl acetate (3:2 v/v) 
as the eluent to yield the product 2,3-bis(acetoxymethyl)anisole (167) (0.31 g, 28 %) 
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as a white solid; mp 90-92 ·C (Lit. 90-91 ·C); MS (FAB) found 252.0995, C13H160S; 
requires 252.0998; Vrnax (CHCh)/cm-1 1746 (C=O) and 2853; IlH (400MHz; CDCh) 
2.05 (s, 3H, CH3), 2.08 (s, 3H, CH3), 3.85 (s, 3H, OCH3), 5.19 (s, 2H, CH2), 5.27 (s, 
2H, CH2), 6.93 (d, J 8.4, lH, Ar-H), 7.02 (d, J 7.6, IH, Ar-H) and 7.34 (1, J 8.0, IH, 
Ar-H); Oc (400MHz; CDCh) 20.9 (CH3), 21.0 (CH3), 55.8 (OCH3), 57.6 (CH2), 63.9 
(CH2), 111.2 (Ar-C), 121.9 (Ar-C), 122.5 (C), 130.1 (Ar-C), 137.0 (C), 158.6 (C), 
170.7 (C) and 170.9 (C). 
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Appendix I 
X-Ray crystal structure of5-Bromo-6-methyl-3-phenyl-4,5,6,7-tetrahydrobenzo[dJisoxazol-4-one (85) 
om 
\ 
Table 1. Crystal data and structure refinement for (85). 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
Cell volume 
Z 
Calculated density 
Absorption coefficient J.1 
P(OOO) 
Crystal colour and size 
. Reflections for cell refinement 
Data collection method 
9 range for data collection 
Index ranges 
Completeness to 9 = 26.00° 
Intensity decay 
Reflections ,collected 
Independent reflections 
Reflections with ~20' 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refinement method 
Weighting parameters a, b 
Data 1 restraints 1 parameters 
Final R indices [F2:> 20'] 
R indices (all data) 
Goodness-of-fit on F2 
Largest and mean shiftlsu 
Largest diff. peak and hole 
(85) 
Cl4Hl2BrN02 
306.16 
150(2) K 
MoKa, 0.71073 A 
monoclinic, P21/c 
a=7.8801(5)A 
b = 11.1370(7) A 
c = 14.1152(9) A 
1232.39(14) A3 
4 
1.650 glcm3 
3.328 mm-1 
616 
a=900 
p = 95.815(2)° 
y=90° 
colourless, 0.41 x 0.27 x 0.19 mm3 
5683 (9 range 2.33 to 28.39°) 
Bruker SMART 1000 CCD diffiactometer 
()) rotation with narrow frames 
2.33 to 28.90° 
h -10 to 10, k -14 to 14,1-18 to 18 
99.9% 
0% 
10595 
2988 (Rint = 0.0195) 
2575 
semi-empirical from equivalents 
0.318 and 0.531 
direct methods 
Full-matrix least-squares on p2 
0.0712, 1.8709 
2988/01164 
RI = 0.0387, wR2 = 0.1187 
RI = 0.0455, wR2 = 0.1230 
1.066 
0.001 and 0.000 
0.706 and -0.556 e A-3 
ii 
Appendix 
Appendix 
Table 2. Atomic coordinates and equivalent isotropic displacement parameters (N) for (85). Ueq is 
defined as one third of the trace of the orthogonalized ug tensor. 
x y z Ueq 
0(1) -0.0863(2) 0.6916(2) 0.46033(15) 0.0248(4) 
N(I) -0.1322(3) 0.6463(2) 0.54835(19) 0.0237(5) 
C(1) 0.0105(3) 0.6156(2) 0.59902(19) 0.0179(5) 
C(2) 0.1543(3) 0.6388(2) 0.5462(2) 0.0176(5) 
C(3) 0.0830(3) 0.6853(2) 0.46143(19) 0.0191(5) 
C(4) 0.1695(4) 0.7253(3) 0.3787(2) 0.0228(5) 
C(5) 0.3484(4) 0.6712(3) 0.3856(2) 0.0249(6) 
C(6) 0.4379(3) 0.6817(3) 0.4859(2) 0.0234(6) 
C(7) 0.3403(3) 0.6255(3) 0.5628(2) 0.0209(5) 
0(2) 0.4170(3) 0.5741(2) 0.63032(16) 0.0313(5) 
C(8) -0.0032(3) 0.5649(2) 0.69454(19) 0.0199(5) 
C(9) -0.1497(4) 0.5882(3) 0.7401(2) 0.0257(6) 
C(10) -0.1698(4) 0.5358(3) 0.8272(2) 0.0333(7) 
C(11) -0.0442(5) 0.4596(3) 0.8700(2) 0.0327(7) 
C(12) 0.1008(4) 0.4376(3) 0.8268(2) 0.0303(6) 
C(13) . 0.1229(4) 0.4899(3) 0.7386(2) 0.0242(6) 
C(14) 0.4531(4) 0.7230(3) 0.3096(2) 0.0354(7) 
Br(I) 0.47180(4) 0.85107(3) 0.52385(2) 0.03359(14) 
Table 3. Bond lengths [A] and angles [0] for (85). 
0(1)-C(3) 1.334(3) O(I}-N(I) 1.421(3) 
N(1)-C(I) 1.316(4) C(1)-C(2) . 1.442(4) 
C(1)-C(8) 1.476(4) C(2)-C(3) 1.370(4) 
C(2)-C(7) 1.468(4) C(3)-C(4) 1.479(4) 
C(4)-C(5) 1.527(4) C(5)-C(6) 1.521(4) 
C(5)-C(14) 1.530(4) C(6)-C(7) 1.527(4) 
C(6}-Br(I) 1.972(3) C(7}-O(2) 1.218(4) 
C(8)-C(13) 1.396(4) C(8)-C(9) 1.402(4) 
C(9)-C(10) 1.385(5) C(10)-C(11) 1.394(5) 
C(ll)-C(12) 1.371(5) C(12)-C(13) 1.401(4) 
C(3}-O(I}-N(I) 108.3(2) C(I}-N(I}-O(I) 106.7(2) 
N(I)-C(I)-C(2) 110.2(2) N(I)-C(I)-C(8) 117.3(2) 
C(2)-C(I)-C(8) 132.5(2) C(3)-C(2)-C(1) 104.2(2) 
C(3)-C(2)-C(7) 119.5(3) C(I)-C(2)-C(7) 136.3(3) 
0(1 )-C(3)-C(2) 110.5(2) 0(1)-C(3)-C(4) 121.0(2) 
C(2)-C(3)-C(4) 128.5(2) C(3)-C(4)-C(5) 109.1(2) 
C(6)-C(5)-C(4) 111.5(2) C(6)-C(5)-C(14) 113.0(3) 
C(4)-C(5)-C(14) 111.5(3) C(5)-C(6)-C(7) 114.2(2) 
C(5)-C(6}-Br(l) 111.3(2) C(7}-C(6}-Br(l) 105.25(19) 
iii 
O(2)-C(7)-C(2) 
C(2)-C(7)-C(6) 
C(13)-C(8)-C(1) 
C(10)-C(9)-C(8) 
C(12)-C(11)-C(l0) 
C(8)-C(13)-C(12) 
125.5(3) 
114.3(2) 
121.4(2) 
120.2(3) 
120.2(3) 
119.8(3) 
O(2)-C(7)-C(6) 
C(13)-C(8)-C(9) 
C(9)-C(8)-C(1) 
C(9)-C(10)-C(11) 
C(11)-C(12)-C(l3) 
Table 4. Hydrogen coordinates and isotropic displacement parameters (A2) for (85). 
x y 
H(4A) 0.1768 0.8141 
H(4B) 0.1034 0.6990 
H(5) 0.3342 0.5835 
H(6) 0.5521 0.6421 
H(9) -0.2354 0.6402 
H(IO) -0.2694 0.5517 
H(ll) -0.0591 0.4229 
H(12) 0.1868 0.3867 
H(l3) 0.2236 0.4742 
H(l4A) 0.5702 0.6924 
H(14B) 0.4544 0.8108 
H(14C) 0.4018 0.6988 
Table 5. Torsion angles [0) for (85). 
C:(3)-()(1)-~(1)-C(1) 
O(I)-}l(I)-C(I)-C(8) 
C:(8)-C(1)-C(2)-C(3) 
C:(8)-C(1)-C(2)-C(7) 
~(1)-()(1)-C(3)-C(4) 
C(7)-C(2)-C(3)-()(1) 
C(7)-C(2)-C(3)-C( 4) 
C:(2)-C(3)-C(4)-C(5) 
C(3)-C(4)-C(5)-C(l4) 
C(14)-C(5)-C(6)-C(7) 
C(14)-C(5)-C(6)-Br(l) 
C(I )-C(2)-C(7)-()(2) 
C:(1)-C(2)-C(7)-C(6) 
Br(I)-C(6)-C(7)-()(2) 
Br(1 )-C(6)-C(7)-C(2) 
C(2)-C(1 )-C(8)-C(13) 
C(2)-C(1 )-C(8)-C(9) 
0.5(3) 
-179.7(2) 
179.3(3) 
-1.3(5) 
179.5(2) 
-179.3(2) 
0.8(4) 
18.4(4) 
-172.1(3) 
-177.2(3) 
63.7(3) 
8.9(5) 
-171.7(3) 
-94.2(3) 
86.3(2) 
-23.7(5) 
159.2(3) 
z U 
0.3781 0.027 
0.3189 0.027 
0.3717 0.030 
0.4875 0.028 
0.7112 0.031 
0.8579 0.040 
0.9293 0.039 
0.8568 0.036 
0.7089 0.029 
0.3198 0.053 . 
0.3141 0.053 
0.2463 0.053 
O(I)-}l(I)-C(I)-C(2) 
}l(1)-C(1)-C(2)-C(3) 
~(1)-C(1)-C(2)-C(7) 
~(1)-()(1)-C(3)-C(2) 
C(1)-C(2)-C(3)-()(1) 
C:(l)-C(2)-C(3)-C(4) 
O(I)-C(3)-C(4)-C(5) 
C(3)-C(4)-C(5)-C(6) 
C(4)-C(5)-C(6)-C(7) 
. (4)-C(5)-C(6)-Br(I) 
C:(3)-C(2)-C(7)-()(2) 
(3)-C(2)-C(7)-C(6) 
(5)-C(6)-C(7)-()(2) 
(5)-C(6)-C(7)-C(2) 
~(1)-C(1)-C(8)-C(13) 
~(1)-C(1)-C(8)-C(9) 
(13)-C(8)-C(9)-C(IO) 
iv 
Appendix 
120.2(2) 
119.3(3) 
119.2(2) 
120.1(3) 
120.4(3) 
-0.3(3) 
0.1(3) 
179.5(3) 
-0.4(3) 
0.2(3) 
-179.7(3) 
-161.5(3) 
-44.7(3) 
56.2(3) 
-62.9(3) 
-171.8(3) 
7.6(4) 
143.4(3) 
-36.1(3) 
155.5(3) 
-21.6(4) 
-1.0(4) 
C(1 )-C(8)-C(9)-C(1O) 
C(9)-C(10)-C(II)-C(12) 
C(9)-C(8)-C(13)-C(l2) 
C(11)-C(12)-C(13)-C(8) 
176.2(3) 
0.9(5) 
0.9(4) 
0.1(5) 
v 
C(8)-C(9)-C(10)-C(II) 
C(10)-C(11)-C(12)-C(13) 
C(I)-C(8)-C(13)-C(12) 
Appendix 
0.1(5) 
-1.0(5) 
-176.2(3) 
Appendix 
AppeodixII 
X-Ray crystal structure of (123). 
HIlB) HIlA) 
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H(1BA) 
HI1A) 
0(2) 
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Table I. Crystal data and structure refinement for (123). 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
Cell volume 
Z 
Calculated density 
Absorption coefficient 11 
F(OOO) 
Crystal colour and size 
Reflections for cell refinement 
Data collection method 
e range for data collection 
Index ranges 
Completeness to e = 26.00° 
Intensity decay 
Reflections collected 
Independent reflections 
Reflections with p2>20" 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refinement method 
Weighting parameters a, b 
Data 1 restraints 1 parameters 
Final R indices [F~ 20"] 
R indices (all data) 
Goodness-of-fit on F2 
Absolute structure parameter 
Largest and mean shift/su 
Largest diff. peak and hole 
(123) 
ClIH9N03 
203.19 
150(2) K 
MoKa, 0.71073 A 
orthorhombic, Pna21 
a = 11.2713(16) A 
b = 19.538(3) A 
c =4.0480(6) A 
891.4(2)N 
4 
1.514 g/cm3 
0.1l2 mm-1 
424 
colourless, 0.62 x 0.17 x 0.13 mm3 
2694 (9 range 2.76 to 26.98°) 
Bruker SMART 1000 CCD diffractometer 
ID rotation with narrow frames 
2.08 to 28.94° 
h-14to 14, k-25 to 25, 1-5t05 
100.0 % 
0% 
7541 
1246 (Riot = 0.0408) 
1017 
semi-empirical from equivalents 
0.934 and 0.986 
direct methods 
Full-matrix least-squares on F2 
0.0388, 0.3691 
1246/1/144 
RI = 0.0354, wR2 = 0.0817 
RI = 0.0522, wR2 = 0.0916 
1.035 
-10(10) 
0.000 and 0.000 
0.251 and-Q.171 eA-3 
viii 
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Table 2. Atomic coordinates and equivalent isotropic displacement parameters (A2) 
for (123). Ueq is defined as one third of the trace of the orthogonalized uij tensor. 
0(1) 
C(1) 
0(2) 
C(2) 
C(3) 
N(I) 
C(4) 
C(5) 
C(6) 
C(7) 
C(8) 
C(9) 
C(10) 
0(3) 
C(ll) 
x 
0.99165(14) 
0.9636(2) 
1.03087(14) 
0.86262(19) 
0.7919(2) 
0.69804(18) 
0.82463(19) 
0.7598(2) 
0.7961(2) 
0.8976(2) 
0.9641(2) 
0.9249(2) 
0.8341(2) 
0.74515(15) 
0.9130(2) 
y z 
0.72230(7) 0.1643(5) 
0.78964(11) 0.0899(7) 
0.83074(7) 0.2164(5) 
0.80304(11) -0.1156(6) 
0.74798(1l) -0.2292(6) 
0.75739(10) -0.4153(6) 
0.67804(11) -0.1385(6) 
0.61980(12) -0.2340(7) 
0.55552(12) -0.1367(7) 
0.54755(11) 0.0532(7) 
0.60354(11) 0.1451(7) 
0.66830( 10) 0.0525(6) 
0.87381(12) -0.2109(7) 
0.88678(8) -0.3784(6) 
0.93237(11) -0.1152(8) 
Ueq 
0.0271(4) 
0.0234(5) 
0.0291(4) 
0.0228(5) 
0.0217(5) 
0.0274(5) 
0.0214(5) 
0.0265(5) 
0.0282(6) 
0.0283(6) 
0.0272(5) 
0.0227(5) 
0.0259(5) 
0.0357(5) 
0.0290(6) 
Table 3. Bond lengths [A] and angles [0] for (123). 
0(1)-C(9) 1.372(3) 0(1)-C(1) 
C(I)-O(2) 1.217(3) C(1)-C(2) 
C(2)-C(3) 1.416(3) C(2)-C(10) 
C(3)-N(I) 1.3l1(3) C(3)-C(4) 
C(4)-C(9) 1.383(3) C(4)-C(5) 
C(5)-C(6) 1.378(3) C(6)-C(7) 
C(7)-C(8) 1.377(3) C(8)-C(9) 
C(10)-O(3) 1.237(3) C(10)-C(11) 
C(9)-O(I)-C(I) 122.22(19) 0(2)-C(I)-O(I) 
0(2)-C(1)-C(2) 128.2(2) 0(1)-C(1)-C(2) 
C(3)-C(2)-C(1) 119.8(2) C(3)-C(2)-C(10) 
C(I)-C(2)-C(10) 119.8(2) N(I)-C(3)-C(2) 
N(I)-C(3)-C(4) 118.6(2) C(2)-C(3)-C(4) 
C(9)-C(4)-C(5) 117.8(2) C(9)-C(4)-C(3) 
C(5)-C(4)-C(3) 123.8(2) C(6)-C(5)-C(4) 
C(5)-C(6)-C(7) 120.3(2) C(8)-C(7)-C(6) 
C(7)-C(8)-C(9) 118.5(2) 0(1)-C(9)-C(4) 
0(1)-C(9)-C(8) 115.9(2) C(4)-C(9)-C(8) 
0(3)-C(10)-C(2) 120.9(2) 0(3)-C(10)-C(11) 
C(2)-C(10)-C(II) 121.3(2) 
ix 
Appendix 
1.386(3) 
1.434(3) 
1.471(3) 
1.462(3) 
1.406(3) 
1.387(4) 
1.391(3) 
1.500(3) 
113.1(2) 
118.70(19) 
120.4(2) 
122.3(2) 
119.1(2) 
118.38(19) 
120.3(2) 
120.6(2) 
121.78(19) 
122.3(2) 
117.8(2) 
Hydrogen coordinates and isotropic displacement parameters (A 2) for (123). 
Appendix 
Table 4. 
x y 
H(IA) 0.677(2) 0.8014(\4) 
H(lB) 0.652(2) 0.7230(\3) 
H(5) 0.6907 0.6248 
H(6) 0.7513 0.5165 
H(7) 0.9215 0.5030 
H(8) 1.0350 0.5981 
H(IIA) 0.8813 0.9750 
H(\lB) 0.9931 0.9245 
H(IlC) 0.9163 0.9359 
Table 5. Torsion angles [0] for (123). 
(;(9)-<)(1~(1)-<)(2) 
O(2~(1 ~(2~(3) 
O(2~(I~(2~(10) 
ql~(2~(3)-N(I) 
ql~(2~(3~(4) 
N(I~(3~(4~(9) 
N(I~(3~(4~(5) 
(;(9~(4~(5~(6) 
(;(4~(5~(~(7) 
q6~(7~(8~(9) 
(;(1)-<)(1~(9~(8) 
q3~(4~(9)-<)(l) 
q3~(4~(9~(8) 
q7~(8~(9~(4) 
ql~(2~(10)-<)(3) 
ql~(2~(10~(II) 
178.4(2) 
-177.4(3) 
3.5(4) 
179.4(2) 
-1.0(3) 
178.8(2) 
-1.3(3) 
0.3(4) 
-0.8(4) 
2.1(4) 
179.7(2) 
1.7(3) 
-178.7(2) 
-2.6(4) 
-177.5(2) 
3.9(4) 
z U 
-0.464(8) 0.033 
-0.500(8) 0.033 
-0.3662 0.032 
-0.1999 0.034 
0.1204 0.034 
0.2690 0.033 
-0.2072 0.044 
-0.2018 0.044 
0.1262 0.044 
(9)-<)(I~(I~(2) 
O(I~(I~(2~(3) 
O(I~(I~(2~(10) 
ql0~(2~(3)-N(I) 
ql0~(2~(3~(4) 
q2~(3~(4~(9) 
q2~(3~(4~(5) 
q3~(4~(5~(6) 
q5~(6~(7~(8) 
(;(1)-<)(1~(9~(4) 
q5~(4~(9)-<)(1) 
q5~(4~(9~(8) 
q7~(8~(9)-<)(1 ) 
q3~(2~(lO)-<)(3) 
q3~(2~(10~(lI) 
Table 6. Hydrogen bonds for (123) [A and 0]. 
D-H ... A 
N(I )-H(IA) ... O(3) 
N(l)-H(lB) ... O(2') 
d(D-H) 
0.91(3) 
0.92(3) 
Symmetry operations for equivalent atoms 
, x-1I2,-y+3/2,z-1 
d(H ... A) 
1.87(3) 
2.07(3) 
x 
d(D ... A) 
2.587(2) 
2.956(3) 
<(DHA) 
134(2) 
163(3) 
-1.1(3) 
2.0(3) 
-177.2(2) 
-1.4(3) 
178.1(2) 
-0.8(3) 
179.1(2) 
-179.6(2) 
-0.5(4) 
-0.8(4) 
-178.2(2) 
1.3(4) 
177.0(2) 
3.4(4) 
-175.3(2) 
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X-Ray crystal structure of2,3-Bis(dibromomethyl)anisole (159) 
The data were collected at ISO(2)K on a Broker Apex 11 CCD diffractometer. The structure was solved by 
direct methods and refined on F2 using all the reflections·. All the non-hydrogen atoms were refined using 
anisotropic atomic displacement parameters and hydrogen atoms were inserted at calculated positions 
using a riding model. Parameters for data collection and refinement are summarised in Table I. 
There are both It-lt Oand Br-Br interactions in the lattice. 
• O.M. Sheldrick, SHELXTL Version 6.12, Broker AXS, Madison WI, 2001. 
xi 
Table I. Crystal data and structure refinement for (159). 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal description 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 27.50° 
Absorption correction 
Max. and min. transmission 
Refmement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(l)] 
R indices (all data) 
Extinction coefficient 
Largest diff. peak and hole 
(159) 
C9H8Br40 
451.79 
150(2) K 
0.71073 A 
Monoclinic 
P2(1)/c 
a = 7.9770(3) A 
b,: 22.1919(9) A 
c = 6.8715(3) A 
1165.59(8) A3 
4 
2.575 Mglm3 
13.775 mm-I 
840 
0.36 x 0.12 x 0.04 mm3 
colourless lath 
1.84 to 31.90°. 
IF 106.6220(10)°. 
-ll<=h<=ll, -32<=k<=31, -10<=1<=9 
14001 
3749 [R(int) = 0.0397] 
100.0% 
Semi-empirical from equivalents 
0.6088 and 0.0829 
Full-matrix least-squares on F2 
3749/0/128 
1.029 
RI = 0.0284, wR2 = 0.0608 
RI = 0.0467, wR2 = 0.0659 
0.00264(16) 
0.900 and -0.775 e.A-3 
xii 
Appendix 
Appendix 
Table 2. Atomic coordinates (x 1(4) and equivalent isotropic displacement parameters (A2x 103) for 
(159). 
U( eq) is defined as one third of the trace of the orthogonalized uij tensor. 
x y z U(eq) 
C(1) -420(4) 7875(1) 5577(4) 21(1) 
0(1) 318(2) 7283(1) 5863(3) 19(1) 
C(2) 2064(3) 7229(1) 6013(3) 14(1) 
C(3) 3151(4) 7724(1) 6103(3) 17(1) 
C(4) 4902(3) 7627(1) 6228(3) 16(1) 
C(5) 5555(3) 7048(1) 6273(3) 16(1) 
C(6) 4469(3) 6552(1) 6204(3) 14(1) 
C(7) 5227(3) 5929(1) 6245(3) 16(1) 
Br(l) 6064(1) 5796(1) 3868(1) 26(1) 
Br(2) 7137(1) 5793(1) 8712(1) 24(1) 
C(8) 2697(3) 6636(1) 6089(3) 13(1) 
C(9) 1429(3) 6137(1) 6057(3) 15(1) 
Br(3) 1038(1) 5624(1) 3654(1) 20(1) 
Br(4) 2120(1) 5655(1) 8544(1) 20(1) 
xiii 
Table 3. Bond lengths [A] and angles [0] for (159). 
C(I)-O(l) 
0(1)-C(2) 
C(2)-C(3) 
C(2)-C(8) 
C(3)-C(4) 
C(4)-C(5) 
C(5)-C(6) 
C(6)-C(8) 
C(6)-C(7) 
C(7)-Br(2) 
C(7)-Br(I) 
C(8)-C(9) 
C(9)-Br(3) 
C(9)-Br(4) 
C(2)-0(1)-C(1) 
0(1 )-C(2)-C(3) 
0(1)-C(2)-C(8) 
C(3)-C(2)-C(8) 
C(2)-C(3)-C(4) 
C(5)-C(4)-C(3) 
C( 4 )-C( 5)-C( 6) 
C( 5)-C( 6)-C(8) 
C( 5)-C( 6)-C(7) 
C(8)-C( 6)-C(7) 
C(6)-C(7)-Br(2) 
C(6)-C(7)-Br(l) 
Br(2)-C(7)-Br(J) 
C(6)-C(8)-C(2) 
C(6)-C(8)-C(9) 
C(2)-C(8)-C(9) 
C(8)-C(9)-Br(3) 
C(8)-C(9)-Br(4) 
Br(3)-C(9)-Br( 4) 
1.430(3) 
1.372(3) 
1.390(4) 
1.405(3) 
1.391(4) 
1.384(3) 
1.394(3) 
1.405(3) 
1.505(3) 
1.951(2) 
1.956(2) 
1.496(3) 
1.955(2) 
1.956(2) 
117.3(2) 
122.8(2) 
115.5(2) . 
121.7(2) 
118.9(2) 
120.6(2) 
120.4(2) 
120.2(2) 
118.8(2) 
121.0(2) 
111.62(16) 
110.72(15) 
109.52(12) 
118.1(2) 
124.6(2) 
117.3(2) 
112.78(15) 
111.79(15) 
110.94(12) 
l, 
Symmetry transfonnations used to generate equivalent atoms: 
xiv 
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Table 4. Anisotropic displacement parameters (A2x 103) for (159). The anisotropic 
displacement factor exponent takes the form: -21t2[ h2 a*2U11 + ... + 2 h k a* b* U12 ] 
Ull U22 U33 U23 U13 U12 
C(1) 23(2) 15(1) 26(1) 2(1) 8(1) 7(1) 
0(1) 18(1) 13(1) 26(1) 1(1) 6(1) 3(1) 
C(2) 14(1) 16(1) 10(1) 1(1) 2(1) 1(1) 
C(3) 23(1) 12(1) 14(1) 0(1) 3(1) 3(1) 
C(4) 19(1) 13(1) 15(1) -1(1) 4(1) -4(1) 
C(5) 16(1) 18(1) 14(1) 0(1) 5(1) -1(1) 
C(6) 16(1) 14(1) 11(1) 1(1) 3(1) 2(1) 
C(7) 15(1) 14(1) 17(1) -1(1) 3(1) 2(1) 
Br(I) 35(1) 20(1) 28(1) 0(1) 18(1) 7(1) 
Br(2) 21(1) 20(1) 26(1) 4(1) -3(1) 3(1) 
C(8) 16(1) 11(1) 10(1) 0(1) 2(1) -1(1) 
C(9) 18(1) 11(1) 16(1) -1(1) 4(1) 0(1) 
Br(3) 22(1) 16(1) 18(1) -3(1) 1(1) -3(1) 
Br(4) 24(1) 17(1) 17(1) 3(1) 7(1) -3(1) 
xv 
Table 5. Hydrogen Coordinates (x 104) and isotropic displacement parameters (A2x 10 3) 
for (159). 
x y z U(eq) 
H(IA) -1663 7853 5503 32 
H(lB) -292 8045 4312 32 
H(lC) 191 8131 6721 32 
H(3) 2706 8122 6080 20 
H(4) 5656 7962 6283 19 
H(5) 6752 6988 6350 19 
H(7) 4282 5630 6209 19 
H(9) 283 6328 6001 18 
xvi 
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